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ABSTRACT 
 
Three main morphologies of cell death have been described in the diseased 
myocardium, type I, better known as apoptotic cell death, which is characterized by 
cell shrinkage and chromatin condensation, type II, or cell death with autophagy, 
presents a morphology with intracellular accumulation of autophagic vacuoles and 
type III, better known as necrosis, is characterized by cellular swelling and rapid 
loss in cellular membrane integrity. However, recent literature strongly argues 
against rigid classifications in the context of cell death mechanisms but rather 
suggests to adopt a view of cell death as a dynamic and integrative cellular 
response. Furthermore, the contribution of autophagy in cell death or cell survival 
is still poorly understood. Therefore the aims of this study were twofold: (i) to 
characterize the contribution of each cell death type in context of the severity and 
duration of an ischaemic insult and (ii) to determine whether manipulation of the 
autophagic pathway affects the contribution of cell death and translates into 
protection of the heart.   
 
Rodent derived cardiac myoblast cells were grown in Dulbecco’s Modified Eagle’s 
Medium (DMEM) supplemented with 10% fetal bovine serum (FBS), and incubated 
under 5% CO2 conditions. Cells were submitted to protocols of 2, 4 and 8 hrs of 
simulated ischaemia (SI) under hypoxic conditions in a humidified environment 
containing 0.1% O2, 5% CO2 and the balance N2, followed by 1 hr of reperfusion 
respectively. We employed a modified ischaemic buffer containing either 2-deoxy-
D-glucose, sodium dithionate or both, with the aim to create an ischaemic insult of 
mild (mild SI), moderate (moderate SI) and severe (severe SI) character 
respectively.  
 
We evaluated the contribution of each cell death mode using a combination of 
viability- and ATP assays. Molecular markers for each cell death process such as 
LC3, PARP and HMGB1 were evaluated using 3-dimensional fluorescence 
techniques as well as western blot analysis and flow cytometry. Next, autophagy 
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was induced or inhibited prior to the ischaemic insult, using rapamycin and 3MA 
respectively, and similar parameters were evaluated after 2 hours of mild or 
moderate SI. Propidium Iodide exclusion and Fluorescence Resonance Energy 
Transfer (FRET) in combination with mitochondrial inner membrane depolarization 
were employed to assess the onset of cell death dynamically. Flow cytometry was 
employed to evaluate the degree of protection. In addition, the ATP levels and 
reactive oxygen species (ROS) were evaluated.  
 
Our results strongly indicate a differential induction of cell death, which is 
dependent on the severity and duration of the ischaemic insult. Mild SI led to the 
induction of autophagy and apoptosis, whilst moderate or severe SI induced both 
apoptotic and necrotic cell death without an indication of autophagy. Only mild SI, 
but not moderate and severe SI, resulted in an ATP surge. 
 
Moreover, our data provide direct evidence that increased autophagy delays the 
loss of cellular membrane integrity and delays caspase-3 activation as well as 
mitochondrial depolarization in ischaemic cardiomyocytes. Our results show a 
profound effect of increased autophagy on the onset of apoptosis as well as 
necrosis under simulated ischaemic conditions, providing cellular protection. This 
ATP surge observed during mild SI was abolished with increased autophagy. 
Furthermore, our results indicate a profound effect of autophagy on ROS 
generation. Under normoxic conditions, increased autophagy induced a significant 
decrease in ROS while the inhibition of autophagy significantly increased ROS 
generation. However, when increasing or decreasing autophagy prior to the 
ischaemic insult, ROS increased significantly in both scenarios.  
 
The results suggest that the severity of ischaemia determines the mode of cell 
death differentially. An increase in autophagic responsiveness and flux, as induced 
through rapamycin treatment, provides a selective advantage for tissue against 
injury, possibly by maintaining intracellular ATP levels through the provision of 
metabolic substrates. Autophagy is described as an inherent cellular mechanism 
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which affects the onset of cell death and exhibits protective effects in the ischaemic 
myocardium when upregulated prior to the ischaemic insult.  
 
The protective effect of increased autophagy was mirrored in the isolated perfused 
rat heart model, reflected by improved functional recovery during 
ischaemia/reperfusion.  
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OPSOMMING 
 
Die drie belangrikste morfologiese beskrywings van seldood in die hart sluit die 
volgende in: tipe I, beter bekend as apoptose wat gekenmerk word deur 
selkrimping en chromatienkondensering, tipe II, of seldood deur middel van 
autofagie wat gekenmerk word deur die intrasellulêre versameling van autofagiese 
vakuole en tipe III, beter bekend as nekrose wat gekenmerk word deur sel swelling 
en ‘n vinnige verlies aan membraanintegriteit. Onlangse literatuur waarsku egter 
teen die onbuigsame klassifikasie van seldoodmeganismes en stel voor dat 
seldood as ‘n dinamiese proses met integrerende sellulêre meganismes beskou 
moet word. Die bydrae van autofagie in seldoodmeganismes word ook nog nie 
goed verstaan nie. Die doel van hierdie studie is dus tweevoudig: (i) om die bydrae 
van elke tipe seldood te bepaal in konteks van die felheid en tydperk van die 
iskemiese ingryping en (ii) om te bepaal of the manupilering van autofagie ‘n 
betekenisvolle bydrae lewer in seldoodmeganismes en sodoende tot beskerming 
van die hart kan lei. 
 
Kardiale mioblaste wat van rotweefsel afkomstig is, is in Dulbecco se 
gemodifiseerde Eagle medium (DMEM), waarby daar 10% fetale kalfserum gevoeg 
is en wat onderhewig was aan 5% CO2 toestande, onderhou. Selle was 
onderhewig aan protokolle van 2, 4 en 8 ure gesimuleerde iskemie (SI) onder 
hipoksiese toestande in ‘n humiditeitsomgewing wat 0.1% O2, 5% CO2 en die 
balans N2 bevat. Daarna was die selle onderhewig aan 1 uur reperfusie. ‘n 
Gemodifiseerde iskemiese buffer wat óf 2-deoksie-D-glukose óf natriumdithionaat, 
of beide bevat, is gebruik om lig, matig en strawwe iskemiese toestande na te 
boots. 
 
Die bydrae van elke tipe seldood is geëvalueer tydens bogenoemde toestande 
deur gebruik te maak van ‘n kombinasie van sellewensvatbaarheid- en ATP 
tegnieke. Molekulêre merkers, wat LC3, PARP en HMGB1 insluit, is gebruik om 
deur middel van 3-dimensionele fluoresensie tegnieke, westelike kladtegnieke en 
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vloeisitometrie die verskillende vorme van seldood te ondersoek. Autofagie is ook 
geïnduseer en geïnhibeer voor die iskemiese ingryping, deur middel van 
rapamycin en 3MA, respektiewelik om die rol van autofagie tydens seldood te 
bepaal. Propidium iodite uitluiting en fluoresensie resonansie energie oordrag 
(FRET) in kombinasie met ‘n merker vir mitochondriale binneste membraan 
depolarisasie is gebruik om die aanvang van seldood dinamies te ondersoek. 
Vloeisitometrie is gebruik om die graad van beskerming aan te dui, terwyl 
intrasellulêre ATP vlakke en reaktiewe suurstof spesies (ROS) ook gemeet is. 
 
Ons resultate het getoon dat daar ‘n differensiële indusering van seldood plaasvind 
wat afhanklik is van die felheid en tydsduur van die iskemiese ingryping. ‘n Ligte 
graad van iskemie lei tot die indusering van autofagie en apoptose, terwyl matige 
en strawwe iskemie beide apoptose en nekrose induseer sonder autofagie. Verder 
het slegs ‘n ligte graad van iskemie ‘n skerp styging in ATP tweeggebring, terwyl 
dit nie die geval was tydens matige en strawwe iskemie nie. 
 
Ons data verskaf ook direkte bewyse dat ‘n toename in autofagie die verlies van 
sellulêre membraanintegriteit vertraag. Dit het ook ‘n vermindering in caspase-3 
aktivering en mitochondriale depolarisasie in iskemiese kardiomiosiete 
teweegebring. Die data dui aan dat ‘n toename in autofagie ‘n beduidende effek op 
apoptose en nekrose tydens gesimuleerde iskemiese toestande het om sodoende 
selbeskerming te verskaf. Die skerp styging in ATP wat tydens die ligte graad van 
iskemie teweeggebring is, is opgehef met ‘n toename in autofagie. Ons resultate 
dui ook daarop dat autofagie ‘n beduidende rol in ROS generering speel. Onder 
normoksiese omstandighede veroorsaak ‘n toename in autofagie ‘n insiggewende 
afname in ROS generering, terwyl die inhibisie van autofagie ROS generering 
insiggewend laat toeneem. Wanneer autofagie egter voor die iskemiese ingryping 
verhoog of verlaag word, vermeerder ROS generering in beide gevalle. 
 
Hierdie resultate bewys dat die graad van iskemie ‘n invloed het op die tipe 
seldood wat geïnduseer word. ‘n Toename in autofagie reaksietyd en vloei, soos 
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bewerkstellig deur rapamycin, verskaf ‘n selektiewe voordeel vir weefsel teen 
beskadiging, heel waarskynlik deur die handhawing van intrasellulêre ATP-vlakke 
deur die verskaffing van metaboliese substrate. Autofagie word beskryf as ‘n 
inherente sellulêre meganisme wat seldood beïnvloed en die iskemiese 
miokardium beskerm wanneer dit opgereguleer word voor die iskemiese ingryping. 
Hierdie beskermende rol van autofagie wat in die weefselkultuur waargeneem is, is 
ook in die geïsoleerde geperfuseerde rot hart model waargeneem, waar 
funksionele herstel verbeter is tydens iskemie/reperfusie. 
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Zusammenfassung 
 
Die drei morphologischen Erscheinungen des Zelltodes im Herzen sind Typ I 
Apoptose, gekennzeichnet durch Zellschrumpfung und Chromatinverdichtung, Typ 
II Autophagie, charakterisiert durch die Bildung von Autophagosomen und Typ III, 
Nekrose, gekennzeichnet durch den Verlust der Zellmembranintegrität. Die 
gegenwärtige Literatur postuliert jedoch gegen eine rigide Klassifizierung der 
Zelltodmechanismen und schlägt vor, Zelltod als einen dynamischen und 
integrativen Prozess zu betrachten. Weiterhin wird die eigentliche Beteiligung von 
Autophagie in der Entwicklung des Zelltodes oder an dem Versuch des 
Zellüberlebens kaum verstanden. Der Zweck der vorliegenden Studie ist daher 
zweifach: (i) die Beteiligung eines jeden Zelltodtypes im Verhältnis zur Stärke und 
Dauer eines ischämischen Zustandes zu charakterisieren und (ii) festzustellen, ob 
eine Manipulation des Signalweges der Autophagie diese Beteiligung beeinflusst 
und zu einem Schutz des Herzgewebes beiträgt.  
 
Herzmyoblastzellen wurden in Dulbecco’s Modified Eagle’s Medium (DMEM) und 
10% fötalem bovinem Serum (FBS) kultiviert und unter 5% CO2 inkubiert. Zellen 
wurden einem Protokoll von 2,4 und acht Stunden simulierter Ischämie (SI) unter 
sauerstoffarmen Bedingungen (0.1% O2, 5% CO2 und Stickstoffbalance) 
ausgesetzt, gefolgt von einer Stunde einer Reperfusion. Ein ischämischer Puffer 
versetzt mit entweder 2-deoxy-D-glucose oder Sodiumdithionat oder beidem wurde 
jeweils genutzt, um eine Ischämie von mildem (mild SI), moderatem (moderate SI) 
oder starkem (severe SI) Charakter herbeizuführen.  
 
Die Beteiligung eines jeden der verschiedenen Zelltode wurde durch die Nutzung 
einer Kombination von ATP und Viabilitätstechniken evaluiert. Molekulare Marker 
für jeden Zelltodprozess, wie LC3, PARP und HMGB1 wurden unter der Nutzung 
von drei- dimensionaler Fluoreszenztechnik, Western Blot und 
Durchflusszytometrie evaluiert. Als nächstes wurden Autophagie durch Rapamycin 
und 3MA vor dem ischämischen Zustand induziert oder gehemmt und gleiche 
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Parameter nach zwei Stunden milder und moderater SI evaluiert. Techniken wie 
Propidium Iodide Ausschlussverfahren und Fluorescence Resonsance Energy 
Transfer (FRET) in Kombination mit mitochondrialer Membrandepolarisation 
wurden eingesetzt, um den Beginn oder den Ausbruch des Zelltodes dynamisch zu 
messen. Durchflusszytometrie wurde genutzt, um das Ausmaß des Zellschutzes 
zu evaluieren. Zusätzlich wurden ATP und reaktive Sauerstoffspezies (ROS) 
evaluiert.  
 
Unsere Ergebnisse zeigen deutlich eine differenzierte Zelltodinduktion auf, die in 
Abhängigkeit von der Stärke und Dauer der Ischämie steht. Milde SI führte zu  
Autophagie und Apoptose, während moderate und starke SI Apoptose und 
Nekrose herbeiführte, ohne Anzeichen für Autophagie. Nur milde SI, nicht jedoch 
moderate und starke SI, führte zu einem Anstieg in ATP. 
 
Weitherhin liefern unsere Ergebnisse direkten Beweis dafür, dass induzierte 
Autophagie den Verlust der Zellmembranintegrität und die Aktivierung von 
Caspase-3, sowohl auch mitochondriale Depolarisation in ischämischen Myozyten 
verzögert. Unsere Ergebnisse verdeutlichen einen tiefgreifenden Effekt von 
induzierter Autophagie auf den Ansatz von Apoptose- und Nekrosebeginn während 
simulierter Ischämie, was zum Zellschutz führt. Der während der milden SI 
beobachtete ATP- Anstieg konnte aufgehoben werden, wenn Autophagie induziert 
wurde. Weitherhin zeigen unsere Ergebnisse einen tiefgreifenden Effekt von 
Autophagie auf die Herstellung von reaktiven Sauerstoffspezies. Unter normalen 
Sauerstoffbedingungen führt induzierte Autophagie zu einer Abnahme in ROS, 
während die Hemmung von Autophagie die ROS- Herstellung signifikant erhöht. 
Wenn jedoch Autophagie vor der Ischämie induziert oder gehemmt wird, steigt 
ROS in beiden Fällen an.  
 
Die Ergebnisse weisen darauf hin, dass die Stärke einer Ischämie den Typus 
Zelltod differenziert bestimmt. Ein Anstieg in der Reaktionsfähigkeit und- kapazität 
für den Autophagieprozess, herbeigeführt durch die Vorbehandlung mit 
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Rapamycin, führt einen selektiven Vorteil herbei, der sich schützend auf das 
Gewebe auswirkt. Dies ist möglicherweise durch die Erhaltung des intrazellulärem 
ATP- Gehaltes und durch eine Bereitstellung von metabolischen Substraten 
bewirkt. Autophagie wird hier als ein zellulär innewohnender Mechanismus 
beschrieben, der, wenn induziert, den Ausbruch des Zelltodes zeitlich beiinflusst 
und sich schützend auf das ischämische Herzmuskelgewebe auswirkt.  
 
Die schützende Wirkung von induzierter Autophagie wurde auch im isolierten 
perfusionierten Herzmodell widergespiegelt, in dem sich funktionelle 
Wiederherstellung nach Ischämie/Reperfusion verbesserte.  
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CHAPTER 1   INTRODUCTION 
 
 
1.1. MOTIVATION FOR STUDY 
 
 
The myocardium relies on a highly efficient system of energy conversion as 
sufficient ATP availability is crucial to maintain its contractile function. The ATP 
demand in the heart is extremely high. If this demand cannot be met due to an 
ischaemic event, cardiac myocytes die rapidly with deleterious effects on the 
myocardial tissue. This tissue damage impairs organ function both acutely and 
chronically to an extent that can threaten the patient’s life. The morbidity and 
mortality from myocardial infarction and heart failure remain significant and 
unacceptably high (Kloner & Rezkalla, 2004, Ashrafian et al., 2007).  
 
Two challenges arise when addressing the diseased myocardium, which include 
the dynamics of cell death and the role of autophagy. Cardiac myocytes may die 
through three differential cell death pathways, namely autophagy, apoptosis and 
necrosis. These have previously been described as distinct static processes that 
induce and execute cell death. The accurate distinction between the modes of cell 
death is crucial, because of their association with cell loss in human pathologies 
(Lemasters, 1999, Degterev et al., 2005, Golstein & Kroemer, 2006). However, 
recent advances in reporting real-time data of dying cells suggest that cell death is 
a much more dynamic and molecularly overlapping event than previously 
described. Hence, there is a strong argument against a rigid classification of cell 
death mechanisms (Maiuri et al., 2007, Leist & Nicotera, 1997) which is supported 
by recent recommendations to exercise cautious use of cell death terminologies 
(Kroemer et al., 2009, Kroemer et al., 2005). Moreover, the existence of “grey 
zones” between cell death modes and the existence of the “point of no return” 
(PONR) within these have been revealed. This revelation challenges for the 
integration of new concepts in describing the cellular death process. It motivates 
the current challenge of re-defining and re-describing cell death modes and may 
necessitate a different more dynamic contextualization of known cell death 
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parameters. This may include the need for distinguishing between cells that are in 
the process of dying and dead cells to better locate and control the onset of cell 
death. 
 
Secondly, although autophagy has been described as a mode of cell death, this 
degradation process of redundant or faulty cell components is constitutive in all cell 
types containing a lysosomal compartment. Autophagy occurs as part of the cell’s 
daily activities and as a response to metabolic stress or starvation. However, 
extremely little is known about the role of autophagy in the heart and whether it is 
beneficial for the myocardial energy profile. Limited knowledge is available on the 
effects of autophagy and autophagic flux on the dynamics of apoptosis and 
necrosis onset in context of the intracellular metabolic environment, as well as the 
role of autophagically generated adenosine triphosphate (ATP) in this regard. 
Therefore, when adopting a view of cell death as a dynamic and integrative cellular 
response, the impact of autophagy on the cell’s metabolic capacity and ATP 
availability has also to be assessed integratively.  
 
Using H9c-2 myoblasts as model, the aims of this study are: 
 
(i) 
• to determine the contribution of each death mode in dependency of the 
duration and severity of simulated ischaemia 
• to determine metabolic parameters 
• to determine molecular parameters 
• to relate results to ex vivo model 
 
and (ii) 
• to induce/inhibit autophagy and investigate the onset of cell death 
• to determine necrotic cell death dynamically 
• to determine apoptotic cell death dynamically 
• to determine metabolic parameters 
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• to determine molecular parameters 
• to relate results to ex vivo model 
HYPOTHESIS 
 
 
Firstly, it is hypothesized, that the relative contribution of each mode of cell death is 
dependent on the duration and severity of the ischaemic insult which is governed 
by the cell’s underlying metabolic capacity at a given point in time. Secondly, it is 
hypothesized that the onset of apoptosis and necrosis depends on the cell’s 
autophagic activity prior to the ischaemic event due its impact on the cells 
metabolic capacity.  
 
If the above hypothesis is verified, then autophagy in the metabolically perturbed 
heart has to be re-evaluated as an underestimated contributor to energy-producing 
metabolism, and hence, a novel avenue for metabolic-based treatment.  
 
An in-depth knowledge of the process and mechanism of autophagy, apoptosis 
and necrosis is required, in order to conduct this study. The following literature 
discussion addresses the current understanding of the cell death pathways, their 
molecular aspects in general as well as in the diseased myocardium. 
 
Before that, however, and in line with this discussion and study, I would like to 
draw the attention to an important question: Are cells dying for the sake of dying or 
is cell death a response to ensure the highest likelihood of self preservation? 
Therefore, the biochemical parameters and the morphology which indicate cell 
death might actually be a failed self preservation response. 
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CHAPTER 2 LITERATURE DISCUSSION 
 
 
2.1. Introduction 
 
The concept of damage control in the myocardium was for the first time introduced 
by Braunwald in 1974: “…just because myocardial tissue lies within the distribution 
of a recently occluded artery does not mean that it is necessarily condemned to 
death” (Braunwald, 1974). It has since been the aspiration to therapeutically 
reduce the amount of cell death which may be associated with a better clinical 
outcome. However, despite the development of various interventions to provide 
cardiac protection and to reduce the morbidity and mortality from myocardial 
infarction and heart failure, the residual death rate remains significant (Ashrafian et 
al., 2007). A constant effort is being made to identify therapeutic strategies with a 
growing focus on the improvement of cardiac energetics. Nevertheless, cardiac 
illness ranks as the most frequent cause of mortality, and has reached epidemic 
proportions (Cohen et al., 2000). It has been estimated that, in 10 years time, it will 
be the major cause of death in the world (Murray & Lopez, 1997). 
 
The accurate distinction between the modes of cell death is crucial, because of 
their association with cell loss in human pathologies (Golstein & Kroemer, 2006). 
The recent advances in reporting real-time data of dying cells suggest that cell 
death is a much more dynamic and molecularly overlapping event than previously 
described (Degterev et al., 2005). Currently there is a strong argument against a 
rigid classification of cell death mechanisms (Maiuri et al., 2007, Leist & Nicotera, 
1997) which is supported by recent recommendations to exercise cautious use of 
cell death terminologies (Kroemer & Galluzzi, 2009, Kroemer et al., 2005). This 
motivates the current challenge of re-defining and re-describing cell death modes 
and their underlying mechanism, and may necessitate a different more dynamic 
contextualization of known cell death parameters (Lemasters, 1999). Moreover, 
limited knowledge is available on the effects of autophagy and autophagic flux on 
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the dynamics of apoptosis and necrosis onset within the intracellular metabolic 
environment, as well as the role of autophagically generated adenosine 
triphosphate (ATP) in this regard.  
 
The recognition of extensive cross talk between different cell death pathways 
begins to provide insights into the complexity of the cell death decision making 
process. It becomes clear that cell death with autophagy, apoptosis and necrosis 
molecularly interdigitates on various levels, and thus constructs a dynamic 
response. Its outcome may depend on a cell- specific net result of signals, which 
are governed by the type of insult, its duration, and the intracellular metabolic 
capacity to maintain a favourable cellular environment (Degterev et al., 2005, 
Izyumov et al., 2004, Bonfoco et al., 1995). This suggests the need for 
consideration of stress-, time- and response kinetics and demands precise use of 
multiple detection methods (Klionsky et al., 2008) as well as a clear terminology 
when reporting measured parameters (Kroemer et al., 2009, Kroemer et al., 2005). 
 
In this literature discussion, cell death is viewed as a dynamic and integrative 
cellular response to ensure the highest likelihood of self preservation. Suggestions 
are offered for conceptualizing cell death modes and their morphological features, 
both individually and in relation to one another. It addresses the need for 
distinguishing between dying cells and dead cells so as to better locate and control 
the onset of cell death in the myocardium. Most importantly, the fundamental role 
of autophagy and the effects of the intracellular metabolic environment on the 
kinetics of the cell death modes are stressed.  
 
This discussion will firstly introduce the different types of cell death, discussing 
their current definition and cell morphology. The signalling pathways forming the 
molecular basis for the morphological changes will then be addressed, as well as 
their key- and modulating molecules. The occurrence of each mode of cell death in 
the diseased myocardium will be addressed, as well as detection methodologies 
used to asses cell death. The molecular overlap of cell death pathways will be 
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examined, substantiating the view of a dynamic and integrative response concept. 
Importantly, the context of the energetic condition of the cell will be stressed, with 
the aim of dissecting out the relationship between energy availability, severity and 
duration of cellular stress and mode of cell death. Understanding the dynamic 
nature of the cell death process and autophagy’s central role, new insights for 
therapeutic intervention in preventing cell death might be revealed. 
 
Three main morphologies of cell death are described. Type I: apoptotic cell death, 
(Kerr, 1971) which is characterized by cell shrinkage and chromatin condensation. 
Type II: cell death with autophagy, (De Duve & Wattiaux, 1966, Schweichel & 
Merker, 1973) which presents a morphology with intracellular accumulation of 
autophagic vacuoles. Type III: necrosis, characterized by cellular swelling and 
rapid loss of cellular membrane integrity (Festjens et al., 2006). A cell may show 
morphological or molecular features characteristic of autophagy, apoptosis or 
necrosis without having completely lost membrane integrity, having undergone 
complete nuclear fragmentation or having been engulfed by a neighbouring cell 
(Kroemer et al., 2005). In other words, the cell is in the process of dying but still 
alive, as the membrane disintegration or nuclear fragmentation or engulfment is not 
yet complete. This bears the crucial possibility of cells being salvageable after the 
onset of dying. This view necessitates the recognition that cell death is induced as 
opposed to executed.  
 
2.2. Autophagy  
 
2.2.1. Definition and Role 
 
Cells make use of two major systems for protein degradation, the ubiquitin-
proteasome system for short-lived proteins and the vacuolar degradative pathway, 
also termed the lysosomal system, for long-lived proteins (Yorimitsu & Klionsky, 
2005). The lysosomal system sources its material from intra- or extracellular loci. 
Degradation of exogenous materials and plasma membrane proteins is mediated 
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via endo- and phagocytosis, whilst degradation of cytoplasmic proteins and 
organelles is achieved by autophagy (Yorimitsu & Klionsky, 2005). This non-
selective vacuolar degradation process is a highly conserved pathway within 
eukaryotes. Autophagy, from the Greek self-eating, was first described in 1965 (De 
Duve & Wattiaux, 1966); however, the extent of its physiological importance in 
maintaining cellular homeostasis only recently became clear.  
 
Three types of autophagy are known: (i) chaperone-mediated autophagy (CMA), 
(ii) microautophagy and (iii) macroautophagy (Mizushima, 2005). CMA involves 
selective motif tagged protein translocation directly through the lysosomal 
membrane, (Dice, 2007) microautophagy involves the trapping and engulfing of 
cytosolic regions by lysosomes, and macroautophagy is characterized by the 
formation and accumulation of double membrane intermediate vesicles (Baba et 
al., 1994). Most importantly, macroautophagy is the primary mechanism for 
cytoplasm-to-lysosome delivery and is commonly termed autophagy. The possible 
degree of collaboration between these proteolytic systems (Mizushima, 2007) is 
influenced by growth conditions (Fuertes et al., 2003).  
 
Macroautophagy is the primary mechanism for cytoplasm-to-lysosome delivery, 
and is commonly termed autophagy. Autophagy is the degradation of redundant or 
faulty cell components. This occurs as part of the cell’s daily activities as a 
response to metabolic stress or starvation, which determines the flux through the 
autophagic pathway (Fig 2.1). Autophagy is mediated by a unique organelle, the 
autophagosome, and is constitutive in all cell types containing a lysosomal 
compartment. However, the cellular autophagic capacity varies between tissue 
type and tissue condition and determines a number of pathophysiological 
outcomes. It needs to be stressed that autophagy is a mechanism used by all 
mammalian cells to control and maintain protein homeostasis.  
 
Autophagy not only governs the baseline turnover of intracellular proteins and 
organelles, but also drives the generation of amino acids under nutrient poor 
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conditions.  These generated amino acids are recycled and provide an additional 
energy source for intermediary metabolism, ATP generation and biosynthetic 
pathways. On the one hand, in order to preserve normal cellular function, a fast 
and responsive degradation system for irreversibly damaged proteins is essential 
(the reader is directed to reviews Levine & Yuan, 2005, Codogno & Meijer, 2005, 
Klionsky, 2005, Hamacher-Brady et al., 2006). The dimension of time is crucial in a 
cell’s response scheme. If this autophagic degradation system is not in place, 
proteins will rapidly undergo molecular interactions, leading to their accumulation 
and storage with adverse effects on the intracellular environment (Cuervo, 2004). 
Therefore, this “preventative” mechanism of protein replacement at a baseline 
level, when the cell is still functional, provides rapid adaptation to a changing 
environment and to changing cellular demands.  
 
 
 
 
 
 
 
 
Figure 2.1: Representative cell with extensive accumulation of 
autophagic vaculoles, indicating type II cell death with 
autophagy. Increased autophagy is seen after 40 min of 
myocardial ischaemia (Edinger & Thompson, 2004).  
 
2.2.2. The induction of Autophagy 
 
Since the autophagic degradation mechanism is nonspecific and does not need a 
consensus protein motif, it allows for high capacity bulk degradation. In view of 
pathway flux through a system, this is advantageous, as it brings about a high 
degree of adaptability and efficiency. The identification of the genes underlying this 
process, which are termed autophagy-related-genes (ATG), greatly contributed to 
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the understanding of the molecular pathway and has led to the introduction of an 
ATG nomenclature to describe the molecular control of autophagosome formation. 
Autophagy related genes are designated as ATG and their proteins as Atg. The 
majority of ATG genes are conserved from yeast to human and even in plants 
(Cuervo, 2004). Three basic steps can describe the autophagic pathway:  
 
(1). Formation of isolation membrane and preautophagosome 
(2). Formation of Autophagosome  
(3). Formation of autolysosome 
 
 
(1). Formation of isolation membrane and preautophagosome 
 
Inactivation of mammalian target of rapamycin kinase (mTOR kinase), induce the 
formation of a membrane sac, the isolation membrane, which elongates and 
encloses a fraction of the cytoplasm (Mizushima, 2005). The origin of the isolation 
membrane has not yet been identified; either it could be formed de novo or the 
endoplasmic reticulum (ER) could be the membrane provider (Cuervo, 2004). The 
assembly of what is called a preautophagosome now commences. Two 
coordinated conjugation events (Cuervo, 2004) drive this assembly and elongation 
of participating proteins in the formation of the isolation membrane.  
 
In brief, in the first conjugation system, Atg proteins 5, 7, 10 and 12 undergo 
multimerization with Atg16. This leads to the formation of an Atg16 homotetramer 
which assembles with four Atg12-Atg5 conjugates. This complex exists in the 
cytosol, and only a small fraction of the complex localizes to the autophagic 
isolation membrane throughout the elongation process (Yorimitsu & Klionsky, 
2005). Importantly, the Atg12-Atg5 conjugation is a constitutive process, since the 
complex is formed immediately after Atg12 and Atg5 synthesis, independent of 
starvation induced autophagy.  
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In the second conjugation system, the protein Atg8 is conjugated with 
phosphatidylethanolamine (PE). This process is dependent on Atg7 and Atg3. For 
the process to occur, Atg4, a cysteine protease, c-terminally cleaves Atg8 at a 
specific recognition site (Fass et al., 2007). This provides access to a glycine 
residue, needed for the conjugation of Atg8 with PE, a process mediated by Atg3. 
The first conjugation product is now needed to stabilize the Atg8/PE conjugation 
product. Atg8/PE or its mammalian homologue, microtubule associated protein 1-
light chain 3 (MAP1-LC3) is required as a structural component of the 
autophagosome and is therefore recruited to the autophagosome membrane. The 
two conjugation systems are strongly interdependent. If the first complex is 
defective, the second one cannot be functional (Ferraro & Cecconi, 2007). 
 
(2). Formation of Autophagosome  
 
Two kinase complexes, PI3 kinase and Atg1, participate in the late stages of 
autophagosome formation, inducing tubulation of the autophagosome. Atg6 (and 
the mammalian orthologue, beclin-1) belong to the PI3 kinase (PI3-K) class III 
complex. Phosphatidylinositol 3-phosphate (PIP3), the reaction product of the 
mammalian homologue PI3-K class III, Vps34, is also directed to the 
preautophagosomal membrane. Together with class III PI3-K, it possibly provides a 
scaffold on the post-Golgi membrane for supplying membrane components (Kihara 
et al., 2001). This complex therefore plays a key role in increasing the size of the 
pre-autophagosomal membrane. When Atg1 interacts with Atg13, progression 
towards a complete autophagosome takes place, where complete closure of the 
membrane leads to the sequestration of cytoplasm into a double-membrane 
cytosolic vesicle (Yorimitsu & Klionsky, 2005). At this stage the autophagosome 
maturation process has generated large structures of 300-900 nm. The Atg16-
Atg12-Atg5 complex now dissociates, as the autophagosome formation is 
completed (Yorimitsu & Klionsky, 2005). 
 
(3). Formation of autolysosome 
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The Atg9 membrane protein plays a role prior to the autophagosome closure. 
Fusion of the autophagosome sides to one another is followed by another fusion 
event between the autophagosome and lysosome, generating an autolysosome. 
The former autophagosomal and phagocytosed content now becomes accessible 
to hydrolases, and degradation and recycling can now take place (Cuervo, 2004). 
The degradation process takes place rapidly (5-10 min) due to the enormous 
accumulation of cathepsin proteases. The low pH and a thiolreductase ensure 
substrate denaturation.   
  
2.2.3. Regulation and control of Autophagy 
 
Nutrient deprivation, leading to a shift in the cytosolic AMP/ATP ratio is the usual 
stimulus for autophagy. However, regulation of autophagy induced by nutrient 
starvation seems to be an organ dependent process as it occurs in varying 
degrees in different organs (Yorimitsu & Klionsky, 2005). Autophagy is regulated 
mainly at the sequestration and maturation steps. One may differentiate between:  
 
(1). Regulatory molecules upstream of the autophagic pathway,  
(2). Key regulatory molecules of the autophagic pathway, and  
(3). Modulating molecules, proximal to the autophagic machinery. 
 
(1). Regulatory molecules upstream of the autophagic pathway 
 
It is now generally accepted that mTOR kinase, as a nutrient sensor kinase, 
negatively regulates autophagy. This enzyme, which receives negative input from 
AMPK, may be interpreted as the ‘thalamic gateway to autophagic conscience’. 
mTOR itself is regulated through the class I phosphoinositol 3-kinase (PI3-K), that 
allows membrane binding and activation of Akt/PKB. Class I PI3-K phosphorylates 
phosphatidylinositol-phosphate (PIP) and phosphatidylinositol-4,5-bisphosphate 
(PIP2) to generate phosphatidylinositol-3,4-bisphosphate and phosphatidylinositol-
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3,4,5-trisphosphate (PIP3), which bind via Pleckstrin Homology (PH) domains to 
protein kinase B (PKB/AKT) and its activator phosphoinositide dependent kinase 1 
(PDK-1). Activation of this pathway has an inhibitory effect on autophagy.  
 
mTOR is a sensor for amino acids and ATP and can integrate hormone stimuli via 
the class I PI3-kinase/PKB pathway. The phosphoinosite phosphatase, PTEN, 
positively regulates autophagy by inhibiting the actions of PI3-K (Klionsky, 2005). 
mTOR is controlled by specific amino acids, such as leucine and histidine (Nixon, 
2006). The inhibitory effect of amino acids on autophagy can be relieved by 
rapamycin. Only a few amino acids are required for regulation, the number and 
kind varying among different tissues (Kadowaki et al., 2006).  
 
mTOR acts in two ways: 
 
Firstly, it directly or indirectly causes hyperphosphorylation of the autophagy 
protein Atg13. This protein modulates Atg1, a serine/threonine-specific kinase and 
appears to act as a convergence point for signals that regulate autophagy 
(Neufeld, 2007). When mTOR is not stimulated by nutrients, for example during 
starvation, or when it is inhibited by rapamycin, autophagosome formation is 
favoured and kinase activity of Atg1 increases. On the other hand, when mTOR is 
stimulated by nutrients, Atg13 becomes hyperphosphorylated which reduces its 
affinity to- and association with Atg1. This blocking of the association between Atg1 
and Atg13 results in autophagy not being favoured. There is evidence that Atg1 
might be sufficient to override nutrient signals to induce autophagy, since its over 
expression leads to rapid induction of autophagy (Neufeld, 2007). Furthermore, 
Atg1 overexpression strongly decreases mTOR activity, suggesting an mTOR Atg1 
mutually antagonistic feedback loop possibly amplifying nutrient signals (Neufeld, 
2007). However, the mammalian homologue of Atg1 has not yet been identified 
(Mavrakis et al., 2007). Furthermore, although Atg1 is a key regulator of 
autophagy, Atg substrates in that context have not yet been found (Deminoff & 
Herman, 2007).   
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Secondly, mTOR interacts with a signalling cascade that controls phosphorylation 
of effectors that regulate transcription and translation of specific proteins, some of 
which are required for autophagy (Klionsky, 2005). The protein kinase p70S6K is 
regulated by mTOR and plays a role in protein translation and autophagy activation 
(Klionsky et al., 2005). The inhibition of mTOR is also required to enhance the 
expression of specific autophagic genes, such as Atg8 and Atg14. Autophagy 
sequestration, fusion and degradation are ATP dependent processes. It is 
noteworthy to mention the association of mTOR with the outer mitochondrial 
membrane, where it is ideally situated to sense changes in the ATP/AMP ratio. 
Furthermore it also localizes with LC3-positive membranes, suggesting an 
involvement in the autophagosome maturation step (Mavrakis et al., 2007). 
 
Amino acids play a central role in the regulation of mTOR, and therefore of 
autophagy. The autophagic machinery receives negative regulatory input from 
amino acids through different entry points on the cell. Leucine for example may be 
sensed at the plasma membrane, and can act on mTOR, on Class III PI3-K and 
the ERK signalling pathway, thereby inhibiting autophagy via those three avenues 
(Kadowaki et al., 2006). Other amino acids, such as glutamine, may act via the 
axis of integrins-p38 MAPK pathway, causing cell swelling and inhibition of 
autophagy (Kadowaki et al., 2006).  
 
 
Metabolically, amino acid availability, which is modulated through autophagy, 
affects proteolysis and ATP generation. Amino acids may be the product of 
autophagic protein degeneration and a substrate for the citric acid cycle and ATP 
synthesis.  
 
Recent data suggest that AMPK is required for autophagy in yeast as well as in 
mammalian cells. However, to what extent AMPK induces and mediates 
autophagy, is not known. AMPK negatively modulates protein synthesis, and 
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therefore switches off ATP dependent processes (Dyck & Lopaschuk, 2006). AMP 
binds to AMPK, inducing phosphorylation and activation of AMPK through LKB1 
(Høyer-Hansen & Jäättelä, 2007). Autophagy itself is an ATP dependent 
mechanism and requires a certain degree of ATP input (Meijer & Codogno, 2007). 
Moreover, the cell can then survive for some time by utilizing autophagically 
generated amino acids feeding into the tricarboxylic acid cycle and to synthesize 
new proteins needed to adapt to the altered condition. In many cases, where 
AMPK is known to be activated, autophagic flux is increased. An example is the 
hypoxic environment, where AMPK activation is involved in maintaining energy 
homeostasis.  
 
Autophagy induced by glucose deprivation in cardiac myocytes has been shown to 
inactivate mTOR and to activate AMPK. When AMPK is inhibited, the induced 
autophagic response is inhibited, suggesting a specific role of AMPK for autophagy 
in ischaemic events. Moreover, AMPK may be required for autophagy of 
mitochondria, since inhibition of mitochondrial ATP synthesis promotes massive 
autophagy of mitochondria (Meijer & Codogno, 2007).  
 
(2).  Key regulatory molecules of the autophagic pathway 
 
Atg6/Beclin-1 is an evolutionary conserved protein family that functions in 
autophagy in yeast and mammals, as part of a complex with Class III PI3K/Vps34. 
This interaction is formed via a highly conserved beclin-1 domain, which is needed 
for autophagy to take place (Furuya et al., 2005). It was first described as a protein 
that interacts with bcl-2 in mouse brain, where its overexpression has been shown 
to reduce viral infection and neural cell apoptosis in sindbis virus encephalitis 
(Liang et al., 1998). Due to its properties of interacting with bcl-2 and its structure, it 
has been named beclin. Beclin-1 promotes autophagy as cells with reduced beclin-
1 expression show reduced autophagy (Erlich et al., 2007, Yu et al., 2004). 
Traumatic brain injury has shown to dramatically elevate beclin-1 levels near the 
injury site (Erlich et al., 2006). Furthermore, heterozygous disruption of beclin-1 
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induces spontaneous tumours (Qu et al., 2003, Erlich et al., 2006). The beclin-1 
gene is monoallelically deleted in 40-75% of cases of human sporadic breast, 
ovarian and prostate cancer (Qu et al., 2003). Furthermore, the disruption of 
beclin-1 increases the frequency of spontaneous malignancies and accelerates the 
formation of pre-malignant lesions (Qu et al., 2003). These findings indicate that 
beclin-1 functions as a haplo-insufficient tumour suppressor gene. Furthermore, 
endogenous beclin-1 is frequently expressed at low levels in human breast 
carcinoma epithelial tissue, but is highly and ubiquitously expressed in normal 
breast epithelia (Liang et al., 1999). The protein, beclin-1, is able to shuttle from the 
cytoplasm into the nucleus, where it loses its function in the control of autophagy 
and tumourigenicity.  
 
Most interesting is the finding that beclin-1 binds to bcl-2, an important negative 
regulator of apoptosis. Beclin-1 has recently been identified as a novel Bcl-2-
homology-3 (BH-3) only protein, carrying a BH3 domain. It interacts with Bcl-2 and 
its homologue Bcl-XL (Maiuri et al., 2007). Importantly, BH3 domains of other 
proteins, such as Bad, competitively disrupt this bcl-2/beclin-1 interaction, which 
causes autophagy of mitochondria (mitophagy). However, only ER targeted Bcl-2 
can inhibit autophagy induced by beclin-1, suggesting a spatial organization of 
autophagy and apoptosis control (Maiuri et al., 2007). Bcl-2 inhibits autophagy 
through its direct interaction with beclin1. Bcl-2 downregulation increases 
autophagy. This might possibly function as a homeostat, maintaining autophagy for 
cellular survival (Levine & Yuan, 2005). Beclin-1 physically interacts with several 
Bcl-2 antiapoptotic proteins, an interaction which may be disrupted by proapoptotic 
proteins (Erlich et al., 2007). It has been hypothesized that this interaction may 
sensitize cells to apoptosis, due to neutralizing the antiapoptotic effect and 
additionally inhibiting autophagy (Erlich et al., 2007). 
 
Recent literature points out that the PI3-K signalling pathway also controls 
autophagy, despite its known antiapototic effects (Levine et al., 2008, Sarbassov et 
al., 2005, Petiot et al., 2000). PI3-K belongs to a family of enzymes that 
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phosphorylates the 3’-hydroxyl group on the inositol ring of phosphoinositides. It is 
involved in signal transduction pathways which control, for example, differentiation 
and apoptosis (Petiot et al., 2000, McIlroy et al., 1997). Due to their control of 
proliferation and survival, they are attractive drug targets (Stephens et al., 2005). 
The PI3-K/Akt signalling pathway encompasses enzymes with known anti-
apoptotic functions (Walls et al., 2007). Distinct classes of PI3-K control autophagy 
in opposite directions. The product of class III PI3-K is required for autophagy, 
whilst the products of class I PI3-K have inhibitory effects (Codogno & Meijer, 
2005).  
 
Interestingly, glucose deprived H9c-2 cells, derived from rat cardiomyocytes, have 
been shown to undergo cell death with autophagy, which could be reduced with 3-
methyladenine (3MA), an inhibitor of the autophagic pathway (Aki et al., 2003, 
Seglen & Gordon, 1982). However, when the dominant negative PI3-K class I was 
overexpressed, this mode of cell death was accelerated (Aki et al., 2003). In 
human colon cancer, HT-29 cells, it has been shown that an increase in class I 
PI3-K products reduced autophagy. In contrast, an increase in class III PI3-K 
products stimulates autophagy, which is inhibited when silencing class III PI3-K 
(Petiot et al., 2000). The distinct functional roles of the two families of kinases also 
become clear when considering their product localization. Phosphatidylinositol 3-
phosphate, PI(3)P, has been shown to accumulate to a great extent, but 
transiently, on the phagosomal membrane; however, it is only detectable after the 
phagosome has sealed (Vieira et al., 2001). Class III PI3-K, which is responsible 
for PI(3)P synthesis, is essential for phagolysosome formation, whilst class I PI3-K 
is required for optimal phagocytosis, but not phagosomal maturation (Vieira et al., 
2001). Class III PI3-K is anchored to cytoplasmic membranes via the p150 adaptor 
protein, which is the homologue to the yeast Vps 15 protein. In mammalian cells, 
this adaptor/enzyme complex is associated with the protein, beclin-1. Furthermore, 
distinct roles of the two classes have been described regarding control and 
regulation of the actin cytoskeleton, vesicular trafficking and insulin-stimulated DNA 
synthesis (Siddhanta et al., 1998).  
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(3). Modulating molecules, proximal to the autophagic machinery  
 
A role for MAPKs in the control of the maturation step has been proposed. 
Evidence is provided that especially the MAPK, ERK, is involved in the regulation 
of the autophagosome maturation process. Furthermore, inhibition of p38 has been 
shown to promote autophagosome accumulation (Corcelle et al., 2007). In a 
colorectal cancer cell line, a p38 inhibitor or genetic ablation of p38α kinase 
induced cell cycle arrest and autophagy (Simone, 2007). Furthermore, p38 is 
activated in the regulation of autophagy associated with cell swelling. This process 
is sensitized by integrins, which in turn activates Src to activate p38 and leads 
finally to suppression of autophagy (Codogno & Meijer, 2005). 
 
2.2.4. Autophagy in the myocardium 
 
Already 30 years ago, autophagy has been described in cardiomyocytes and has 
been emphasized as an important repair mechanism during sublethal injury. 
Especially because of the terminally differentiated nature of cardiomyocytes, a 
functional degradative system like autophagy is essential for cellular function. It 
was observed that a fetal mouse heart, kept for 1 h in organ culture, undergoes 
autophagy, which was accelerated by oxygen and glucose deprivation. However, 
its function could be restored following resupply of oxygen and glucose. It was also 
observed that when the period of injury lasted for three to four hours, many cells 
became necrotic (Sybers et al., 1978). Two years later, Decker and co-workers 
observed the initiation of lysosomal autophagy during and after hypoxia in perfused 
rabbit hearts, and highlighted the role of this phenomenon as a repair effort 
employed by cardiac cells (Decker & Wildenthal, 1980).   
 
Thirty years later, autophagy and its role in cell survival and death is a growing 
focus of attention in cardiovascular research; however, only a limited number of 
studies have determined the role of autophagy in the myocardium. For unknown 
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reasons, cell death with autophagy has not previously been considered as a 
significant role player in ischaemia.  
 
Recent studies have demonstrated that autophagy occurs in the hypertrophied, 
failing and hybernating myocardium (Kunapuli et al., 2006). In an 
anoxia/reoxygenation study of isolated cardiomyocytes, the inhibition of autophagy 
caused an inrease in the number of necrotic cells, which was dramatically 
increased when apoptosis was inhibited simultaneously (Dosenko et al., 2006).  
Autophagy is induced by ischaemia and reperfusion (Takagi et al., 2007). 
However, the activation mechanisms seem to differ. Firstly, glucose deprivation but 
not serum starvation strongly induces myocyte autophagy (Matsui et al., 2007). 
Amino acid deprivation also induces autophagy, however not as strongly as the 
former. These results indicate the role of a differential autophagic response, 
depending on the intracellular metabolic microenvironment.    
 
In failing human hearts it has been shown that the three cell death modes act in 
parallel to varying degrees, as assessed by terminal deoxytransferase-mediated 
dUTP nick-end labeling (TUNEL), complement 9- and ubiquitin labelling (Kostin et 
al., 2003). The tissue was sampled from the left ventricular free wall of hearts from 
patients with end stage heart failure due to idiopathic dilated cardiomyopathy. 
However, the exact state of tissue in terms of cell composition, bioenergetics and 
vascularization has unfortunately not been investigated. The incidence of 
autophagic cardiomyocytes in failing hearts has been shown to be greater than the 
incidence of apoptotic cells (Takemura & Fujiwara, 2006).  
 
Autophagy has also been described in the ischaemic myocardium after six 
episodes of ischaemia. An increase in cathepsin D, beclin-1 and other autophagic 
indicators were observed. Most interestingly, apoptosis was activated after the first 
episode, attenuated after three episodes, and then decreased drastically after 6 
cycles. Apoptosis was present primarily in patchy areas of necrosis. These results 
indicate the stress dependent response of the myocardium with all three response 
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schemes, autophagy, apooptosis and necrosis (Yan et al., 2005). It has been 
suggested that autophagy participates in the phase leading from cardiac 
hypertrophy to cardiac failure, and that load-induced activation of autophagy is 
maladaptive, as it amplifies pathological remodelling of the heart (Rothermel & Hill, 
2007). These findings underline the fine line between autophagy as adaptive 
response, and autophagy which becomes maladaptive when, although 
metabolically viable, the cell cannot functionally perform.  
 
2.2.5. Detection Methods for Autophagy 
 
The detection methodology determines the extent of pathway characterization. A 
number of aspects of the molecular machinery can be monitored. However, only a 
limited number of specific molecular marker proteins are available to monitor the 
autophagic process due to lack of differential gene expression. This is the case 
especially for higher eukaryotes. A combination of analytical techniques seems to 
be necessary to gain best insight into the dynamic nature of the autophagic 
pathway (Klionsky et al., 2007).  
 
Transmission electron microscopy (TEM) remains the standard method for 
monitoring autophagy in tissue; however, it is labour intensive and gives no 
indication of the progress within or flux through the autophagic pathway. A growing 
body of evidence suggests that mammalian microtubule-associated protein 1 light 
chain 3, LC3, which functions as a structural component during autophagosome 
maturation, is a reliable biomarker for autophagy (Martinet et al., 2006). The major 
challenge is that the level of autophagosomes, as measured through LC3 
visualization, is not equivalent to the flux through the autophagic system (Brady et 
al., 2006). The punctate and ring-shaped structures of GFP-LC3, which can be 
visualized through fluorescence microscopy, have been proposed as a good 
molecular marker for isolation membranes and autophagosomes (Yorimitsu & 
Klionsky, 2005). Autolysosomes, on the other hand, are only weakly stained 
(Mizushima, 2004). Therefore, this pattern does not indicate the autophagy 
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process per se (Klionsky, 2005). Furthermore, not only can LC3 be present under 
normal nutrient conditions, but is also rapidly degraded during autophagy (Martinet 
et al., 2006). Changes in the steady state concentrations of pathway intermediates 
do not give any conclusive information about the flux through the pathway. Low 
levels of LC3 may in fact be indicative of very active autophagy, and high LC3 
levels may indicate the opposite.  
 
Monitoring lysosomal LC3 turnover in the absence and presence of inhibitors 
would circumvent this problem and has been proposed as a new methodology 
standard (Klionsky, 2005). Inhibition of lysosome activity by protease inhibitors, for 
example, would represent the cumulative autophagic activity at a given time point 
(Mizushima, 2004). Overexpression of GFP-linked LC3, using lysosomal protease 
inhibitors, in combination with TEM, fluorescence microscopy and immunoblotting 
analysis seems to be an elegant and thorough solution for monitoring autophagy. 
Via immunoblotting, the ratio of unlipidated cytosolic LC3-I to autophagosome-
associated phosphatidylethanolamine-modified LC3-II, can be semi-quantified 
electrophoretically (Kabeya et al., 2000). The 16 kD to 18 kD ratio correlates with 
the extent of change in LC3 conversion (Mizushima, 2004). The amount of LC3-II 
clearly correlates with the number of autophagosomes (Mizushima & Yoshimori, 
2007). However, LC3-II itself is degraded by autophagy, making interpretation of 
results problematic. Furthermore, the increase in LC3-II is often much larger than 
the decrease in LC3-I, due to their different immunoreactivity (Mizushima & 
Yoshimori, 2007). A comparison of LC3-II between samples in the presence or 
absence of lysosomal protease inhibitors is again advised, rather than summation 
of LC3-I and LC3-II (Mizushima & Yoshimori, 2007). An increase in the LC3-II 
signal despite the presence of a lysosomal protease inhibitor would indicate 
increase in autophagic flux (Mizushima & Yoshimori, 2007). 
 
A combination with real-time observation in living cells is a feasible approach to 
trace organelle autophagy (Mizushima, 2004) using mitotracker and lysotracker 
dyes. The use of fluorescent LC3 and a counter-fluorescent lysosmal- or 
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mitochondrial marker allows the entire autophagic process to be followed 
(Bampton et al., 2005). Another challenge, however, lies in the fact that the extent 
of LC3 accumulation is cell line dependent (Klionsky, 2005). In some pathologies, 
additional immunohistochemical detection of granular cytoplasmic ubiquitin 
inclusions may be used as an additional indicator for autophagic cell degeneration 
(Martinet et al., 2006). 
 
For immunocytochemistry analysis, care should be taken with the use of 
detergents in the fixation and pemeabilisation protocol, as for example, saponin, 
Triton X-100, CAPS or digitonin have been shown to induce fluorescence puncta 
regardless of autophagy induction (Ciechomska and Tolkovsky, 2007). Also, 
especially in cells transiently overexpressing LC3, aggregates and punctate dots 
containing LC3 have been described, calling for careful interpretation in these 
cases (Kuma et al., 2007). Furthermore, recently a tandem fluorescent reporter 
protein has been suggested to avoid the degradation of GFP-LC3 due to lysosomal 
and acidic conditions. Here a construct using a mRFP-GFP tandem fluorescent-
tagged LC3 has been shown to give useful information about the maturation 
process, as the monomeric red fluorescent protein is stable in an acidic 
environment (Kimura et al., 2007).  
 
 
2.3. Apoptosis  
 
2.3.1. Definition and Role 
 
In the 1960s it was observed that ischaemic liver tissue showed scattered 
hepatocytes in surviving parenchyma, with small masses of cytoplasm and specks 
of condensed nuclear chromatin. The name shrinkage necrosis was suggested 
(Kerr, 1971). Early in the 70s Currie, Wyllie and Kerr detected shrinkage necrosis 
in a set of other experiments, and it became clear that this distinctive form of cell 
death with defined ultrastructural features was an inherent programmed 
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phenomenon with homeostatic function on cell population size (Kerr et al., 1972). It 
was decided to name it apoptosis, a morphological term from the Greek “falling 
off”, as autumn leaves fall off trees in an inherently seasonal manner. This 
homeostatic role of selected apoptosis is manifest, not only in the embryological 
process, but also ongoing in the adult organism, such as in the control of the 
formation and maintenance of glandular architecture (Debnath et al., 2002). 
 
Cell shrinkage is combined with pyknosis (chromatin condensation) and 
karyorrhexis (nuclear fragmentation) (Fig 2.2). At an early stage, condensed 
chromatin tends to marginate in crescents around the nuclear envelope. The 
plasma membrane of the cell begins to bleb, which will lead to apoptotic bodies, if 
phagocytes are not present (Denecker et al., 2001). Apoptosis may be separated 
into phases of initiation or induction, integration or determination and execution. It 
might be of importance to integrate these phases into apoptosis as process, 
represented by the induction- and integration phase versus apoptosis as endpoint, 
represented by the execution phase. These phases would be separated by the 
point of no return, where induction changes to execution. Induction involves the 
introduction of apoptotic stimuli or signals (Takemura & Fujiwara, 2006). During 
determination, the signal is transferred to the nucleus, where it controls expression 
of proapoptotic or prosurvival mediators. In biochemical terms, the execution is a 
well preserved phase of the death machinery.  
 
The term apoptosis was originally used to describe a defined morphology, 
however, criticism has been raised, that the same terminology is now being used to 
describe a concept (Sloviter, 2002). The exact description of molecular and 
morphological events has therefore been urged (Kroemer et al., 2009).  
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Figure 2.2: Type II, apoptotic cell death. This type of cell death is 
morphologically characterized by cell shrinkage and pyknosis, 
and occurs after 2-4 hrs of coronary artery occlusion (Edinger & 
Thompson, 2004). 
 
 
 
2.3.2. Pathway of Apoptosis 
 
The signal for apoptosis can either arise from the extracellular or intracellular 
environment, giving rise to an intrinsic and extrinsic apoptotic pathway (Galluzzi et 
al., 2007). The intrinsic pathway of apoptosis relies on mitochondria to integrate 
and release a number of regulatory components that subsequently activate 
caspase proteases, which in turn cleave death- inducing substrates. Central to the 
intrinsic pathway are mitochondria, which in this context, are literally a matter of life 
and death in the cell. For life, due to their crucial role as ATP provider through the 
process of oxidative phosphorylation, for death, due to their role in sequestering 
pro-apoptotic signals and in releasing cytochrome c, required for cytosolic 
caspase-9 activation. Moreover, mitochondrial Ca2+ uptake has been shown to be 
critical in initiating depolarization of mitochondria and propagating an apoptotic 
signal by mitochondrial waves (Pacher & Hajnóczky, 2001). In contrast, the 
extrinsic pathway relies on extracellular death ligands, which transmit the signal via 
caspases within the cytoplasm, which ultimately activate the same executioner 
caspases as employed by the intrinsic pathway.   
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Caspases have been subdivided into subfamilies, based on their substrate 
preference and extent of sequence identity. Functionally, caspases can be 
classified into three groups. Firstly there are initiator caspases, containing a death 
effector domain (DED), such as caspase-8 and caspase-10, or a caspase 
activation and recruitment domain (CARD), such as caspase-2 and -9. Both 
domains interact with complementary domains from adaptor proteins in order to 
cluster initiator caspases and subsequently to induce autoproteolysis. Secondly, 
there are effector or executioner caspases, such as caspase-3, -6 and -7, which 
contain short prodomains. Lastly, there are also caspases involved in immune 
control. Importantly, activated initiator caspases induce a proteolytic cascade with 
all benefits of signal amplification, by activating downstream effector caspases 
(Kunapuli et al., 2006). Caspases are synthesized as zymogens, which can be 
activated by either proteolytic cleavage, by self activation or through interaction 
with a regulatory subunit (Hengartner, 2000).  The caspases cleave a restricted set 
of target proteins at a position after an aspartate residue. Close to 100 caspase 
substrates have been suggested, indicating the complexity of this molecular death 
programme.   
 
A number of models have been developed for the mitochondrial release of 
apoptogenic factors, however, none of them has been proved. They involve either 
pore/channel formation in- or rupture of the outer mitochondrial membrane. In this 
pathway, the mitochondrial outer membrane permeability (MOMP) is activated and 
triggers the release of apoptogenic factors such as cytochrome c, apoptosis 
inducing factor (AIF), SMAC (Second mitochondria-derived activator of 
caspase)/DIABLO (Direct IAP-Binding Protein with low pI) and the serine protease, 
Omi/HtrA2. The mitochondrial membrane permeabilization (MMP) has been 
considered as point-of-no-return in the process of apoptosis. Cytochrome c 
contributes to caspase-9 activation via the formation of a cytosolic apoptosome 
complex with subsequent caspase-3 activation.  
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The integrity of the mitochondrial membrane is largely under the control of the Bcl-
2 family (Denecker et al., 2001). At least 20 members of the Bcl-2 family have been 
identified, all sharing at least one Bcl-2 homology (BH) domain. MOMP is regulated 
by members of the Bcl-2 family. Members of this family can homodimerize, but can 
also form pro/anti-apoptotic heterodimers (Hengartner, 2000).  This capability gives 
rise to a large number of dimer combinations within a cell, providing a large 
information network pool, which can sensitize or desensitize the cell to commit to a 
death pathway, including the neutralization of signals (Hengartner, 2000).  The bcl-
2 family of proteins can be divided into three groups, based on their conserved bcl-
2 homology domains. The prosurvival members are Bcl-2, Bcl-XL, Bcl-w and A1, 
which all contain BH1-4 domains. Bcl-2 is anchored to the outer mitochondrial and 
endoplasmic reticulum membrane and blocks the release of mitochondrial 
cytochrome c into the cytoplasm (Grandgirard et al., 1998). The proapoptotic 
members, on the one hand, can be further divided into those containing only one 
BH3 domain, the so called BH3-only proteins. These include Bad, Bid, Bik, Bmf, 
Bim, Hrk, Noxa and Puma and act as apoptosis sensors. On the other hand there 
are members such as Bak, Bax and Box, which contain multi-BH3 domains and 
serve as executioners of apoptosis (Shroff et al., 2007). Importantly, cell death 
during anoxia occurs via the bcl-2 regulated intrinsic apoptotic pathway (Shroff et 
al., 2007). Whilst anti-apoptotic Bcl-2 and Bcl-xl block MOMP, the pro-apoptotic 
BH3-only proteins, Bim and Bid promote MOMP via activation of the multi-domain 
proteins Bax and Bak (O’Connell & Stenson-Cox, 2007).  
 
The extrinisic pathway relies on extracellular death ligands to recruit and integrate 
adapter proteins that recruit the initiator caspases-8 and 10. In brief, extracellular 
death signals, such as TNF-α or Fas-L, bind to their receptor, inducing it to form a 
trimeric complex, which then recruits a number of intracellular adaptor proteins, 
forming a complex known as death-inducing signalling complex or DISC. DISC 
formation leads to the recruitment and activation of the initiator caspases (Kunapuli 
et al., 2006), which starts the proteolytic cascade. Caspase-8, once activated, 
cleaves and activates procaspase-3 as well as Bid. In that way Bid connects the 
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extrinsic and intrinsic pathway, as truncated Bid triggers the activation of Bax and 
Bak with subsequent cytochrome c release.    
 
Both extrinsic and intrinsic pathways merge on the level of execution with caspase-
3, which is activated and whose proteolytic activity results in cell death. Caspase 
mediated cleavage of the nuclear lamins is required for nuclear condensation and 
fragmentation (Hengartner, 2000).  However, a network model of this simplistic 
dichytome pathway view has been suggested, taking into account that different 
components of the death machinery differ in their impact on system performance 
(Kimchi, 2007). In this context, high throughput genome screening of cells exposed 
to death signals identified a large number of death promoting genes, encoding so 
called death associated proteins (DAP) confirming this model (Kimchi, 2007). One 
of the most extensively studied proteins is DAP-kinase, a Ca2+ regulated Ser/Thr 
kinase, whose substrates are involved in membrane blebbing and cell death with 
autophagy (Kimchi, 2007). It has therefore been suggested that this kinase acts as 
a molecular switch, driving the cell’s phenotypic outcome in different directions.  
 
2.3.3. Modulating molecules of the apoptotic pathway 
 
A large number of molecules inducing apoptosis have been described. However, 
the signalling mechanism within the network of pro-apoptotic triggers is less well 
understood. In particular, the molecular overlap of the signalling pathway inducing 
apoptosis in context with the cell’s metabolic profile remains to be elucidated.  
 
Biological oxidants, peroxynitrite, free radicals, and superoxides have been shown 
to be triggers of apoptosis (Levrand et al., 2006). Mitogen activated protein kinases 
(MAPKs) play a distinct role in modulating apoptosis and therefore, the fate of the 
cell (Wang et al., 1998). Induction of apoptosis in HeLa cells using H2O2 caused a 
sustained activation of all three MAPK subfamilies, namely extracellular signal-
regulated protein kinase (ERK), c-Jun N-terminal kinase/stress-activated protein 
kinase (JNK) and p38 (Wang et al., 1998). Apoptosis was enhanced when ERK 
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activation was inhibited (Wang et al., 1998). In this model, however, p38 inhibition 
had no effect on apoptosis. Furthermore, it has been shown that c-Jun N-terminal 
kinase/stress-activated protein kinase (JNK) inhibitory mutants almost double their 
rate of apoptosis, induced by oxidative stress and reperfusion injury (Dougherty et 
al., 2002). Interestingly, ERK has been shown to induce α-enolase, a rate limiting 
enzyme in the glycolytic pathway (Mizukami et al., 2004). Therefore, a direct ERK 
modulated molecular link might exist between ATP availability and induction of 
apoptosis (Mizukami et al., 2004). 
 
Local metabolic conditions and the intensity of the initial insult determine the 
prevalence of either apoptosis or necrosis (Nicotera et al., 1999). There is 
evidence that this decision is controlled on both the mitochondrial and caspase 
activation levels (Stridh et al., 1999). In both in vitro and in vivo studies where ATP 
was depleted by phosphate-trapping carbohydrates such as fructose, TNF-induced 
apoptosis was completely blocked (Latta et al., 2000). In glucose deprived rat 
neonatal cardiac myocytes exposed to hypoxia, a significant positive correlation 
between myocyte ATP concentration and percentage apoptotic cells has been 
described. In particular, ATP generation through glycolysis is a determinant of the 
form of cell death, independent of cellular acidification (Tatsumi et al., 2003). This 
indicates that a possibly preferred apoptotic mode of cell death with caspase 
activation can be replaced by an ATP independent pathway, such as necrosis. On 
the other hand, several caspases may possibly have vital functions that are not 
death related, indicating that their activation may not always indicate cell death 
(Nicotera et al., 1999). Interestingly, loss of mitochondrial transmembrane potential 
and cytochrome c release has been observed in both apoptotic and necrotic cells 
(Shiraishi et al., 2001, Tatsumi et al., 2003).  
 
Interestingly, proteolytic mediators involved in necrotic cell death, such as 
cathepsins, have also been described as role players in apoptosis (Leist & 
Jäättelä, 2001). This view is supported by the notion that the caspase inhibitor 
zVAD-fmk efficiently blocks cathepsin B (Leist & Jäättelä, 2001). Moreover, 
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interactions between cathepsins and caspases, such as cathepsin B mediated 
caspase-3 activation, might synergistically control the induction of either apoptosis 
or necrosis (Yamashima, 2000, Yamashima, 2004). Other physiological factors, 
such as hormonal feedback mechanisms also appear to have an impact on 
apoptosis induction (Zhu et al., 2006). 
 
2.3.4. Apoptosis in the myocardium 
 
Over the last 10 years, increasing evidence has suggested an important role for 
apoptosis in myocyte death (Takemura & Fujiwara, 2006). Myocardial apoptosis 
has been detected in a number of cardiovascular pathologies such as 
ischaemia/reperfusion injury, myocardial infarction, hypertrophy, heart failure and 
hypoxia. In experimental models for myocardial infarction it has been shown that 
particularly in the first 2-4 hours of coronary artery occlusion, most cell death 
manifests with apoptotic morphology (Kajstura et al., 1996). Importantly, research 
indicates that apoptosis is deeply involved in the pathology of almost all types of 
heart disease. Due to the central position of apoptosis, which occurs most likely 
time wise between cell death with autophagy and necrosis, this is of particular 
importance. TUNEL positive cells are especially increased at the borders of 
subacute and old infarcts, indicating apoptotic cell death which might be dependent 
on the metabolic environment across the injury. Moreover, bcl-2 has been shown 
to be overexpressed in the surviving cardiomyocytes around the acute infarcted 
region (Takemura & Fujiwara, 2006). 
 
There is substantial evidence that the MAPKs ERK, p38 and JNK are activated in 
cardiac myocytes in response to stress. For example, in rat neonatal cardiac 
myocytes exposed to ischaemia, a rapid activation of these MAPKs is observed. 
Reoxygenation further activates the MAPKs, which lead to morphological 
characteristics of apoptosis in 18% of cells (Yue et al., 2000). However, when 
pretreated with an ERK inhibitor, the number of cells showing apoptotic 
morphology increased to 33%, indicating a protective role of ERK. On the other 
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hand, p38 and JNK have been shown to mediate apoptosis in cardiomyocytes 
subjected to ischaemia/reperfusion (Yue et al., 2000). Other models have shown 
an increase in JNK activation only upon reperfusion, but not by ischaemia alone 
(Engelbrecht et al., 2004). Antisense oligonucleotide treatment targeting JNK 
isoforms revealed that the JNK1 isoform plays a preferential role in apoptosis 
induced by ischaemia/reperfusion (Hreniuk et al., 2001).   
 
2.3.5. Detection Methods for Apoptosis 
 
Usually a combination of techniques is employed to report morphological features 
and to assess the process of apoptosis (Krysko et al., 2008). Various 
methodologies are available to describe and quantify the characteristic 
morphological and molecular changes associated with apoptosis. Electron 
microscopy is the gold standard for diagnosing apoptosis, providing most 
convincing evidence for the presence of an apoptotic morphology and 
ultrastructure (Takemura & Fujiwara, 2006).  A number of biochemical markers 
have been used to identify the onset of apoptosis. DNA fragmentation into 180-200 
base pairs, manifesting in a DNA ladder, can be assessed through gel 
electrophoresis - the DNA ladder is opposed to the DNA smear found in necrosis.  
 
Furthermore, the TUNEL assay has been used widely for apoptosis detection, 
where the dUMP is attached to the 3’ end of DNA, which is then visualized using 
fluorescence microscopy. However, false positive TUNEL results have demanded 
additional techniques. Another hallmark for apoptosis is the loss in membrane 
polarization, leading to translocation of phosphatidyl serine from the inner to its 
outer leaflet. Phospholipid binding proteins, such as Annexin-V, interact in a Ca2+ 
dependent fashion with phosphatidyl serine, which can be visualized through 
immunocytochemical techniques, using flow cytometry or microscopy.  
 
An efficient clearance mechanism of dying cells is crucial for tissue homeostasis, 
not only for modulation of immune responses, but also for a functional living 
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organism in general. In vivo, under pathological conditions, apoptosis and necrosis 
may often co-exist (Nicotera et al., 1999). In this regard it has been demonstrated 
that necrotic cells can also externalize phosphatidylserine, a hallmark for early 
apoptosis, indicating - at least in part - a controlled mechanism of necrotic cell 
death (Krysko et al., 2006). Another emerging technique to detect apoptosis is 
time-lapse imaging. Time-lapse imaging allows morphological changes to be 
followed, and gives insight into the dynamics of apoptosis as process. A 
combination of epifluorescence- and differential interference contrast- microscopy 
allows molecular- and general cell morphology to be monitored (Krysko et al., 
2008). Furthermore, changes in the nucleus through pyknosis or karyorrhexis lead 
to specific patterns of cellular granularity or internal complexity, which can be 
examined through fluorescence microscopy or flow cytometry.  
 
Flow fluorocytometry is effectively employed to identify morphological changes, 
simply through the characterization of the forward and side scatter pattern of a 
given cell population. Cell permeable fluorochromes, such as propidium iodide, and 
surface markers such as Annexin V, can be used to distinguish early and late 
stage apoptotic cells from necrotic cells (Krysko et al., 2008). Immunoblot detection 
techniques or multi-colour fluorescence microscopy are widely used techniques to 
determine subcellular protein redistribution of cytochrome c or AIF, and are often 
used in combination with colocalization studies using mitochondrial markers. As 
caspase-3 cleavage and downstream poly (ADP-ribose) polymerase (PARP) 
cleavage are crucial components within the apoptotic pathway, their activation and 
cleavage in living cells can be used to determine the onset of apoptosis 
dynamically. Using fluorescence-resonance energy transfer (FRET) with a suitable 
FRET pair, possessing the caspase-3 cleavage sequence, the cellular commitment 
to apoptosis can be visualized and temporal and spatial interrelationships 
described (Tyas et al., 2000).  
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2.4. Necrosis  
 
2.4.1. Definition and Role 
 
Necrosis, from the Greek “death, causing to die”, is a degenerative process in 
which cellular integrity is completely lost, causing the cell to die (Hamacher-Brady 
et al., 2006). The term has been used for about 2 000 years to define drastic 
changes in tissue, visible to the naked eye (Kunapuli et al., 2006). Necrosis is 
characterized by cytoplasmic swelling, irreversible plasma membrane damage and 
irreversible changes in the nucleus such as pyknosis, karyorrhexis and karyolysis 
as well as organelle swelling and breakdown (Fig 2.3) (Festjens et al., 2006). 
Necrosis has historically been described not as a controlled mode of cell death, but 
rather as a passive and accidental process that is a consequence of physical and 
chemical stress. However, recent literature shows that necrosis is a result of a well-
orchestrated interplay of signalling cascades, with an extensive crosstalk between 
biochemical and molecular events on various cellular levels. Furthermore, some 
signalling molecules, which play a role in autophagy and apoptosis, are also found 
to take part in this “programmed necrosis” (Edinger & Thompson, 2004). 
Physiological settings where necrosis occurs, include immune defence 
mechanisms, chondrocytes in the mammalian growth plate, ovulation and colon 
epithelial cell turnover (Festjens et al., 2006). Programmed necrosis has been 
described in actively proliferating cells in response to DNA damage, where it was 
initiated through hyperphosphorylation of the DNA repair protein, PARP (Edinger & 
Thompson, 2004). Moreover, necrosis has been implicated in a number of 
pathological settings, such as neurodegenerative diseases, stroke and ischaemia. 
It has also been described as a role player in tumour promotion and growth (Han et 
al., 2008).   
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Figure 2.3: Type III, necrotic cell death. This morphology is 
seen in the central zone of myocardial infarction (Edinger & 
Thompson, 2004). 
 
 
2.4.2. Pathway of Necrosis 
 
Different experimental systems representing various cell types and death inducers 
have demonstrated a common sequence or programmed course of intracellular 
events specific to necrotic cell death. This sequence includes mitochondrial 
dysfunction and swelling, ROS production and perinuclear clustering, ATP 
depletion, loss of Ca2+ homeostasis as well as the activation of calpains and 
cathepsins with subsequent lysosomal- and plasma membrane rupture (Golstein & 
Kroemer, 2006). It has been suggested that necrosis serves as the cell’s default 
pathway, as inhibition of apoptosis and autophagy can induce necrosis (Golstein & 
Kroemer, 2006). This is the case when the mitochondrial membrane 
permeabilization (MMP) is suppressed and at the same time pro-apoptotic proteins 
and beclin-1 are knocked out. In other models the deletion of functional caspases 
is sufficient to induce necrotic cell death. Both cases show that apoptotic signalling 
directs the pathway flux and the apoptotic capacity determines at what time point 
this new pathway is entered. Sufficient ATP is needed for caspase activation as 
well as for the rearrangements of the cytoskeleton for trafficking and clustering. 
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ATP generation, either via glycolysis or mitochondrial oxidative phosphorylation, is 
needed to execute nuclear pyknosis, DNA fragmentation and phosphatidylserine 
exposure (Denecker et al., 2001). Most interestingly, due to the PARP induced 
rapid cytoplasmic NAD depletion, glycolysis is inhibited, inducing an ATP 
dependent necrotic cell death (Edinger & Thompson, 2004). This would indicate 
that PARP activation runs a metabolic test on the cell, which results in a decision 
between necrosis or cell survival and DNA repair. Inactivation of PARP through 
caspase mediated cleavage would preserve the intracellular ATP pool and would 
allow apoptosis to proceed and to be completed (Denecker et al., 2001). How 
much PARP induced DNA repair a cell can metabolically afford, before entering 
necrosis, remains to be elucidated.  
 
Necrotic cells are found in the central zone of the infarct, indicating a relationship 
between the mode of cell death and the metabolic microenvironment of the tissue. 
In the setting of acute myocardial infarction, there is a need for therapy that 
reduces the amount of necrosis, leading to a better clinical outcome (Kloner & 
Rezkalla, 2004). Necrotic cell death of cardiomyocytes is a major contributor to 
heart failure associated with cardiac pathologies such as ischaemia/reperfusion 
injury (Tavernarakis, 2007). It is therefore crucial to understand the underlying 
molecular mechanisms generating the cellular morphology so characteristic for 
necrosis. PI3-kinase is known to activate glucose metabolism. In myoblasts dying 
from hypoxia- induced necrosis, PI3-K accelerates this mode of cell death, due to 
its acidosis inducing effects (Aki et al., 2001). This highlights the role of glucose 
metabolism and anaerobic glycolysis in hypoxia and its effect on the mode and 
extent of cell death (Aki et al., 2001). 
 
2.4.3. Regulation and control of Necrosis 
     
The current state of knowledge cannot yet provide clear distinctions between 
induction, propagation and execution of necrosis. Death receptors, belonging to the 
TNF-receptor super family, play a crucial role in transmitting extracellular stimuli 
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and to induce a stress response. The pleiotropic cytokine and ligand TNF-α 
mediated receptor-induced necrosis has been well described in L929 cells 
(Denecker et al., 2001, Denecker et al., 2001), which can be inhibited with 
antioxidants or a respiratory chain complex I inhibitor, indicating the profound role 
of ROS generation. In contrast to apoptotic cells, cells undergoing necrosis are still 
able to synthesize proteins (Saelens et al., 2005), which supports the fact that 
necrosis may also be programmed. Synthesis of proteins is sustained and the rate 
remains constant until the cell loses its membrane integrity. It has been suggested 
that this extended time window for protein translation might result in newly 
synthesized products that alert other cells, or can provide “danger” signals for 
immune competent cells.   
 
2.4.3.1. Inducing and key molecules 
 
Death receptors can elicit non-apoptotic, caspase independent cell death, that 
appears necrotic, through the receptor-interacting protein (RIP). When RIP 
expression is reduced, a decrease in autophagic cell death can be observed (Yu et 
al., 2006). It has been suggested that the kinase, RIP1, acts as a main initiator and 
propagator of necrosis. It has been demonstrated that TNF-induced programmed 
necrosis can be inhibited by caspase-8 cleavage of RIP or by RIP deficiency (Chan 
et al., 2003). Furthermore, this caspase independent death, induced by the Fas 
ligand, is absent in cells deficient of the Fas-associated death domain (FADD) 
(Holler et al., 2000). FADD is an important adaptor molecule which is situated 
upstream from RIP1. RIP1 knockout models have shown protection against 
necrosis in L929 cells. When caspase-8 is suppressed, a RIP1 dependent non-
apoptotic cell death has been described in macrophages treated with LPS. 
Furthermore, the reduction of caspase-8 expression also shows features of 
autophagy, indicating that caspase-8 can regulate both apoptotic and non-
apoptotic cell death (Holler et al., 2000). 
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It has also been shown that DR signalling in the presence of caspase inhibition 
triggers an alternative non-apoptotic cell death pathway that showed morphologies 
of both necrosis and autophagy. It has therefore been termed necroptosis 
(Degterev et al., 2005). The same group identified a small molecule out of a large 
chemical library screen, termed necrostatin-1, which inhibits this morphological 
picture (Degterev et al., 2005). Most interestingly, necrostatin has been shown to 
potently inhibit all examples of DR induced necrosis, such as in TNF-α treated 
L929 cells, or necrosis induced through RIP kinase activity. These results suggest 
the existence of a common DR mediated pathway (Degterev et al., 2005). The 
pan-caspase inhibitor z-VAD-fmk has been shown to induce autophagy and 
necrotic cell death in macrophages, but not in muscle cells such as vascular 
smooth muscle cells or C2C12 myoblasts (Martinet et al., 2006). This observed 
sensitivity has been attributed to a differential expression level of RIP1, suggesting 
that caspase inhibition causes RIP activation and subsequent autophagy. These 
data indicate that Fas, TRAIL and TNF-receptors can initiate cell death via two 
signalling mechanisms, the caspase-8 and RIP dependent pathway. Moreover, RIP 
has shown to be a substrate of caspase-8, which enhances TNF-induced 
apoptosis. Caspase-8 might therefore play a role as a molecular crossover point 
between extrinsic apoptotic and necrotic cell death (Lin et al., 2007). Furthermore, 
overexpression of bcl-2 can delay the onset of TNF-α induced necrosis. Most 
interestingly, this does not manifest in early cytochrome c release. It is plausible 
that the binding of bcl-2 to beclin-1 creates a molecular link between autophagy 
and necrosis. Furthermore, the second messenger, ceramide, which is generated 
through sphingomyelin hydrolysis accumulates before the onset of caspase-
independent cell death. RIP1 knockdown protected cells against TNF-α induced 
ceramide generation and cell death, indicating sharing of the same pathway 
between ceramide and RIP1.   
 
Necrotic cells are phagocytosed only after loss of membrane integrity, which 
provides them with a time window to activate and release pro-inflammatory 
molecules. One such pro-inflammatory molecule, which is passively released in 
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necrotic cells, is the protein high mobility group box I (HMGB1). In the nucleus it 
acts as an architectural component, binding to chromatin. Outside the cell it 
functions as an inflammatory mediator. The high mobility group proteins are small 
DNA-binding proteins that play an important role in the control of transcription. 
Some members of this group have also been shown to exert extracellular 
functions. They are also termed alarmins, denoting host proteins that are rapidly 
released during infection or tissue damage, and that have mobilizing and activating 
effects for host defence and tissue repair (Apetoh et al., 2007). HMGB1 is released 
by activated macrophages as well as necrotic cells, and in turn activates more 
macrophages to secrete angiogenetic factors (Schlueter et al., 2005).  
 
Most interestingly, HMGB1 rapidly leaks out of necrotic cells, but not from apoptotic 
cells. It has been observed that in activated monocytes, HMGB1 redistributes from 
the nucleus to endolysosomes, indicating a non-classical, vesicle mediated 
secretion pathway (Gardella et al., 2001). Whether necrotic cells show a similar 
HMGB1 release pattern, is not clear (Gardella et al., 2001).   
 
2.4.3.2. Modulating molecules 
 
Calcium homeostasis is crucial for cellular signalling. Ca2+ is to a large extent 
stored in the ER, and its release is tightly regulated. It is also a positive effector of 
mitochondrial function. Ca2+ overload leads to excessive stimulation of the TCA 
cycle, with an overproduction of ROS.  It has therefore been suggested that Ca2+ 
acts as an amplifier of necrosis. Furthermore, tissue acidosis, which is a result of 
excessive anaerobic glycolysis, increases Ca2+ influx and contributes to Ca2+ 
overload. The interplay of phospholipases (particularly the Ca2+ dependent cPLA2, 
which cleaves arachidonic acid (AA) out of phopholipid bilayers) with ROS to 
generate lipid peroxides, may contribute to the disruption of organelle- and plasma 
membranes. Contribution of cPLA2 to necrotic cell death has previously been 
indicated (Sapirstein & Bonventre, 2000). In a model of ischaemic injury, we have 
recently shown a p38 driven cPLA2 translocation pattern, with a possible role for 
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cPLA2 in deciding cell fate (Loos et al., 2008). Translocation processes, however, 
are dependent on a functional cytoskeleton to provide a framework for molecular 
trafficking. The cytoskeletal actin filament is important, not only to maintain 
architectural integrity of the cell, but also plays a role in regulating cell survival and 
death. Actin has been shown to be involved in the re-distribution process of 
mitochondria during TNF-α induced necrosis. Furthermore, it has been 
demonstrated that the inhibition of F-actin reorganization with cytochalasin in an 
ischaemic model with cardiomyocytes, prevents the onset of apoptosis (Okada et 
al., 2005). Furthermore, F-actin reorganization has also been shown to play a role 
in protection against necrosis induced by osmotic stress, during reoxygenation 
(Okada et al., 2005).  
 
ATP availability plays a crucial role in determining the onset of necrosis, and has 
been described as a switch from apoptosis to necrosis (Leist et al., 1997). A 
growing body of knowledge suggests that ATP availability determines the mode of 
cellular death. A highly interesting study has been performed in human T cells, 
which showed an ATP dependent switch in the decision making between apoptotic 
and necrotic cell death. When ATP depletion was achieved through pyruvate, to 
allow only mitochondrial ATP production, apoptosis was induced. However, when 
treated with a blocker of mitochondrial synthesis, cells died necrotically. 
Furthermore, an ATP depletion of >50% was needed to change the mode of cell 
death from apoptotic to necrotic (Leist et al., 1997). Restoration of glycolytic ATP 
generation was sufficient to allow apoptosis to take place. Nitric oxide (NO) has 
also been shown to drive the decision making process between apoptosis and 
necrosis through NO-dependent failure of mitochondrial ATP synthesis. In this 
model, cells undergoing apoptosis converted to necrosis, a process which could be 
reversed by replenishing the cells by glucose supplementation (Leist et al., 1999).  
Moreover, a protective role for bcl-2 in this context has been described, where ATP 
depleted and bcl-2 transfected cells were treated with the apoptosis inducer, 
staurosporine (Single et al., 2001). In the ischaemic myocardium, it has been 
shown that ATP levels at reperfusion were replenished faster and necrosis was 
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reduced, when using an ATP-hydrolase inhibitor (Grover et al., 2004). These 
results provide evidence for an ATP dependent onset of necrosis. On the other 
hand, the observation that translation persists during necrosis of Jurkat and L292 
cells speaks against a massive loss in intracellular ATP (Festjens et al., 2006).  
 
2.4.4. Detection Methods for Necrosis 
 
The evaluation of cell morphology and cellular membrane integrity is a hallmark for 
detecting necrotic cell death. Cellular swelling and membrane damage can be 
evaluated with light, fluorescent or electron microscopy methods. The most 
commonly used techniques often address cellular membrane integrity with 
fluorescent dyes, such as propidium iodide (Saelens et al., 2005), or the 
nonspecific DNA degradation process resulting in the characteristic DNA smear 
compared to the 200bp fragments occurring in apoptosis. Membrane integrity can 
also be assessed through monitoring the release of enzymes, for example lactate 
dehydrogenase, which is measured indirectly spectrophotometrically through 
NADH. However, recently immunohistochemical analyses of key role players such 
as HMGB1 have also been employed, where its release into the cytoplasm was 
indicative of necrotic processes. Moreover, the onset of lysosomal membrane 
integrity loss and the subsequent cathepsin B release resulting in a diffuse 
cytoplasmic signal pattern, is also employed (Carloni et al., 2007). In the 
myocardium, immunohistochemical detection of the ninth component of 
complement (C9), part of the membrane attack complex (MAC) has been shown to 
be a useful marker for necrosis, especially in tissue undergoing autolysis or when 
inflammatory infiltration is less obvious (Lazda et al., 2000). Moreover, 
immunohistological C9 staining has shown to be a simple, reliable and sensitive 
method, especially for the detection of early necrosis (Doran et al., 2007). Another 
advantage in this method is the usability of paraffin wax embedded material. Even 
within necrotic myocardial tissue, different states of cell death depending on 
cellular function have been described, such as coagulation necrosis, coagulative 
myocytolysis and colliquative myocytolysis (Baroldi, 1974).  
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The mitochondrial permeability transition (MPT) has been described as a causative 
event in necrotic cell death induced by oxidative stress or ischaemia/reperfusion 
injury. Using confocal microscopy, its onset can be visualized by the redistribution 
of the cytosolic fluorophore, calcein, into depolarized mitochondria (Lemasters et 
al., 1998). Cyclosporin A, which blocks the MPT, prevents necrotic cell death in 
response to a number of injury types. Moreover, as the onset of MPT occurs in 
increasing numbers of mitochondria, it has been proposed that the cellular 
response proceeds in the order of autophagy, apoptosis and finally necrosis. The 
progression to the next death mode is at least in part dependent on cellular ATP 
levels (Lemasters, 1999). The release of creatine kinase as a measure of 
membrane integrity and nuclear staining with ethidium homodimer-1 are also 
widely used techniques to assess necrosis (Shiraishi et al., 2001).  
 
2.5. Dynamics within modes of cell death 
 
2.5.1. Defining the PONR 
 
Although the existence of the point-of-no-return (PONR) is still controversial, 
unravelling the identity of a restriction point for cell death could be highly 
significant, as it could lead to a better understanding of the time point when a cell is 
still salvageable. The PONR enables the distinction of cell death induction from cell 
death execution; of cell death as a process from cell death as endpoint and thus 
the distinction between a living and an already dead cell. A better understanding of 
locating and characterizing the PONR may introduce novel interventions to 
modulate its position, so as to increase the chance of reversibility for the benefit of 
cell survival. Similar to the need for cautious use of nomenclature for cell death, a 
clear report on parameters and a combination of techniques are needed to indicate 
the position of the PONR. Mitochondrial membrane permeabilization has been 
considered as the PONR in many models of programmed cell death (Galluzzi et 
al., 2008, Leber et al., 2007, Galluzzi et al., 2007) Other parameters have also 
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been indicated such as: caspase activation (Youle & Strasser, 2008, Golbs et al., 
2007) governed by Bcl-2 family proteins, a point beyond which interference with 
caspase cannot salvage the cell (Rami et al., 2008) and the dissipation of 
mitochondrial transmembrane potential ∆Ψm (Galluzzi et al., 2007) or cytochrome 
c interactions (Kagan et al., 2009).  
 
However, only a dynamic perspective on the position of the PONR can reveal its 
significance. The PONR indicates that the cellular stress response is highly 
dynamic and characterized by organellar population kinetics, (Pacher & Hajnóczky, 
2001) permeability kinetics, release kinetics, diffusion and transport kinetics. These 
in turn will determine accumulation kinetics, thresholds, degradation capacity and 
turnover kinetics. This suggests that not only apoptosis, but necrosis and cell death 
with autophagy may also be delineated by the cell’s PONR. As the cell death 
process is not static, but rather a net result of regulatory networks, the PONR is 
unlikely to be restricted in position. A common theme of these regulatory networks 
is a perturbation in ATP and mitochondrial function, linking stress signal 
transduction pathways to regulators which control characteristic (Ferraro et al., 
2008) and often progressively developing (Lemasters et al., 1999) morphological 
changes. Control of the PONR position through the cell’s metabolic efforts would 
ensure the highest likelihood of cellular preservation. 
 
2.5.2. Conceptualizing the PONR 
 
A conceptual model which considers kinetics, for understanding the dynamic 
interrelationship between autophagy, apoptosis and necrosis is therefore 
proposed. According to this model, characteristic morphological features for each 
cell death mode are layered in the z-dimension, where the z-distance between 
them indicates the process and endpoint of dying, separated by the PONR. The 
features (Fig 2.4) are titled: 1 - “autophagy baseline”, which indicates a viable cell 
with basal autophagic flux, 2 - “autophagy induced” indicating increased 
autophagic flux beyond basal levels, 3 - “cell death with autophagy”, indicating 
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excessive autophagy, 4 - “apoptosis induced”, indicating the onset of the apoptotic 
cascade, 5 - “apoptosis executed” indicating the endpoint of apoptotic cell death, 6 
- “necrosis induced”, indicating the onset of a leaky membrane, and 7 - ”necrosis 
executed”, indicating complete loss of membrane integrity. In experimentally 
controlled conditions, a “pure” morphology and type of cell death may often be 
described. As a basal level of autophagic flux is inherent to all eukaryotic cells with 
a lysosomal system, (Codongo & Meijer, 2005) feature 1 is indicated in any given 
stress response and mode of cell death. Cell death with autophagy is thus 
represented by features 1, 2, and 3, apoptotic cell death by features 1, 4, and 5 
and necrotic cell death by features 1, 6, and 7 (Golstein & Kroemer, 2006, 
Degterev et al., 2005, Maiuri et al., 2007).  
 
2.5.3. Assessing the PONR  
 
When endogenous regulators that control the intracellular metabolic environment 
and cell death, (Klionsky et al., 2008, Golstein & Kroemer, 2006, Kroemer et al., 
2009, Festjens et al., 2006) are examined according to this model, their role in the 
time process of cell death may be indicated more clearly. Any control condition can 
thus be described as stage 1 with a cell- and tissue specific basal autophagic flux, 
and  the sum of all kinetic parameters can indicate the cell’s or tissue’s position 
(stages 2-7) within this dynamic model. Moreover, the effect of specific 
endogenous modulators or signalling events such as the release and translocation 
of key molecules may be dissected out in their relation to the PONR and the stages 
of this model. However, in order to asses the PONR, a combination of 
recommended detection methods (Klionsky et al., 2008, Golstein & Kroemer, 2006, 
Kroemer et al., 2009, Festjens et al., 2006) is suggested. Further it is suggested 
that kinetic parameters for autophagy, apoptosis and necrosis as well as cell 
specific parameters, intra- and extracellular metabolic parameters and insult 
parameters be carefully considered (Table 2.1). For example, a combination of 
data on basal autophagic flux, (Hamacher-Brady et al., 2006, Klionsky et al., 2008, 
Klionsky, 2008) the time needed to reach its maximal attainable activity, as well as 
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vital dye uptake dynamics (Clausen & Gissel, 2005, Miyata et al., 2006, Ramadass 
& Bereiter-Hahn, 2008) and onset of dissipation of mitochondrial transmembrane 
potential ∆Ψm (Galluzzi et al., 2007) should be placed into context with the cell’s 
metabolic substrate preference and ATP household over time (Ferraro et al., 2008) 
in order to describe the PONR. It is crucial that multiple parameters be acquired at 
multiple points in time, and examined in context with one another, to capture the 
dynamic character of temporal signalling during cellular response. This approach 
may be aided by: (i) increased utilization of live cell imaging techniques which 
report the dynamics of dye exclusion between the onset of a leaky membrane up to 
the loss of its integrity during necrosis or (ii) assessment of the time scale of 
caspase activation through fluorescence resonance energy transfer (FRET) 
microscopy (Li et al., 2009, Tyas et al., 2000). To allow increased understanding of 
such dynamic events on a cell population level, this approach may be strengthened 
by data generated from living cells with fluorescence- activated cell sorting, 
particularly when tandem dyes are available (Shvets et al., 2008).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
Table 2.1: Suggestions of kinetic parameters to be acquired to complement 
for the assessment of autophagy and cell death dynamics. It is advised to
as measured (e.g. FRET e
‘%autophagy’, ‘%apoptosis’, ‘%necrosis’, 
parameters in relation to one another.
 
 
 
 
 
 
 
 
 
 
fficiency, intensity profile in arbitrary units), avoiding terminology like 
 ‘% viability’, and to contextualize the listed 
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 detection methods 
 report acquired data 
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Figure 2.4: Model of typical appearance of different types of cell death.  Cells are 
counterstained for LC3 (green), actin (red) and nuclei (blue). Fluorescence 
micrographs indicate morphological features for cell death with autophagy 
(micrograph 1, 2 and 3), apoptosis (micrograph 1, 4 and 5) and necrosis 
(micrograph 1, 6 and 7). Cell death with autophagy is indicated with increasing 
accumulation of autophagic vacuoles (micrograph 2 and 3), apoptosis shows cell 
shrinkage, nuclear pyknosis and karyorrhexis (micrograph 4 and 5) and necrosis 
shows cell swelling, membrane impairment and karyolysis (micrograph 6 and 7). 
The z-distance between the micrographs may indicate the process and endpoint of 
dying, separated by the point-of-no-return, PONR. 
1 1
3
2
7
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2.6. Dynamics between modes of cell death 
 
A growing body of knowledge disputes the view that the cell death process is 
merely one static “suicide” pathway a cell commits to, but rather argues that it is 
the net result of a dynamic integrative signalling network, which permits molecular 
overlap and grey zones. Recognition of the extensive cross talk between different 
cell death pathways begins to provide insight into the complexity of the cell death 
decision-making process. Although in many conditions a distinct morphology of 
one of the above types of cell death may be encountered, multiple pathological 
conditions present themselves with morphological overlap (Degterev et al., 2005, 
Lockshin & Zakeri, 2004). As the position of the PONR is likely to be dynamic, so is 
the onset of cell death modes. This contributes to the shared morphological 
features. Furthermore, the order of the appearance of morphological 
characteristics for cell death with autophagy, apoptosis and necrosis over time may 
not necessarily suggest a preferred cellular way of dying, but may rather result 
from the metabolic condition that governs the cell’s stress response at that point in 
time. Importantly, autophagy appears to be a central and upstream role player 
when cells respond to metabolic perturbations (Karantza-Wadsworth et al., 2007). 
Autophagy helps cells avoid a metabolic crisis and thus affects the downstream 
cell death pathways. The cell protects itself from dying, therefore autophagic 
activity has an impact on the onset of other death modes through intricating the 
cell’s metabolic balance sheet. Cell death may therefore be viewed from the 
perspective of a dynamic response that provides cellular adaptability to a given 
stressful condition which can, context specific, extend into the process and 
endpoint of death (Kroemer et al., 2009). If there is a genetically encoded cellular 
intention, then it is likely to foster a will for survival as opposed to death. The 
overlap of autophagy, apoptosis and necrosis pathways, their onset and the PONR 
position translates time dependently into the observed morphology and cellular 
survival rate. It is therefore important to understand these dynamics, because only 
then can the opportunities presented, by delaying an onset of cell death, as 
opposed to inhibiting a pathway, be utilized.  
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Figure 2.6: The overlap of autophagy, apoptosis and necrosis pathways, their onset and 
the PONR position translates time- dependently into the observed morphology and 
cellular survival rate. The cell’s response to an insult is highly dynamic and 
morphological features between the death modes can overlap. The control of the PONR 
position through the cells metabolic efforts would maintain a high survival rate, ensuring 
highest likelihood of cellular preservation. 
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2.6.1. Greyzones Autophagy/Apoptosis 
 
The dynamic relationship between autophagy and apoptosis is most clear before 
the activation of caspases is triggered (Debnath et al., 2005). Similar stimuli can 
either induce autophagy, apoptosis or both because several signals are shared 
between them. Autophagy may end with apoptosis and apoptosis may begin with 
autophagy. Caspases and autophagy can be simultaneously activated within a 
dying cell (Yu et al., 2004). Cells with substantial amounts of autophagic vacuoles 
mostly do not die (Lockshin & Zakeri, 2004). Cells with high levels of autophagy 
induced by Atg1 over-expression present themselves with a hybrid cell death-
showing cell death with autophagy and apoptotic characteristics (Neufeld, 2007). 
When using caspase inhibitors, their survival is enhanced (Neufeld, 2007). 
 
There is an indication that autophagy occurs or is de-inhibited, when apoptosis is 
not functional. In cells that are unable to undergo Bax/Bak mediated apoptosis 
(Bax/Bak-/-), irradiation massively upregulates autophagy, which suggests that 
autophagy may be the first line of defence against a cellular insult. Fibroblasts from 
double knockout Bax-/- Bak-/- respond with substantial autophagy followed by 
delayed cell death, when treated with DNA-damaging agents (Maiuri et al., 2007). 
In addition, autophagy not only limits metabolic stress but also minimizes genomic 
instability (Lockshin & Zakeri, 2004). These findings support the dynamic response 
concept of autophagy mediating a direct onset delay of apoptosis. Apoptosis-
deficient cells with functional autophagy machinery induce additional autophagy 
under stress which increases the likelihood of recovery. In support of the concept 
of cell death being dynamic is the recent investigation of caspase regulatory 
network dynamics, where the use of live cell reporters revealed a partial state of 
cell death, which can persist for hours (Albeck et al., 2008). 
 
The inverse relationship between autophagy and the onset of apoptosis is likely to 
manifest when decreasing or inhibiting autophagy. If the autophagic energy control 
mechanism is inhibited, apoptosis competent cells become sensitized and undergo 
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apoptosis earlier. The use of inhibitors of autophagy leads to cell death through 
apoptosis which can be reduced with caspase inhibitors (Boya et al., 2005). Cells 
which are deprived of the cytoprotective functions of autophagy might be more 
vulnerable and sensitized to insult. This view is supported by the notion that RNAi 
against beclin-1 and atg5 enhances starvation- induced apoptotic cell death 
(Levine & Yuan, 2005). A decrease in autophagic responsiveness and flux may 
induce tissue injury earlier, due increased accumulation of damaged protein 
aggregates and large dysfunctional mitochondria, leading to increased ROS, 
defective ATP generation, less efficient metabolic pathways and a decrease in 
lysosomal stability. Loss of lysosomal integrity leads to a release of lysosomal 
hydrolases into the cytosol (Wattiaux & Wattiaux-De Coninck, 1984) which brings 
about an inhibition in autophagic maturation, contributing to the accumulation of 
dysfunctional mitochondria. This process sensitizes cells to pro-apoptotic signals 
(Kiselyov et al., 2007). The inactivation of lysosome-associated membrane protein-
1 (LAMP1), through RNA interference, inhibits the fusion of autophagosomes and 
lysosomes in HeLa cells, which adopt characteristics of both autophagy and 
apoptosis (Gonzalez-Polo et al., 2005).  
 
2.6.2. Greyzones Apoptosis/Necrosis 
 
Despite a possible direct onset delay of necrotic cell death we, however, propose 
that the profound effect of autophagy on necrosis is brought about indirectly. The 
indirect onset delay of necrosis is due to autophagy’s role in causing onset delay of 
apoptotic cell death. This necessitates a closer look at the cell’s metabolic 
performance in the light of the dynamic relationship between apoptotic and necrotic 
cell death. Common denominators for both apoptotic and necrotic cell death are 
triggers such as hypoxia, heat shock, viruses or oxidative stress, and second 
messengers such as Ca2+, capase-8 or stress-dependent transcription factors 
(Leist & Nicotera, 1997). It is suggested that necrosis serves as the cell’s default 
pathway, as it can be induced by the inhibition of apoptosis and autophagy 
(Golstein & Kroemer, 2006). It is important to note that ATP availability plays a 
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crucial role in determining the onset of necrosis. When ATP depletion is achieved 
in the cell through culture in glucose-free medium with pyruvate, allowing only 
mitochondrial ATP production, apoptosis is induced. However, when cells are 
treated with a blocker of mitochondrial ATP synthesis, necrosis is induced. ATP 
depletion of >50% is needed to change the mode of cell death from apoptotic to 
necrotic (Leist et al., 1997). Also, restoration of glycolytic ATP generation is 
sufficient to allow apoptosis to take place. We propose that autophagically 
generated amino acids and substrate intermediates may be involved in maintaining 
ATP at sufficient levels for longer, thus delaying the switch from apoptosis to 
necrosis. Conversely, when autophagy is dysfunctional or an additional autophagic 
response is not occurring timely, one may speak of an indirect premature onset of 
necrosis.  
Despite the above described ATP- dependent effect on apoptosis and necrosis, 
nitric oxide (NO) has also been shown to drive the decision-making process 
between apoptosis and necrosis through NO-dependent failure of mitochondrial 
ATP synthesis. In this model, cells undergoing staurosporine induced apoptosis 
converted to necrosis, where the cell’s ability to activate caspases and undergoing 
apoptosis could be recovered when replenished with glucose supplementation 
(Leist et al., 1999). 
 
In the ischaemic myocardium it is demonstrated that ATP levels at reperfusion are 
replenished faster and necrosis is reduced when using an ATP-hydrolase inhibitor 
(Grover et al., 2004). In glucose- deprived rat neonatal cardiac myocytes exposed 
to hypoxia, a positive correlation between myocyte ATP concentration and the 
percentage of apoptotic cells is described. By increasing the glucose 
concentration, apoptosis progressively replaces necrotic cells, (Tatsumi et al., 
2003) underlining the importance of substrate availability in the cell death decision-
making process. ATP generation, through either glycolysis or mitochondrial 
oxidative phosphorylation, is needed to execute nuclear pyknosis, DNA 
fragmentation and phosphatidylserine exposure (Denecker et al., 2001). It may be 
speculated that the duration and severity of the insult determines whether 
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autophagy can be induced timely, in order to have an effect on the cell’s ATP 
household. It also becomes clear that the cell’s inherent ATP supply and demand 
behaviour influences the prevalence of either apoptosis or necrosis (Nicotera et al., 
1999).   
 
2.6.3. Greyzones Autophagy/Necrosis 
 
Recent studies also show a molecular link between autophagy and necrosis. It is 
suggested that necrosis manifests as a result of an unsuccessful autophagic stress 
response (Maruyama et al., 2008), which supports our view that autophagy is 
induced as a stress response to increase likelihood of survival. When autophagy 
and apoptosis are inhibited in mouse- derived photo-receptor cells, necrotic cell 
death is induced (Kunchithapautham & Rohrer, 2007). It was also observed that a 
foetal mouse heart kept for 1 hr in organ culture undergoes autophagy followed by 
progressive necrosis (Artal-Sanz & Tavernarakis, 2005, Sybers et al., 1976). This 
confirms that autophagy acts as the first line of defence during a stress response.  
 
The heart’s capacity for sensing ROS and reacting to it through increased 
degradation of oxidatively damaged proteins to maintain intracellular ATP may lead 
to a direct onset delay of necrosis. This scenario may be the case during death 
receptor-induced necrosis, where ROS is generated from either mitochondrial or 
non-mitochondrial sources (Morgan et al., 2008). On the one hand, the autophagic 
removal of oxidatively damaged mitochondria may preserve the cell for a specific 
time which may depend on the intensity and duration of the initial insult (Bonfoco et 
al., 1995). On the other hand, mutation studies demonstrated that 
autophagosomes and lysosomes synergize as proteolytic systems to facilitate 
necrosis (Samara et al., 2008). This suggests that autophagy may be using 
proteases that also mediate necrosis or that parts of the machinery for apoptosis 
and necrosis are recruited to complete execution initiated by autophagy. Despite 
the close relationship of proteolytic systems in autophagy and necrosis, another 
level of pathway interaction becomes clear, as autophagically generated amino 
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acids such as glutamine may act through the integrin-p38 mitogen-activated 
protein kinase (MAPK)- pathway, causing cell swelling and inhibition of autophagy 
(Ravikumar et al., 2003). This interaction suggests that necrosis can be induced 
when autophagic capacity is insufficient to maintain a favourable environment. In 
C. elegans, autophagy is induced early during necrotic cell death (Samara et al., 
2008). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.7: ATP- dependent relationship between autophagy, apoptosis 
and necrosis. Autophagy induces direct and indirect onset delay of 
apoptosis and necrosis through ATP generation and removal of damaged 
mitochondria and apoptotic stimuli. Energy homeostasis is more likely to 
be maintained. 
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2.7. Cell death with autophagy – a rare exception? 
 
The exact contribution of cell death with autophagy and its role in 
pathophysiological conditions remains to be elucidated. Only a few conditions are 
known where cell death with autophagy functions as a physiological mechanism. In 
cells of salivary glands of Drosophila larvae, autophagy is not a failed survival 
attempt, but rather a physiologically controlled cell death mechanism (Bergmann, 
2007). Moreover, cell death with autophagy also seems to play a role in 
cardiovascular diseases such as degenerative aortic valve disease (Mistiaen et al., 
2005). In these rare cases, autophagy may be a “complete” cell suicide mode 
(Nixon, 2006). The other point of view is that excessive levels of autophagy can 
induce cell death with autophagy without the activation of caspases, leading to a 
degradation of organelles with a preservation of the cytoskeleton until late stages 
(Levine & Yuan, 2005). Cells that lack critical apoptosis regulators appear to die 
with massive amounts of autophagic vacuoles, (Debnath et al., 2005) possibly 
compensating for the defects in apoptosis. Thus it can be argued that there is 
some indication that cell death with autophagy, when excessively induced, is due 
to bioenergetic failure (Ferraro & Cecconi, 2007). Such cases deserve more study 
in highlighting the central role of the cell’s metabolic capacity. 
 
2.8. Conclusion and future outlook 
 
This review emphasizes the importance of understanding cell death as a dynamic 
response concept by discussing the dynamics within and between cell death 
modes. By proposing a conceptual model for understanding the dynamic 
interrelationship between autophagy, apoptosis and necrosis it is hoped that this 
can contribute towards clarifying cell death definitions and processes in order to 
accelerate communication. It is also hoped that it can shed light onto the centrality 
of autophagy within the cell death machinery in context of cellular energy 
homeostasis and its effect on the onset of apoptosis and necrosis. It becomes 
apparent that kinetic parameters such as autophagic capacity, its response time 
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and the cell’s metabolic capacity may affect the PONR and offer opportunities for 
cell survival. The importance of locating and characterizing the PONR has been 
stressed, as this may introduce novel interventions to modulate the PONR position, 
interventions which may be applied to increase the chance of reversibility for the 
benefit of cell survival. 
 
The high degree of plasticity in the induction and execution of cell death will require 
the use of more sophisticated and inclusive assays. The use of advanced real- 
time observation techniques in combination with simulated network models (Huber, 
et al., 2007) will offer clues to unravel the dynamic behaviour of cellular 
commitment to survival and may offer the platform for analyzing the position of 
each PONR between the individual death modes. Moreover, it is hoped to have 
shown that autophagic response parameters provide additional time to the process 
of dying, and thus ultimately increase the window of opportunity for novel 
therapeutic interventions.  
 
This review highlights that new treatment strategies may focus on delaying the 
onset of each death mode, rather than inhibiting it. Such strategies may be based 
on a combined therapy, targeting autophagic as well as apoptotic pathways 
(McMullen et al., 2004). Most crucially, the role of autophagy in delaying the onset 
of cell death by the modification of cellular metabolic performance deserves more 
study. 
 
 
2.9. Hypothesis 
 
 
In this study it is hypothesized, that the relative contribution of each mode of cell 
death is dependent on the duration and severity of the ischaemic insult, and is 
governed by the cells underlying metabolic capacity at a given point in time. 
Secondly, it is hypothesized that the onset of apoptosis and necrosis depends on 
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the cell’s autophagic activity prior to the ischaemic event due to an impact of 
autophagy on the cells metabolic capacity.  
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CHAPTER 3    MATERIALS AND METHODS 
 
3.1. Antibodies and chemicals 
 
The following antibodies were obtained from Cell Signaling Technology (MA, USA): 
cleaved caspase-3 antibody (Asp 175) and PARP antibody, pAMPK, mTOR. The 
antibody specific to HMGB1 was purchased from Santa Cruz Biotechnology 
(California, USA). LC3 antibody was obtained from Nano Tools (Germany) and 
beclin-1 was obtained from Assay Designs (MI, USA).  Tissue culture tubes, 50 ml 
and 15 ml were used from Greiner Bio-One (Germany). Sterile serological pipettes 
(25 ml and 10 ml) were obtained from LP Italiana SPA and Sterilin Ltd. Pipette tips 
were purchased from Greiner Bio-One. Culture medium, Dulbecco’s modified 
Eagle’s medium (DMEM) was obtained from Highveld (South Africa), trypsin and 
phosphate buffered saline (PBS) from SIGMA-ALDRICH (South Africa) and tissue 
culture flasks and -dishes, cell scraper and microcentrifuge tubes were purchased 
from Greiner Bio-One (Germany). Chambered coverglass slides were used from 
Nunc Lab-Tek (Lab-Tek, 155411, USA). Syringe millipore filter, trypan blue 
reagent, albumine bovine serum (BSA) and Bradford reagent were obtained from 
SIGMA-ALDRICH (South Africa). For the gel electrophoresis a Mini-Protean BIO 
RAD system was used. Ammonium persulfate was purchased from SIGMA-
ALDRICH (South Africa), Acrylamide/bis-Acrylamide from Promega (South Africa) 
and N,N,N,N’-Tetramethylethylendiamin from MERCK (Germany). 
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Antibodies and Markers 
 
Primary 
antibody for 
western blot 
    
Antibody Company/Catnr Host Size (kDa) Dilution 
LC3 Nano Tools 
0231-100/LC3-
5F10 
Mouse 
Monoclonal 
LC3-I: 
18kDa 
LC3-
II:16kDa 
30µl:5000 µl 
Beclin-1 Assay Designs 
905-721-100 
Rabbit 
polyclonal 
~ 57kDa 4µl:5000 µl 
Caspase-3 
(corresponding 
to amino acids 
28-44) 
Cell Signaling 
#9665 
Rabbit 
monoclonal 
17,19,35 
kDa 
5µl:5000 µl 
Cleaved PARP  
(Asp 214) 
Cell Signaling 
#9541 
Rabbit 
monoclonal 
89 kDa 6µl:5000 µl 
pmTOR 
(Ser 2448) 
Cell Signaling 
#2971 
Rabbit 
monoclonal 
289 kDa 5µl:5000 µl 
pAMPKα 
(Thr 172) 
Cell Signaling 
#2535 
Rabbit 
monoclonal 
62 kDa 5µl:5000 µl 
Secondary 
antibody for 
western blot 
    
Antibody Company/Catnr Dilution 
  
Anti-Rabbit 
IgG 
Horseradish 
Peroxidase 
linked 
ECLTM 
NA934V 
 
1.25µl:5000 µl   
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Polyclonal 
Rabbit anti 
mouse 
 
Dako 
Cytomation 
 
1.25µl:5000 µl 
  
 
Primary 
antibody for 
immuno 
fluorescence 
    
Antibody Company/Catnr Host Size (kDa) Dilution 
LC3 Nano Tools 
0231-100/LC3-
5F10 
Mouse 
Monoclonal 
LC3-I: 
18kDa 
LC3-
II:16kDa 
1:50 
Actin Santa Cruz 
Sc-1616 
Rabbit 
polyclonal 
~ 42kDa 1:50 
Cytochrome-c Santa Cruz 
Sc-13560 
Mouse 
monoclonal 
~ 12kDa 1:50 
Beclin-1 Assay Designs 
905-721-100 
Rabbit 
polyclonal 
~ 57kDa 1:50 
HMGB1 Santa Cruz 
sc-26351 
Goat polyclonal ~ 25kDa 1:50 
 
Secondary 
antibody for 
immuno 
fluorescence 
    
Antibody Description Company/Catnr  Dilution 
 
Donkey anti-
rabbit FITC 
 
F(ab’)2 
Fragment 
AEC-
Amersham 
711-096-152 
1:200  
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Donkey anti-
goat FITC 
 
 
F(ab’)2 
Fragment 
 
AEC-
Amersham 
705-096-147 
 
1:200 
 
Donkey anti-
mouse FITC 
 
F(ab’)2 
Fragment 
AEC-
Amersham 
715-096-151 
1:200  
Donkey anti-
rabbit Texas 
Red 
F(ab’)2 
Fragment 
AEC-
Amersham 
711-076-152 
1:200  
Donkey anti-
rabbit FITC 
 
F(ab’)2 
Fragment 
AEC-
Amersham 
711-096-152 
1:200  
 
 
3.2. Experimental animals 
 
Male Wistar rats weighing 220-240 grams were used. Institutional and international 
ethical guidelines were applied with respect to the handling of experimental 
animals. Before experimentation, rats were allowed free access to food and water. 
Animals were anaesthetized with pentobarbital (50 mg/kg) administered 
intraperitoneally before experimentation. Animals were weighed before excision of 
the heart.  
 
3.3. Cell culture preparation 
 
3.3.1. Cells 
 
H9c-2 rat heart myoblasts (European Collection of Cell Cultures – ECACC, Kimes 
& Brandt, 1976), were seeded at 12 000/cm2, and cultured in Dulbecco’s modified 
Eagle’s medium supplemented with 10% fetal calf serum, 4% glutamine and 1% 
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penicillin/streptomycin in a humidified atmosphere, 37°C, in the presence of 5% 
CO2. In detail, cells were washed with 0.01 M sterile phosphate-buffered saline, 
(PBS), trypsinized (0.25% Trypsin – EDTA), centrifuged for 3 min at 6000 x g and 
seeded as follows: 3x105 myoblasts per 25 cm² tissue culture flask, 1x105 
myoblasts per culture dish in six-well plates and 2x104 myoblasts per 8 chamber 
slide. Growth medium was changed every 48 hrs.  
 
3.3.3. Passaging protocol 
 
Cells were passaged when reaching 70-80% confluence. Growth medium was 
discarded and cells rinsed with warm (37°C), steril e PBS. Warm (37°C) 0.25% 
trypsin-EDTA (3 ml) was added and cells were incubated until cells detached from 
the surface (3-4 min). Culture medium (double the volume of trypsin used; 6 ml) 
was added to the cell suspension, which was then transferred to a 15 ml falcon 
tube, centrifuged for 3 min at 6000 x g. Medium was decanted and cells re-
suspended in fresh medium, aliquots for new flasks were made as required 
according to the seeding density.   
 
3.4. Simulated ischaemia (SI) and reperfusion 
 
Control cells were kept under normoxic conditions and 5% CO2. The simulated 
ischaemia lasted for 2, 4 and 8 hrs. Cells were washed with sterile PBS and 
incubated with a filtered sterilized modified ischaemic buffer (Esumi et al., 1991), 
pH 6.4, containing (in mM): 137 NaCl, 12 KCl,  0.5 MgCl2, 0.9 CaCl2, 20 Hepes, 20 
2-deoxy-D-glucose (2DG, Sigma, D-8375), or 0.5 sodium dithionite (SDT, Fluka, 
BioChemika, 71699), or 2DG and SDT under hypoxic conditions in a humidified 
environment containing 0.1% O2, 5% CO2 and the balance N2, followed by a 60 
min washout time under normoxic conditions with growth medium. We employed 
the modified ischaemic buffer (Esumi et al., 1991) with either 2-deoxy-D-glucose 
(Fuglesteg et al., 2008), sodium dithionate (Seyedi et al., 2002), or both (Cumming 
et al., 1996), with the aim to create an ischaemic insult of mild (mild SI), moderate 
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(moderate SI) and severe (severe SI) character respectively. Temperature was 
maintained at 37°C. 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1: In vitro experimental protocol for three time points of SI.   
 
 
3.5. Treatment of cells with rapamycin and 3MA 
 
To establish a dynamic approach of monitoring the onset of apoptosis and necrosis 
over time during the ischaemic insult, in dependency of autophagic activity, cells 
were treated with 5 mM 3MA (Sigma, M9281) or 50 µM rapamycin (Sigma, K4060) 
for 24 hrs. Cells were then washed with PBS and submitted to 2 hrs SI. Live cell 
imaging was performed (see below).  
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Figure 3.2: In vitro experimental protocol of SI for study of onset 
dynamics with induced and inhibited autophagic activity.  
 
 
3.6. Determination of myocyte viability 
 
3.6.1. PI exclusion 
 
The loss of membrane integrity has been described as an indicator for necrotic cell 
death (Festiens et al., 2006). The DNA intercalating dye Propidium Iodide (PI) is 
not able to diffuse through the membrane of viable cells, it is therefore excluded 
from binding to the cells’ nucleus. However, as soon as the cells’ membrane 
integrity is lost, PI diffuses into the cell and intercalates with the DNA. This dye has 
a specificity for double-stranded nucleic acids, absorbing in blue-green (493 nm), 
fluorescing red (630 nm). In combination with Hoechst which diffuses through an 
intact cellular membrane, the PI exclusion technique allows to clearly distinguish 
between viable cells (PI-negative), and cells which have lost their membrane 
integrity (PI-positive). After submission to the experimental protocol, Hoechst 
(Hoechst 33342, Sigma) and PI (Sigma, P4170), in a 1:200 dilution in PBS, were 
directly added onto the cells, using a final concentration of 50 µg/ml and 1 µg/ml 
respectively. Incubation took 10 min and images were acquired immediately 
thereafter. Using the automatic stage setting (Olympus Cell^R Soft Imaging 
Systems), random fields of view were acquired. Using a Xenon-Arc burner 
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(Olympus Biosystems GMBH) as light source, images were excited with the 360 
nm and 572 nm excitation filter; emission was collected using a UBG triple-
bandpass emission filter cube (Chroma). Necrotic cells showed bright red nuclei. 
For each experimental condition, four random fields of view were acquired. The % 
PI-positive cells was calculated as number of PI-positive cells/total cells x 100.     
 
 
 
 
 
 
 
 
 
 
 
Figure 3.3: Fluorescence micrograph showing PI-
negative (right) and PI-positive (left) H9c-2 cells.  
 
 
3.6.2. Nuclear condensation 
 
Nuclear condensation (pyknosis) and fragmentation (karyorrhexis) have been 
described as morphological hallmarks for apoptosis (Kajustra et al., 1996). Using 
the DNA intercalating dye, Hoechst, one is able to clearly distinguish between 
normal nuclear morphology and apoptotic morphology. After submission to the 
experimental protocol, Hoechst 33342 (in a 1:200 dilution in PBS) was directly 
added onto the cells, using a final concentration of 50 µg/ml,  and incubated for 10 
min. Images were acquired immediately thereafter. Using the automatic stage 
setting (Olympus Cell^R Soft Imaging Systems), random fields of view were 
acquired. Cells were graded according to their nuclear signal: 1. normal nuclei with 
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blue chromatin, showing an organized structure with a distribution of hetero- and 
euchromatin, 2. Apoptotic cells, showing bright and highly condensed or 
fragmented nuclei. For each experimental condition, four random fields of view 
were acquired. The apoptotic index was calculated as number of apoptotic 
cells/total cells x 100.     
 
 
 
 
 
 
 
 
 
 
Figure 3.4: Fluorescence micrograph showing normal 
nucleus (right) and pyknotic (arrows) nuclei of H9c-2 
cells.  
 
 
3.6.3. MTT assay 
 
For the assessment of mitochondrial reductive activity, a modification of the 3-[4,5-
dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide (MTT) assay was used 
(Goodwin et al., 1995, Gomez et al., 1997). The assay is based on the cells 
capacity to reduce MTT into blue formazan pigments mainly through mitochondrial 
enzymes of viable cells. Following the submission of cells to SI, cells were washed 
twice with PBS. MTT (0.01 g/ml) was dissolved in PBS, and 500 µl was added per 
culture dish. Cells were incubated for 2 hrs at 37°C and 5% CO2. Cells were then 
washed with PBS and 1000 µl of HCl-isopropanol-Triton (1% HCl in isopropanol; 
0.1% Triton X-100; 50:1) was added to the cells, followed by an agitation period of 
5 min. During this process, cell membranes would lyse and release the formazan 
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pigments. The suspension was centrifuged at 14 000 rpm for 2 min, and the optical 
density (OD) was determined spectrophometrically (Cary Varian) using a 
wavelength of 540 nm. Values were expressed as percentages of control values.  
 
3.7. ATP analysis 
 
ATP levels were determined using the ATP Bioluminescence detection kit 
(ENLITEN®, Promega). This assay uses recombinant luciferase to catalize the 
following reaction:  
ATP + D-Luciferin + O2  Oxyluciferin + AMP + PPi + CO2 + Light (560 nm)   
 
Since ATP is the limiting component in the above reaction, the emitted light is 
proportional to the concentration of ATP. Following trypsinization, cells were 
centrifuged at 4°C and washed in PBS. The pellet wa s then resuspended in 50 µl 
ice-cold lysis buffer (100 mM Tris-HCl and 4 mM EDTA, pH 7.75), which was 
followed by the addition of 150 µl of boiling lysis buffer (Essmann et al., 2003). 
Samples were then incubated for 2 min at 99°C. Lysa tes were centrifuged at 
10 000 rpm at 4°C for 1 min (ALC, PK121R, multispee d refrigerated centrifuge). 
Supernatants were collected for ATP detection; 50 µl of supernatant and 50 µl 
luciferase reagent were used and chemiluminescence was acquired in a 
luminometer (Glomax-96 luminometer, Promega).  
 
3.8. Western blot analysis 
 
3.8.1. Protein extraction 
 
After completion of the experimental protocol, cells were rapidly placed on ice, 
Esumi buffer was removed and cells were carefully washed with cold PBS. Total 
myoblast protein was extracted with a lysis buffer [modified 
radioimmunoprecipitation (RIPA) buffer], pH 7.4, containing (in mM): Tris/HCl 2.5, 
EDTA 1, NaF 50, NaPPi 50, DTT 1, Phenylmethylsulfonyl fluoride (PMSF) 0.1, 
 66 
 
benzamidine 1, 4 µg/ml SBTI, 10 µg/ml leupeptin, 1% NP40, 0.1% SDS, 0.5% Na-
Deoxycholate. A volume of 260 µl lysis buffer was added to the culture flask and 
cells were removed from the plastic surface using a cell scraper. Cell lysates were 
stored short termed at -20°C in microcentrifuge tub es. 
 
3.8.2. Bradford protein quantitation 
 
The rapid and sensitive Bradford method for the quantitation of microgram 
quantities of protein utilizing the principle of protein-dye binding was employed 
(Bradford, 1976). It involves the binding of Coomassie Brilliant Blue G-250 to 
protein which causes a shift in the absorption maximum of the dye from 465 nm to 
595 nm. The increase in absorption at 595 nm is monitored spectrophotometrically 
(Cary Varian).  
   
Cell lysates were defrosted, kept on ice and sonicated for 5 seconds at power level 
3 (Vir Sonic 300, Virtis Gardiner) followed by centrifugation for 10 min at 4°C at 
5000 x g (ALC-PK121R) in order to pellet cell debris and to expose the whole 
cellular protein fraction. For the establishment of a standard curve, a protein 
dilution series was set up, pipetting 2 µg, 4 µg, 8 µg, 12 µg, 16 µg and 20 µg 
albumine bovine serum dissolved in PBS (BSA, 200 µg/ml) and 900 µl Bradford 
reagent into test tubes, adjusted to 1000 µl with deionized water. Sample protein 
concentrations were determined through pipetting 5 µl of the sample supernatant 
with 900 µl Bradford reagent and adjusted to 1000 µl with 95 µl deionized water.   
 
Test tube content was mixed by vortexing, incubated for 5 min at room temperature 
and the absorbance was measured at a wavelength of 595 nm against a reagent 
blank prepared from 900 µl Bradford reagent and 100 µl deionized water, using 
semi-micro cuvettes. The weight of protein in µg/ml was plotted against the 
absorbance and protein concentration was determined.  
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3.8.3. Sodium-dodecyl-sulfate-polyacrylamide gel electrophoresis (SDS-
PAGE) 
 
Laemmli sample buffer was prepared, using (in M): TRIS 0.5, pH 6.8, 10% SDS, 
2.5 ml glycerol, 0.2 ml 0.5% bromophenol blue in deionized water. A volume of 150 
µl mercaptoethanol was then added to 850 µl sample buffer. Cell lysates were 
boiled for 5 min and shortly spun in a microcentrifuge to assure complete sample 
acquisition. Total protein (20 µg) was separated by 10% sodium-dodecyl-sulfate-
polyacrylamide-gel-electrophoresis (SDS-PAGE) and a 4% stacking gel.  
 
3.8.4. Western blot analysis 
 
After completion of the protein separation, proteins were transferred to a PVDF 
membrane (ImmobilonTM P, Millipore) using a semi dry blotting system (BIO RAD 
trans-blot SD). Three blotting buffers were prepared using for anode buffer I (in M): 
Tris-base 0.3, pH 10.4, 20% methanol; for the anode buffer II (in mM): Tris-base 
25, pH 10.4, 20% methanol and for the cathode buffer (in mM): Tris-base 25, ε-
aminohexanoic acid 40, pH 9.4, 20% methanol. The PVDF membrane was soaked 
in methanol for 15 sec, allowed to dry and then soaked in anode buffer II. On the 
anode plate four blotting papers were placed, after being soaked in anode buffer I. 
Two blotting papers, soaked in anode buffer II were added, followed by the PVDF 
membrane and the gel without the stacking gel. Six blotting papers, soaked in the 
cathode buffer were added. To avoid air bubbles, the blotting sandwich was rolled 
with a clean wet glass tube. The systems’ cathode lid was tightly closed and the 
transfer proceeded with 0.5 A, 15 V for 60 min.       
 
Following protein transfer, non-specific binding sites on the membranes were 
blocked for 120 min at room temperature with 5% fat free milk in Tris-buffered 
saline-0.1% Tween 20 (Polyoxyethylenesorbitan monolaurate, Tween 20) (TBST). 
Followed by a washing step with TBST, the membranes were incubated overnight 
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at 4°C with the specific primary antibodies. The pr imary antibody dilution was in 
each case diluted in TBST as stated above.  
 
Membranes were subsequently washed with large volumes of TBST (3x5 min) and 
the immobilized antibody conjugated with a 2.5:10 000 diluted horseradish 
peroxidase-labelled secondary antibody (Amersham Life Sciences), incubated for 
50-60 min at room temperature. After thorough washing with TBST, membranes 
were incubated at room temperature for 1 min with ECLTM detection reagents 
(Amersham Life Sciences) and quickly exposed to an autoradiography film 
(HyperfilmTM) to detect light emission through a non-radioactive method (AXIM 
fixer/developer).  
 
3.9. Immunofluorescence 
 
All solvents and buffers for the labeling were freshly made up and filter sterilized to 
ensure that they are free of particles.  
 
Cells were grown on autoclaved cover glasses which were placed into the culture 
dish. After completion of the experimental protocol, cells were gently washed with 
0.1 M PBS and fixed using 1000 µl fixative per culture dish, made up as 
methanol/acetone in a 1:1 ratio. Culture dishes were incubated for 10 min on ice at 
4˚C and then left to air-dry for 20 min at room temperature. Dried cover glasses 
were then gently rinsed with 1ml PBS and transferred to microscope slides.  
 
For the rest of the labeling procedure, slides were kept in light protected humidified 
staining chambers. The slides were then incubated at room temperature for 20 min 
with 5% donkey serum in PBS, 100 µl per cover glass, to block non specific binding 
sites. Serum was then drained and specific primary antibodies were added in a 
1:50 PBS dilution (50 µl volume) and incubated for 90 min at room temperature. In 
some cases, an overnight incubation step was employed to yield better results. For 
the controls, 50 µl PBS was used instead of primary antibody. The slides were then 
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carefully washed with 1 ml PBS per slide and secondary antibody FITC or Texas 
Red (Jackson, donkey anti rabbit/donkey anti goat) was added in a 1:200 dilution 
(50 µl volume) to all slides, including the PBS controls. To avoid crystals, the 
secondary antibody was briefly centrifuged and the supernatant was used for the 
labeling. Following 30 min incubation at room temperature, the nuclear stain 
Hoechst was added additionally in a 1:200 dilution and incubated for another 10 
min at room temperature. Cover glasses were then carefully washed 3 times with 
1000 µl PBS and transferred to glass microscope slides, mounted with fluorescent 
mounting medium (Dako Cytomation) and finally sealed with commercially 
available nail polish. Slides were then analysed and stored in silver foil at -20˚C.    
   
3.10. Fluorescence Microscopy 
 
Image acquisition was performed on an Olympus Cell^R system attached to an IX 
81 Inverted fluorescence microscope equipped with a F-view-II cooled CCD 
camera (Soft Imaging Systems). Using a Xenon-Arc burner (Olympus Biosystems 
GMBH) as light source, images were acquired using the 360 nm, 472 nm or 572 
nm excitation filter. Emission was collected using a UBG triple-bandpass emission 
filter cube (Chroma). Images were acquired through z-stacks, using an Olympus 
Plan Apo N60x/1.4 Oil objective. The top and bottom focus position parameter 
were selected, indicating the upper and lower dimensions of the sample to be 
acquired, with a step width of 0.26 µm between the image frames. Images were 
processed and background-subtracted using the Cell^R software, and presented in 
a maximum intensity projection.  
 
Through setting up a defined experiment in the Experiment Manager feature of the 
Cell^R software, image acquisition parameters such as exposure time, illumination 
settings and emission filter cube selection were kept constant for all groups and 
ensured appropriate selection of parameters. The DAPI 360 nm excitation wave 
length was used for setting the focal plane, avoiding unnecessary photo-bleaching.  
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3.11. Transfections with GFP-LC3 and CFP-DEVD-YFP 
 
H9c-2 cells were transfected using GenJuice® Transfection Reagent (Novagen®), 
according to the manufacturers protocol. In brief, cells were seeded in 8-chamber 
dishes with a density of 2x104 cells. Per sample, 3 µl of transfection reagent was 
added to 100 µl of serum-free medium, vortexed, and incubated for 10 min at room 
temperature. Thereafter 800 ng of DNA was added, then mixed through gentle 
pipetting and incubated for 15 min at room temperature. DNA/reagent mix was 
added in a drop-wise manner to the cells, which were kept in complete growth 
medium. The DNA/reagent mix was added over the entire surface of the culture 
dish, which was then gently rocked. Cells were incubated for 24 hours, which was 
followed by a change of growth medium. An estimated transfection efficiency of 
10% was achieved. Cells were then incubated for another 24 hrs and visualized.  
 
3.12. Live Cell Imaging 
 
To establish a dynamic approach of monitoring the onset of apoptosis and necrosis 
over time during the ischaemic insult, live cell imaging was performed.  
For that purpose, H9c-2 cells were maintained at 37 °C in growth medium, seeded 
in 8-chamber dishes with a density of 2x104 cells.  
 
3.12.1. Fluorescence Resonance Energy Transfer (FRET) and mitochondrial 
depolarization dynamics 
 
Caspase-3 activity and loss of mitochondrial membrane potential are associated 
with apoptosis, and have been considered as a PONR for apoptosis. To visualize 
this process over time, cells were transfected with 800 ng of CFP-DEVD-YFP 
plasmid DNA construct (Tyas et al., 2000). Cells expressing the CFP-DEVD-YFP 
fusion protein were imaged after pretreatment with 20 nM Tetramethylrhodamine 
Ethyl Ester (TRME, Molecular Probes, T669) for 30 min at 37°C. The cells were 
then treated with modified ischaemic buffer (Esumi et al., 1991, Seyedi et al., 
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2002), which was vigorously gassed with nitrogen to ensure that the buffer was 
largely free of oxygen and then layered with mineral oil (Meldrum et al., 2001, 
Covington et al., 2005, Patel et al., 2006) and placed in a heated chamber (37°C) 
encasing the IX-81 stage. FRET was determined using an IX-81 Olympus 
microscope, coupled to an MT-20 (Soft Imaging Systems) xenon arc lamp, by 
excitation using FRET excitation filters (S430/25x and S500/200, Chroma). 
Fluorescence emission was monitored at 1 frame per 180 seconds by collection 
windows for CFP emission and YFP emission (S470/30m and S535/30m, 
Chroma). CFP/YFP ratios were calculated using the Olympus Cell^R package. 
Mitochondrial membrane potential was monitored simultaneously through exciting 
TMRE by using a 572 nm excitation filter with emission being collected in a third 
channel using a UBG triple bandpass emission filter. Automatic stage settings were 
employed to acquire data from the various conditions concomitantly.     
 
3.12.2. Propidium Iodide uptake dynamics 
 
Propidium Iodide (PI) is a membrane-impermeable dye which intercalates with the 
DNA. Its uptake is therefore an indication for the loss of membrane integrity, a 
hallmark of necrotic cell death. The cells were treated with pre-gassed modified 
ischaemic buffer (containing SDT) containing PI, layered with mineral oil (Meldrum 
et al., 2001, Patel et al., 2006, ) and placed in a heated chamber (37°C) 
surrounding the stage. PI uptake was determined using an IX-81 Olympus 
microscope, coupled to a MT-20 (Soft Imaging Systems) xenon arc lamp by 
excitation using 572 nm excitation filters. Fluorescence emission was monitored at 
1 frame per 180 seconds by collection windows for TexRed emission using a UBG 
triple bandpass emission filter. Automatic stage settings were employed to acquire 
data from the various conditions concomitantly.     
 
3.12.3. LC3 imaging 
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Autophagy is a highly dynamic process. Autophagosomes fuse with lysosomes, to 
form autophagolysosomes, which are responsible for the rapid enzymatic 
degradation of lysosomal content. (Mizushima, 2005). It has also been shown, that 
damaged mitochondria may be part of this cargo, a process called mitophagy 
(Lemasters, 2005). To visualize these processes in our model, H9c-2 cells were 
transfected with 800 ng of LC3-GFP plasmid DNA construct (Yoshimori, 2000). 
Cells expressing the LC3-GFP fusion protein were incubated with 50 nM 
rapamycin for 24 hrs and imaged following pretreatment with 20 nM 
Tetramethylrhodamine Ethyl Ester (TMRE, Molecular Probes, T669) for 30 min at 
37°C or with 10 nM Lysotracker (Lysotracker® Red DN D-99, Molecular Probes, 
L7528). Fluorescence emission was monitored at 1 image frame per four seconds, 
by collection windows for GFP emission and TexRed emission. 
 
3.13. Scanning Electron Microscopy 
 
Cells were seeded onto coverslips, contained in petri dishes with a density of 1x105 
cells and submitted to simulated ischaemia. Imaging of the samples was 
accomplished using a Leo® 1430VP Scanning Electron Microscope. Prior to 
imaging, the coverslips were mounted on a stub with double sided carbon tape. 
The sample was then coated with a thin layer of gold in order to make the sample 
surface electrically conducting. The Scanning electron (SE) images show the 
surface structure of the cells. Beam conditions during surface analysis were 7 KV 
and approximately 1.5 nA, with a working distance of 13 mm and a spot size of 
150.   
 
3.14. Flow Cytometry 
 
3.14.1. PI exclusion 
 
Following submission to the SI protocol, cells were trypsinized using warm (37°C) 
0.25% trypsin-EDTA, incubated until cells detached from the surface (3-4 min), 
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centrifuged for 3 min at 6000 x g and re-suspended in cold PBS. PI was directly 
added onto the unfixed cells, using a final concentration of 1 µg/ml, incubated for 
10 min, and analyzed on the flow cytometer (BD FACSAria I) immediately 
thereafter. A minimum of 5000 events were collected using the 488 nm laser and 
610LP, 616/23BP emission filters.   
 
3.14.2. Tetramethylrhodamine Ethyl Ester (TMRE) intensity 
 
The membrane potential-dependent dye tetramethylrhodamine ethyl ester 
selectively stains for mitochondria with an intact membrane, as described 
previously (Hanley et al., 2002). Following submission to the SI protocol, cells were 
trypsinized using warm (37°C) 0.25% trypsin-EDTA, i ncubated until cells detached 
from the surface (3-4 min), centrifuged for 3 min at 6000 x g and re-suspended in 
cold PBS. Unfixed cells were incubated with 1 µmol/l TMRE in PBS for 30 min at 
37°C, then washed in PBS and immediately analyzed a t room temperature.  A 
concentration of 5 µmol/l Carbonyl cyanide m-chlorophenylhydrazone (CCCP, 
Sigma, C2759) was used as a positive control. Samples were analyzed on the flow 
cytometer (BD FACSAria I) and a minimum of 5000 events were collected, using 
the 488 nm laser and 610LP, 616/23BP emission filters. Fluorescence intensity 
signal was measured using the geometric mean on the intensity histogram.  
 
3.14.3. ROS assessment 
 
Relative ROS generation was evaluated with the aid of 6-carboxy-2’7’-
dichlorodihydrofluoresce in diacetate, di(acetoxymethyl ester (DCF, Molecular 
Probes, D399). Following submission to the SI protocol, cells were trypsinized 
using warm (37°C) 0.25% trypsin-EDTA, incubated unt il cells detached from the 
surface (3-4 min), centrifuged for 3 min at 6000 x g and re-suspended in cold PBS. 
Unfixed cells were incubated with 50 µmol/l DCF in PBS for 20 min at 37°C, and 
then washed in PBS and immediately analyzed at room temperature.  A 
concentration of 100 µmol/l H2O2  was used as a positive control. Samples were 
 74 
 
analyzed on the flow cytometer (BD FACSAria I) and a minimum of 5 000 events 
were collected. The 488 nm laser and 502LP, 530/30BP emission filters were 
employed. Fluorescence intensity signal was measured using the geometric mean 
on the intensity histogram.  
 
3.14.4. Acridine Orange staining 
 
Acridine Orange (AO) is a ratiometric dye, which binds to DNA but also 
accumulates in acidic compartments such as lysosomes. (emission particulars). It 
is therefore being used for DNA related studies as well as an indicator for an 
increase in acidic compartments (Harhaji-Trajkovic et al., 2008). As autophagy is 
characterized by the development of acidic vesicular organelles (AVO’s), AO can 
has been employed to detect and quantify AVO’s (Azad et al., 2008). Following 
submission to the SI protocol, cells were trypsinized using warm (37°C) 0.25% 
trypsin-EDTA, incubated until cells detached from the surface (3-4 min), 
centrifuged for 3 min at 6000 x g and re-suspended in cold PBS.  Acridine Orange 
(Sigma, 212536) was added to the unfixed cells, using a final concentration of 5 
mM, and incubated for 15 min at room temperature. Samples were analyzed on the 
flow cytometer (BD FACSAria I) immediately thereafter and a minimum of 5000 
events were collected. The 488 nm laser and 610LP, 616/23BP and 502LP, 
530/30BP emission filters were employed. Fluorescence intensity signal was 
measured using the geometric mean on the intensity histogram and expressed as 
ratio.    
 
3.15. Perfusion technique of isolated perfused rat heart 
 
Hearts were rapidly excised, arrested in ice-cold (4°C) normal saline solution and 
mounted onto the aortic cannula. Hearts were perfused retrogradely in a non-
recirculating manner at 100 cm H2O for 15 min. During this time, the left atrium was 
cannulated to allow atrial perfusion (atrial pressure 15 cm H2O) according to the 
working heart model of Neely as modified by Opie and co-workers (1971). The left 
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ventricle ejected against a hydrostatic pressure of 100 cm H2O. Perfusate 
temperature was 37 °C and thermostatically controll ed as well as continuously 
monitored by inserting a temperature probe into the pulmonary artery.  
 
3.16. Perfusion Buffer 
 
A modified Krebs-Henseleit bicarbonate buffer was used containing (in mM) NaCl 
119, NaHCO3 25, KCl 4.7, KH2PO4 1.2, MgSO4.7H2O 0.59, Na2SO4 0.59, CaClH2O 
1.25 and glucose 10. Oxygenation was achieved by gassing the perfusate with 
95%O2/5%CO2.  
 
3.17. Determination of function 
 
Coronary (Qe) and aortic (Qa) flow rates in ml/minute were measured manually. 
Aortic pressure was obtained through a side-arm of the aortic cannula which was 
connected to a Viggo-Spectramed pressure transducer and was recorded in mm 
Hg. The peak systolic pressure (PSP) and heart rate (HR) were obtained from the 
recordings made. The following parameters were calculated:   
 
Cardiac output (CO) (ml/min) = (Qa+Qe) 
 
Stroke volume (SV) (ml/min) = (CO/HR) 
 
Mean external power produced by the left ventricle (TW) in mWatts according to 
Kannengieser and coworkers (1979):  
0.002222(PAO-11.25)(CO) where PAO = aortic pressure, CO = cardiac output 
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3.18. Perfusion sequence 
 
Hearts were perfused for a control period, followed by 3 different periods of 
sustained ischaemia and one defined period of reperfusion. The exact perfusion 
protocol will be described in the relevant sections. 
 
Hearts were subjected to sustained ischaemia (normothermic total global 
ischaemia) by simultaneous clamping of both aorta and left atrial supply tubes. 
During the ischaemic period, hearts were enchambered by a small stoppered water 
jacketed chamber for maintenance of the temperature at 36.5 °C. The duration of 
sustained ischaemia will be indicated in the relevant sections. The hearts were 
subsequently reperfused, first retrogradely for 10 min, and then as working hearts 
for 20 min.  
 
 
 
 
 
 
 
 
 
 
 
 
    
Figure 3.5: Ex vivo experimental protocol for 3 time points of global ischaemia.  
 
In an additional series of perfusions, hearts were stabilized and then perfused with 
either 1 nM Rapamycin or 1 mM 3MA for 10 min in working heart mode, followed 
by 40 min retrograde perfusion in the Langendorff mode. Hearts were then 
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subjected to 20 min sustained ischaemia (normothermic total global ischaemia) by 
simultaneous clamping of both aorta and left atrial supply tubes. During the 
ischaemic period, hearts were enchambered by a small stoppered water jacketed 
chamber for maintenance of the temperature at 36.5 °C. The hearts were 
subsequently reperfused, first retrogradely for 10 min, and then as working hearts 
for 20 min.  
 
 
 
 
 
 
 
 
 
 
Figure 3.6: Ex vivo experimental protocol of global ischaemia with 
induced and inhibited autophagic activity.  
 
 
 
3.19. Histology 
 
3.19.1. Fixation and sectioning 
 
Heart tissue was fixed in 10% paraformaldehyde at 4°C to allow slow preservative 
penetration of the fixative into the myocardial tissue (Histologische Technik, Burck, 
1988). The samples were then processed, utilizing automated tissue processing 
(Tissue Tek II). In brief, samples were dehydrated using 70%, 90%, 95% and 
100% ethanol and cleared by using xylol which was followed by paraffin wax 
impregnation (Histosec paraffin wax). Total processing time was 20 hrs.  
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Paraffin embedded sectioning was performed on a R Jung microtome (Heidelberg, 
Germany), generating 5 µm sections which were collected on poly-L-lysine (P8920, 
Sigma) coated slides. Samples were then processed and rehydrated using a xylol 
and an ethanol dilution range. In brief, sections were incubated in xylol, 100%, 
95%, 80% and 50% ethanol, followed by a rinsing step in distilled water.  
 
3.19.2 Haematoxylin Eosin (H&E) staining 
 
Sections were stained using Harris haematoxylin (Merck, solution to Meyer’s, 
161207) (5g Harris haematoxylin, 100g Ammonium Alum, 50 ml 100% ethanol, 
2.5g mercuric acid and 1 l distilled water), 10% acid alcohol (10 ml 1% HCl 
dissolved in 70% ethanol), Scott’s tap water (3.5g NaHCO3, 20g MgSO4, 10 ml 
37% formalin and 1 l tap water) and Eosin (Riedel De-Haën, 32617). H&E staining 
results in deep blue nuclei and pink cytoplasm. Samples were submitted to a 
staining procedure by using a sequence of: xylol, absolute, 95% and 70% ethanol, 
distilled water, Harris haematoxylin, distilled water, acid alcohol, distilled water, 
Scott’s tap water, distilled water, eosin, distilled water, 70%, 95% and absolute 
ethanol followed by xylol.  Slides were mounted using mounting media (Jung, 
tissue freezing medium, 020108926).  
 
3.19.3. Immunofluorescence staining 
 
After completion of sectioning and rehydration, slides were incubated for 15 min in 
pre-warmed (37°C) 0.1% trypsin in PBS, followed by a rinsing step with distilled 
water. This “unmasking” or antigen retrieval facilitates the immunological reaction 
of antibodies with antigens. Samples were then immunostained for LC3, cleaved 
PARP and HMGB1 (as described in section 3.9) where after slides were mounted 
using fluorescence mounting media.  
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3.20. Statistical analysis 
 
The results are expressed as mean values ± SEM and were analyzed by one-way 
Analysis of Variance (ANOVA) with the Bonferroni correction. The α-level was 
0.05. The statistics software, Graph Pad Prism 2.01, was employed to perform 
statistical tests. Data were considered to be statistically significant with a p value 
<0.05. For the time lapse experiments as part of the dynamic onset study, sigmoid 
curves were fitted with Prism according to: LSD test; variable EC50 (Rep=1 Model: 
V4=bottom+(top-bottom)/(1+10^((V3-EC50)*slope)) and probabilities for Post Hoc 
tests with the effect of treatment, were determined.  
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CHAPTER 4 RESULTS: TIME POINTS 
 
4.1. In vitro model: Three time points and three severities of simulated 
ischaemia 
 
The term ischaemia is derived from the Greek “ischein”, to restrict and “haima”, 
meaning blood. In plain terms, it means too little blood (Opie, 1991). This condition 
of ischaemia can be mimicked in an experimental setup and is termed simulated or 
experimental ischaemia.  
In order to assess the role of an ischaemic insult in the induction and execution of 
cell death, H9c-2 cells were submitted to a protocol of simulated ischaemia lasting 
for 2, 4 and 8 hrs followed by a 1 hr reperfusion phase (Fig. 4.1). Rat ventricular 
cardiomyoblast cells, H9c-2, have been widely used as an in vitro model of acute 
myocardial infarct (Krijnen et al., 2005, Agnetti et al., 2005, Bonavita et al., 2003). 
We have therefore chosen this cell line to study the contribution of autophagy, 
apoptosis and necrosis in differential simulated ischaemic settings. 
Components characteristic of an ischaemic event include substrate omission, 
lactate formation, acidosis, high potassium levels and hypoxia (Coetzee & Opie, 
1987). Although ischaemia leads, due to the reduction in coronary flow, to foci of 
tissue hypoxia and anoxia, the metabolic aspects of ischaemia and anoxia in the 
myocardial tissue differ in regard to tissue acidosis, glucose uptake and residual 
oxidative capacity (Opie, 1991). This model of simulated ischaemia we employed, 
has widely been used in the field of cardiovascular research (Krijnen et al., 2005, 
Agnetti et al., 2005, Bonavita et al., 2003). We have chosen a combination of 
originally independent models, as it is our aim to create differential severities of 
simulated ischaemia. A combination of hyperkalemia, acidosis, hypoxia, the 
absence of glucose and metabolic inhibition was chosen to simulate an ischaemic 
event. A modified ischaemic buffer (Esumi et al., 1991) with either 2-deoxy-D-
glucose (Fuglesteg et al., 2008), sodium dithionate (Seyedi et al., 2002), or both 
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(Cumming et al., 1996) was employed with the aim to create an ischaemic insult of 
mild, moderate and severe character respectively. In the myocardium these 
severities may represent the scenarios described as mild, severe and lethal 
ischaemia, found between the infarct zone and the area at risk (Hearse et al., 
1981, Opie, 1991).  Sodium dithionite was chosen, as it allows a reversible 
reperfusion phase, unlike metabolic inhibitors such as KCN (Al-Dadah et al., 2007).     
 
Reperfusion was mimicked by incubating the cells subsequent to the simulated 
ischaemic event in normal culture medium under a 5% CO2 atmosphere at 37°C.  
 
 
 
 
 
 
Figure 4.1: In vitro experimental protocol. Cells were exposed to 2, 4 and 8 
hrs mild, moderate or severe SI, followed by 1 hr reperfusion respectively. 
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4.2. Experimental measurements after 2 hrs SI 
4.2.1. PI exclusion and nuclear condensation  
 
The loss of membrane integrity as well as nuclear condensation (pyknosis) and 
fragmentation (karyorhexis) have been described as morphological hallmarks for 
necrosis and apoptosis respectively (Kajstura et al., 1996). Propidium iodide 
exclusion and Hoechst imaging techniques (Asoh et al., 2005) were used to assess 
the contribution of necrosis and apoptosis in this experimental model of simulated 
ischaemia.  
 
As shown in Fig 4.2., control cells (Con) kept under normoxic conditions, are highly 
viable (0.3±0.2% PI positive cells and 4.8±0.8% pyknotic cells), whilst exposure to 
mild SI increased the number of pyknotic cells significantly [14.1±0.9% (p<0.05)]. A 
significant increase in both PI positive cells and pyknotic cells compared to Con 
cells was observed in cells exposed to moderate SI [10.3±2.3% PI positive cells 
(p<0.05), 9.8 ±1.4% pyknotic cells (p<0.05)] and severe SI [12.1±2.0% PI positive 
cells (p<0.05), 10.9±1.5% pyknotic cells (p<0.05)] respectively. Following a 1 hr 
reperfusion phase (Fig. 4.3.), the number of pyknotic cells further increased in mild 
SI (17.2±1.7%). However, PI positive cells remained at control levels (2.2±1.2%). 
Cell death further increased in cells submitted to moderate SI (18.3±5.3% PI 
positive cells, 18.3±1.5% pyknosis) and severe SI (20.8±4.9% PI positive cells, 
21.3±1.8% pyknotic cells).  
 
The buffer alone did not have any significant effect on cell death (1.6±0.4% PI 
positive cells, 1.3±0.7% pyknosis) compared to control cells (addendum).   
 
 
  
4.2.1.
 2hrs SI/R PI exclusion and
 
 
 
 
 
 
 
 
Figure 4.2:  2 hrs SI. Data expressed as mean ± SEM, statistical 
analysis: ANOVA & Bonferroni correction, * p<0.05 vs Con, 
vs mild SI, n=9, >150 cells counted.
                                                       
 
 
 
 
 
 
 
 
Figure 4.3   
analysis: ANOVA & Bonferroni correction,* p<0.05 vs Con, 
mild SI, n=9, >150 cells counted.
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4.2.2. MTT assay and ATP analysis 
About two percent of the total myocyte ATP is consumed per systole-diastole 
cycle, indicating that the total ATP amount in the cell is consumed in less than one 
minute (Jafri et al., 2001). As the heart beats about three billion times in its life time 
(Hamacher-Brady et al., 2006), it becomes clear that an extremely efficient system 
of energy conversion needs to be in place to maintain myocardial ATP 
homeostasis.  
In order to assess the cell’s metabolic state during the ischaemic event, an MTT 
assay (Gomez et al., 1997, Goodwin et al., 1995) and ATP analysis (Essman et al., 
2003) were performed and results normalized. The MTT assay is based on the 
cell’s capacity to reduce MTT into formazan pigments by (primarily) mitochondrial 
enzymes, indicating the cell’s reductive capacity, which in turn serves as an 
indication for the relative survival rate of the cell. The ATP assay measures total 
ATP availability at the time of injury. A reduction in oxygen availability will attenuate 
oxidative phosphorylation, leading to increased ADP and creatine and decreased 
ATP and creatine phosphate. ATP levels decrease rapidly during ischaemia but 
also recover rapidly after reperfusion (Takagi et al., 2007). The dynamics of ATP 
depletion becomes highly relevant when considering the molecular overlap 
between autophagy, apoptosis and necrosis (Klionsky et al., 2008, Ziporen et al., 
2009, Karantza-Wadsworth et al., 2007). A progressive replacement of necrosis 
with apoptosis has been described when intracellular ATP becomes available (Han 
et al., 2007). 
As shown in Fig 4.4, the relative viability based on MTT decreased significantly 
after 2 hrs mild SI (31.5±2.6%), moderate SI (36.6±4.4%) and severe SI 
(30.3±2.7%) compared to control cells. However, compared to control ATP levels, 
ATP significantly increased in mild SI (264±62.1%) but not so in moderate SI 
(99.5±39%) or severe SI (91±28.9%). Following 1 hr reperfusion (Fig. 4.5), 
mitochondrial viability recovered but remained significantly lower compared to 
control viability [mild SI: 81.1±2.9%; moderate SI:  79.7±1.1%; severe SI: 
78.7±1.0% (p<0.05)]. ATP levels returned to control levels in mild SI (85.5±8.8%), 
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whilst ATP levels significantly decreased in moderate SI [68.3±14.4% (p<0.05)] 
and in severe SI [47.3±5.8% (p<0.05)].  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
4.2.2. 2hrs SI/R MTT assay and ATP analysis
 
 
                   
 
 
 
 
 
 
 
Figure 4.4  
analysis: ANOVA & Bonferroni correction, * p<0.05 vs Con, 
mild SI, n=9
 
             
 
 
 
 
 
  
     
Figure 4.5 2 hrs SI/R. Normalised data expressed as mean ± SEM, statistical 
analysis: ANOVA & Bonferroni correction, * p<0.05 vs Con, 
SI, n=9-10. 
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4.2.3. Western blot analysis
Western blot analysis reveals a differential and gradual induction of phosphorylated 
AMPK following 2 hrs of the ischaemic event (Fig. 4.6). No phosphorylation is 
apparent in control cells but a gradual increase in the band signal is visible from 
mild SI to moderate SI with the strongest signal in severe SI. This phosphorylation 
pattern is lost at reperfusion (Fig. 4.6). Caspase
(Fig. 4.10) analysis revealed an increased cleavage of caspase
primarily in mild SI. A fa
moderate and severe SI. No changes in beclin
state of mTOR (Fig. 4.7) are visible at this early time of ischaemia. 
 
 
4.2.3.
 2hrs SI/R Western blot analysis
 
 
 
 
Figure 4.6:
kDa band following 2 hrs SI (top) and SI/R (below). A 
representative blot is shown.
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-3 and PARP 
 
 
  
 
 
 
 
 
 
Figure 4.7:
kDa band following 2 hrs SI (top) and SI/R (below). A 
representative blot is shown.
 
 
 
 
 
 
Figure 4.8:
kDa band following 2 hrs SI (top) and SI/R (below). A 
representative blot is shown.
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Figure 4.9:
kDa band following 2 hrs SI (top) and SI/R (below). A 
representative blot is shown.
 
 
 
 
 
 
 
 
 
 
Figure 4.10: 
band following 2 hrs SI (top) and SI/R (below). A 
representative blot is shown.
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4.2.4. Immunofluorescence and Scanning Electron Microscopy 
Although transmission electron microscopy (TEM) remains the standard method for 
monitoring autophagy in tissue, it is, however, extremely labour intensive and gives 
no indication of the progress within or flux through the autophagic pathway. A 
growing body of evidence suggests that mammalian microtubule-associated 
protein 1 light chain 3 (LC3), which functions as a structural component during 
autophagosome maturation, is also a reliable biomarker for autophagy. In order to 
assess cellular autophagic activity, cells with numerous LC3 autophagosomes 
were counted (Fig 4.11). Our results indicate that following 2 hrs ischaemia, mild SI 
leads to a significant increase in cells with numerous LC3 punctae [27.8±4.4% 
(p<0.05)] compared to control cells (0.9±0.4%), with no significant increase in 
moderate (6.1±1.4%) and severe SI (3.6±1.1%) (Fig. 4.12). During reperfusion this 
increase in LC3-positive cells in mild SI is lost (Fig. 4.13).  
 
The fluorescence LC3 images (Fig. 4.14) reveal a perinuclear LC3 accumulation in 
mild SI but not in moderate and severe SI. The morphological structure of the cells, 
based on the actin cytoskeleton, indicates loss of membrane integrity in cells 
exposed to moderate and severe SI (Fig. 4.14, 4.15). Immunofluorescence staining 
for beclin-1 (Fig. 4.16, 4.17) reveals a fine tubulin-like pattern in control cells as 
well as in cells exposed to SI. Moreover, cytochrome-c appears to be released in 
mild, moderate and severe SI compared to control cells (Fig 4.16, 4.17).  
 
The chromatin component, High Mobility Group Box chromosomal protein 1 
(HMGB1) has been shown to be released by necrotic cells, triggering inflammation 
(Bonaldi et al., 2003). Our results show a clear relocation of HMGB1 from the 
nucleus to the cytosol during all three ischaemic conditions (Fig. 4.18).  
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The scanning electron (SE) images (Fig. 4.20) show distinct surface morphology 
between the ischaemic groups. Mild SI shows primarily shrunk and membrane-
blebbed cells, which is typical of a morphology associated with apoptosis (Kerr et 
al., 1972). Moderate SI and severe SI on the other hand, show cells which appear 
flat adherent to the surface of the slide and swollen in their morphology, indicating 
loss of membrane integrity and an increase in cell volume. These results are in 
agreement with the morphology of necrosis (Festjens et al., 2006).  
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4.2.4. 2hrs SI/R Immunofluorescence- and Scanning Electron Microscopy 
 
 
 
 
 
 
 
 
 
 
  
Figure 4.11: Fluorescence micrographs showing cells with 
numerous LC3 punctae (right) compared to control conditions 
(left). Scale bar: 0.05 mm (A and C) and 0.02 mm (B and D). 
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4.2.4. 2hrs SI/R Quantification of cells with numerous LC3 punctae 
 
 
 
 
 
 
 
 
 
Figure 4.12: 2 hrs SI. Data expressed as mean ± SEM, statistical 
analysis: ANOVA & Bonferroni correction, * p<0.05 vs Con, # 
p<0.05 vs mild SI n=9, >150 cells counted. 
 
 
 
 
 
 
 
 
Figure 4.13: 2 hrs SI/R. Data expressed as mean ± SEM, statistical 
analysis: ANOVA & Bonferroni correction, * p<0.05 vs Con, # 
p<0.05 vs mild SI n=9, >150 cells counted.  
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4.2.4. 2hrs SI/R Fluorescence Microscopy
 
 
 
 
 
 
 
 
 
 
Figure 4.14: 
Actin/TexRed & Hoechst 33342. A: Con, B: mild SI, C: moderate 
severe SI. 
 
 
 
 
 
 
 
 
 
 
Figure 4.15:
Actin/TexRed & Hoechst 33342. A: Con, B: mild SI, C: moderate 
severe SI
.
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Figure 4.16: 2 hrs SI. H9c-2 myoblasts labelled with Cyt-c/FITC, Beclin-
1/TexRed & Hoechst 33342. A: Con, B: mild SI, C: moderate SI, D: 
severe SI. 
 
 
 
 
 
 
 
 
 
 
Figure 4.17: 2 hrs SI/R. H9c-2 myoblasts labelled with Cyt-c/FITC, 
Beclin-1/TexRed & Hoechst 33342. A: Con, B: mild SI, C: moderate SI, D: 
severe SI. 
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Figure 4.18: 2 hrs SI. H9c-2 myoblasts labelled with HMGB1/FITC.    
A: Con, B: mild SI, C: moderate SI, D: severe SI. 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.19:  2 hrs SI/R. H9c-2 myoblasts labelled with HMGB1/FITC. 
A: Con, B: mild SI, C: moderate SI, D: severe SI. 
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4.2.4. 2hrs SI/R Scanning Electron Microscopy (SEM) 
 
 
 
 
 
 
 
 
 
 
 
            
Figure 4.20:  2 hrs SI.  SEM micrographs of H9c-2 myoblasts. A: Con, B: mild SI, 
C: moderate SI, D: severe SI. Apoptotic cells show characteristic shrinkage and 
membrane blebbing (B). Necrotic cells appear attached and swollen (C and D).  
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4.3. Experimental measurements after 4 hrs SI 
Due to the highly dynamic character of cell death modes within and between one 
another during the progression of an ischaemic insult, it is important to also adopt a 
dynamic approach that includes the investigation of multiple time points during 
ischaemic injury.  
 
4.3.1. PI exclusion and nuclear condensation 
Following 4 hrs SI the results for PI-positive and pyknotic cells indicate an 
exacerbation of the results described at 2 hrs SI. In mild SI no significant increase 
in PI-positive cells was observed (4.5±1.5%) compared to control cells (0.9±0.4%) 
(Fig. 4.21). Pyknotic cells, however, increased significantly [33±3.3% (p<0.05)] 
compared to control cells (10.1±1.0%). In moderate [14.6±3.0% (p<0.05)] and 
severe SI [24.4±2.7% (p<0.05)] a significant increase in PI-positive cells was 
observed. Pyknotic cells increased significantly in moderate SI [16.9±2.6% 
(p<0.05)] and severe SI [17.3±2.2% (p<0.05)] respectively compared to control 
cells (Fig. 4.21). 
 
With reperfusion no increase in PI-positive cells was observed in mild SI 
(1.7±0.8%). However, a significant increase was apparent in moderate SI 
[40.3±6.7% (p<0.05)] and severe SI [92.4±1.8% (p<0.05)] respectively, compared 
to control cells (Fig. 4.22).  An increase in pyknotic cells was observed in mild SI 
[34.6±3.9% (p<0.05)], moderate SI [33.4±5.5% (p<0.05)] and severe SI [31.2±4.5% 
(p<0.05)].  
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4.3.1.
 4hrs SI/R PI exclusion and nuclear condensation 
 
 
 
 
 
 
 
 
 
 
Figure 4.21:  4 hrs SI. Data expressed as mean ± SEM, statistical 
analysis: ANOVA & Bonferroni correction, * p<0.05 vs Con, # p<0.05 vs 
mild SI, n=9, >150 cells counted 
 
 
 
 
    
 
 
 
 
Figure 4.22:  4 hrs SI/R. Data expressed as mean ± SEM, statistical 
analysis: ANOVA & Bonferroni correction, * p<0.05 vs Con, # p<0.05 vs 
mild SI, n=9, >150 cells counted. 
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4.3.2. MTT assay and ATP analysis 
As shown in Fig. 4.22, the relative viability based on MTT decreased significantly 
after 4 hrs mild SI (42.3±1.9%), moderate SI (34.5±1.4%) and severe SI 
(33.0±1.7%) compared to control cells. Compared to control ATP levels, ATP 
significantly increased in mild SI (966.3±85.1%), but not in moderate SI 
(160.0±40.2%); or severe SI (101.7±13.6%). Following a 1 hr reperfusion (Fig. 
4.23), relative mitochondrial viability recovered but remained significantly 
decreased compared to control viability [mild SI: 73.7±2.1%; moderate SI:  
84±3.3%; severe SI: 81.3±3.0% (p<0.05)]. The relative recovery of cells between 
mild and moderate SI is significant.  ATP returned to control levels in mild SI 
[84.3±6.4%], moderate SI [87.5±12.9%] and in severe SI [117.2±20.2%].  
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4.3.2. 4hrs SI/R MTT assay and ATP analysis 
 
 
 
 
 
 
 
 
 
Figure 4.23:  4 hrs SI. Normalised data expressed as mean ± SEM, 
statistical analysis: ANOVA & Bonferroni correction, * p<0.05 vs Con, # 
p<0.05 vs mild SI, n=6-9.  
 
 
 
 
 
 
 
 
 
 
Figure 4.24:  4 hrs SI/R. Normalised data expressed as mean ± SEM, 
statistical analysis: ANOVA & Bonferroni correction, * p<0.05 vs Con, # 
p<0.05 vs mild SI, n=6-9. 
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4.3.3. Western blot analysis
Western blot analysis 
phosphorylated AMPK (Fig. 4.25). The gradual trend seen at 2 hrs (Fig. 4.6) is now 
lost, showing an evenly strong signal in mild, moderate and severe SI. This 
phosphorylation pattern is lost with reperfu
PARP (Fig. 4.29) analyses reveal a strong signal, with the strongest signal in 
cleaved PARP during mild SI. Beclin
almost no signal in severe SI (Fig. 4.27). This gradual decrease
reperfusion, manifesting in an even beclin
phosphorylation in mild and moderate SI but not in severe SI, was observed (Fig. 
4.26).  
 
4.3.3.
 4hrs SI/R Western blot analysis
 
 
Figure 4.25:
kDa band following 4 hrs SI 
representative blot is shown.
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Figure 4.26:
kDa band following 4 hrs SI (top) and SI/R (below). A 
representative blot is shown.
 
 
 
 
 
 
 
Figure 4.27:
kDa band following 4 hrs SI (top) and SI/R (below). A 
representative blot is shown.
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Figure 4.28:
35 kDA bands following 4 hrs SI (top) and SI/R (below). A 
representative blot is shown.
 
 
 
 
 
 
 
 
 
 
Figure 4.29:
band following 4 hrs SI (top) and SI/R (below). A 
representative blot is shown.
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4.3.4. Immunofluorescence and Scanning Electron Microscopy 
When quantifying cells with numerous LC3 autophagosomes as an indication for 
autophagy following 4 hrs ischaemia, our results indicate a significant increase in 
autophagic activity in mild SI [17.2±2.3% (p<0.05)] as well as moderate SI 
[12.6±1.2% (p<0.05)] compared to control cells (0.9±0.4%), with no significant 
increase in severe SI (7.1±1.3%) (Fig. 4.30).  With reperfusion this increase in 
LC3-positive cells in mild and moderate SI is lost (Fig. 4.31).  
 
The fluorescence LC3 and actin cytoskeleton images indicate a prominent 
morphology of apoptosis in mild SI as well as a loss of membrane integrity in cells 
exposed to moderate and severe SI (Fig. 4.32, 4.33). Cells exposed to moderate 
and severe SI still appear larger and swollen and in most cases with an intact 
noncondensed nucleus. Immunofluorescence staining for beclin-1 makes this 
morphology more clear as it also indicates fine cytoskeletal-like cellular 
morphology (Fig 4.34, 4.35). Cytochrome c signals are present in mild, moderate 
and severe SI compared to control cells (Fig 4.34, 4.35). Additional to the 
relocation of HMGB1 from the nucleus to the cytosol, there are also intranuclear 
speckles of HMGB1 signals visible in all three ischaemic conditions (4.36, 4.37). 
 
The Scanning Electron images taken after 4 hrs SI (Fig. 4.38) support the 
molecular features described through fluorescence staining. Mild SI resulted in 
rounded cells with clear membrane blebs indicative of apoptotic cells. Moderate SI 
and severe SI on the other hand, primarily showed cells which remain flat adherent 
and swollen in their morphology with less sharp surface features than control cells, 
indicative of an increased loss of membrane integrity. 
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4.3.4. 4hrs SI/R Quantification of cells with numerous LC3 punctae 
 
 
 
 
 
 
 
 
Figure 4.30: 4 hrs SI. Data expressed as mean ± SEM, statistical 
analysis: ANOVA & Bonferroni correction, * p<0.05 vs Con, # 
p<0.05 vs mild SI n=9, >150 cells counted.  
 
 
 
 
 
 
 
 
Figure 4.31: 4 hrs SI/R. Data expressed as mean ± SEM, statistical 
analysis: ANOVA & Bonferroni correction, * p<0.05 vs Con, # 
p<0.05 vs mild SI n=9, >150 cells counted.  
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4.3.4. 4hrs SI/R Fluorescence Microscopy 
 
 
 
 
 
 
 
 
 
 
Figure 4.32: 4 hrs SI. H9c-2 myoblasts labelled with LC3/FITC, 
Actin/TexRed & Hoechst 33342. A: Con, B: mild SI, C: moderate SI, 
D: severe SI. 
 
 
 
 
 
 
 
 
 
 
Figure 4.33:  4 hrs SI/R. H9c-2 myoblasts labelled with LC3/FITC, 
Actin/TexRed & Hoechst 33342. A: Con, B: mild SI, C: moderate SI, 
D: severe SI. 
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Figure 4.34:  4 hrs SI. H9C2 myoblasts labelled with Cyt-c/FITC, Beclin-
1/TexRed & Hoechst 33342. A: Con, B: mild SI, C: moderate SI, D: 
severe SI. 
 
 
 
 
 
 
 
 
 
 
Figure 4.35:   4 hrs SI/R H9C2 myoblasts labelled with Cyt-c/FITC, 
Beclin-1/TexRed & Hoechst 33342. A: Con, B: mild SI, C: moderate SI, 
D: severe SI. 
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Figure 4.36:  4 hrs SI. H9c-2 myoblasts labelled with HMGB1/FITC A: 
Con, B: mild SI, C: moderate SI, D: severe SI. 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.37:  4 hrs SI/R. H9c-2 myoblasts labelled with HMG1/FITC 
A: Con, B: mild SI, C: moderate SI, D: severe SI. 
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 4.3.4. 4hrs SI/R Scanning Electron Microscopy (SEM) 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.38:  4 hrs SI. SEM micrographs of H9c-2 myoblasts. A: Con, B: mild 
SI, C: moderate SI, D: severe SI. Cells exposed to mild SI appear rounded off 
and shrunk, characteristic for apoptosis (B). Cells exposed to moderate and 
severe SI appear flat and show damaged cell membrane, indicated by its 
rough structure (C and D).   
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4.4. Experimental measurements after 8 hrs SI 
4.4.1. PI exclusion and nuclear condensation 
Following 8 hrs SI, the results for PI positive and pyknotic cells indicate an 
exacerbation of the results described at 4 hrs SI. In mild SI, a significant increase 
in PI-positive cells was observed [18.0±2.2% (p<0.05)] compared to control cells 
(0.6±0.4%) (Fig. 4.39). Pyknotic cells in mild SI increased significantly [61.1±2.8% 
(p<0.05)], compared to control cells (4.8±0.8%). In moderate [77.3±5.8% (p<0.05)] 
and severe SI [66.4±4.8% (p<0.05)] a significant increase in PI-positive cells was 
observed. Pyknotic cells increased, reaching significance in moderate SI [31±3.4% 
(p<0.05)] and severe SI [31.2±4.2% (p<0.05)] compared to control cells (Fig. 4.39). 
 
With reperfusion no further increase in PI-positive cells was observed in mild SI 
(19.9±2.9%). However, a significant increase was described in moderate SI 
[86.9±5.3% (p<0.05)] and severe SI [91.5±3.6% (p<0.05)] compared to control 
cells (Fig. 4.40). An increase in pyknotic cells was observed in mild SI [64.3±2.6% 
(p<0.05)], moderate SI [39.5±4.0% (p<0.05)] and severe SI [43.5±6.1% (p<0.05)] 
(Fig. 4.40).  
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4.4.1.
 8hrs SI/R PI exclusion and nuclear condensation 
 
 
 
 
            
 
 
 
Figure 4.39:  8 hrs SI. Data expressed as mean ± SEM, statistical 
analysis: ANOVA & Bonferroni correction, * p<0.05 vs Con, # p<0.05 vs 
mild SI, n=9, >150 cells counted. 
 
 
 
 
 
 
 
 
Figure 4.40:  8 hrs SI/R. Data expressed as mean ± SEM, statistical 
analysis: ANOVA & Bonferroni correction, * p<0.05 vs Con, # p<0.05 vs 
mild SI, n=9, >150 cells counted. 
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 4.4.2. MTT assay and ATP analysis 
As shown in Fig. 4.41, the relative viability based on MTT decreased significantly 
after 8 hrs mild SI (25±12.6%), moderate SI (16.9±2.5%) and severe SI (8.5±8.9%) 
compared to control cells. Viability in severe SI was significantly lower [8.5±8.9% 
(p<0.05)] compared to mild SI (25±12.6%). Compared to control ATP levels, ATP 
remained significantly increased in mild SI (231±27.7%). A significant decrease in 
ATP was observed in moderate SI [16.9±2.5% (p<0.05)] and severe SI [13.4±2.2% 
(p<0.05)], compared to mild SI (Fig. 4.41).  
 
Following 1 hr reperfusion (Fig. 4.42), the relative survival rate of cells increased 
but remained significantly lower compared to control viability in moderate SI  
[69.8±13.8% (p<0.05)] and severe SI [52.7±5.6.% (p<0.05)]. ATP levels returned to 
control levels in mild SI (107±15.5%) but remained significantly lower in moderate 
SI [18.9±1.9% (p<0.05)] and in severe SI [19±2.5% (p<0.05)] compared to control 
cells (Fig. 4.42).  
 
 
 
 
 
 
 
 
 
 
 
  
  4.4.2. 8hrs SI/R MTT assay and ATP analysis
 
 
 
 
 
 
 
Figure 4.41: 
statistical analysis: ANOVA & Bonferroni correction, * p<
p<0.05 vs mild SI, n=6
 
         
Figure 4.42: 
statistical analysis: ANOVA & Bonferroni correction, * p<0.05 vs Con, 
p<0.05 vs mild SI, n=6
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4.4.3. Western blot analysis
Western blot analysis following 8 hrs ischaemia reveals a gradual increase in 
signal of phosphorylated AMPK, weakest in mild SI and strongest in severe SI (Fig. 
4.43). This phosphorylation pattern is lost with reperfusion.
and cleaved PARP (Fig. 4.47) analyses reveal strong signals, particlarly in mild SI. 
No apparent differences in beclin
The phosphorylation state of mTOR indicates no differences between the groups. 
However, with reperfu
severe SI was observed (Fig. 4.44). 
 
 
4.4.3.
 8hrs SI/R Western blot analysis
 
 
Figure 4.43:
kDa band following 8 hrs SI (top) and SI/R (below). A 
representative blot is shown.
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Figure 4.44:
kDa band following 8 hrs SI (top) and SI/R (below). A 
representative blot is shown.
 
 
 
 
 
 
Figure 4.45:
kDa band following 8 hrs SI (top) and SI/R (below). A 
representative blot is shown.
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Figure 4.46:
kDA band following 8 hrs SI (top) and SI/R (below). 
representative blot is shown.
 
 
 
 
 
 
 
 
 
Figure 4.47:
band following 8 hrs SI (top) and SI/R (below). A 
representative blot is shown.
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4.4.4. Immunofluorescence and Scanning Electron Microscopy 
When quantifying cells with numerous LC3 autophagosomes as an indication of 
autophagy after 8 hrs ischaemia, the results showed a significant increase in 
autophagic activity in mild SI [11.7±1.8% (p<0.05)] with no significant increase in 
moderate SI (6.7±1.5%) or severe SI (6.6±2%) respectively (Fig. 4.48) compared 
to control cells (0.9±0.4%). With reperfusion this increase in LC3-positive cells in 
mild SI is lost (Fig. 4.49).  
 
The fluorescence images taken after 8 hrs SI indicate the most prominent 
morphology of apoptosis in mild SI with clear pyknosis but also karyorhexis, 
resulting in apoptotic bodies indicative of the progression of apoptotic cell death 
(Fig. 4.50, 4.51). LC3 autophagosomes are still clearly visible in these pyknotic 
cells (Fig. 4.50, 4.51). The actin signal reveals complete loss of cytoskeletal 
architecture. Moderate and severe SI indicate complete loss of membrane integrity. 
However, cells appear still large and swollen with karyorhexis also taking place 
(Fig. 4.50, 4.51). The fine pattern of beclin-1 signal is completely lost in all three 
groups, resulting in a more diffuse cytoplasmic beclin-1 signal (Fig. 4.52, 4.53). 
Also, the cytochrome c signal which is still present in mild, moderate and severe SI 
shows a particularly diffuse signal in moderate and severe SI, while a more 
perinuclear granular cytochrome c signal is apparent in cells exposed to mild SI 
(Fig. 4.52, 4.53). HMGB1 appears to be released from most nuclei in mild, 
moderate and severe SI, resulting in a fine granular cytoplasmic pattern, often 
leaving intranuclear speckles of HMGB1 signals (Fig. 4.54, 4.55). 
 
The Scanning Electron images taken after 8 hrs SI (Fig. 4.56) reveal most 
prominent morphology of apoptosis in mild SI, whilst moderate SI and severe SI 
show cells which have lost their membrane integrity completely. 
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4.4.4. 8hrs SI/R Quantification of cells with numerous LC3 punctae 
 
 
 
 
 
 
 
 
 
Figure 4.48:   8 hrs SI. Data expressed as mean ± SEM, statistical 
analysis: ANOVA & Bonferroni correction, * p<0.05 vs Con, # 
p<0.05 vs mild SI n=9, >150 cells counted.  
 
 
 
 
 
 
 
 
Figure 4.49:  8 hrs SI/R. Data expressed as mean ± SEM, statistical 
analysis: ANOVA & Bonferroni correction, * p<0.05 vs Con, # p<0.05 
vs mild SI n=9, >150 cells counted.  
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4.4.4. 8hrs SI/R Fluorescence Microscopy 
 
 
 
 
 
 
 
 
 
Figure 4.50:8 hrs SI. H9c-2 myoblasts labelled with LC3/FITC, Actin/TexRed 
& Hoechst 33342. A: Con, B: mild SI, C: moderate SI, D: severe SI. 
 
 
 
 
 
 
 
 
 
 
Figure 4.51: 8 hrs SI/R H9c-2 myoblasts labelled with LC3/FITC, 
Actin/TexRed & Hoechst 33342. A: Con, B: mild SI, C: moderate SI, D: 
severe SI. 
A 
D B 
C 
A 
D B 
C 
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 Figure 4.52: 8 hrs SI. H9c-2 myoblasts labelled with Cyt-c/FITC, Beclin-
1/TexRed & Hoechst 33342. A: Con, B: mild SI, C: moderate SI, D: severe 
SI. 
 
 
 
 
 
 
 
 
 
Figure 4.53: 8 hrs SI/R. H9c-2 myoblasts labelled with Cyt-c/FITC, Beclin-
1/TexRed & Hoechst 33342. A: Con, B: mild SI, C: moderate SI, D: severe SI. 
A 
D B 
C 
A 
D B 
C 
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Figure 4.54:  8 hrs SI. H9c-2 myoblasts labelled with HMGB1/FITC.      
A: Con, B: mild SI, C: moderate SI, D: severe SI. 
 
 
 
 
 
 
 
 
 
 
Figure 4.55: 8 hrs SI/R. H9c-2 myoblasts labelled with HMGB1/FITC.     
A: Con, B: mild SI, C: moderate SI, D: severe SI. 
A 
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C 
A 
D B 
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4.4.4.8hrs SI/R Scanning Electron Microscopy (SEM) 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.56: 8 hrs SI. SEM micrographs of H9c-2 myoblasts. A: Con, B: mild SI, C: 
moderate SI, D: severe SI. Cells exposed to mild SI show a shrunk cell soma (B). 
Cells exposed to moderate and severe SI show a ring of membrane structures 
and a central soma, indicating cell membrane damage (C and D).  
 
 
  
 
 
 
 
 
 
B D 
C A 
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CHAPTER 5 DISCUSSION: TIME POINTS 
 
5.1. Autophagy, apoptosis and necrosis evaluated concomitantly  
       and dynamically 
 
Literature indicates a great need and interest in clarifying the role of apoptosis and 
necrosis in pathophysiological conditions such as in the ischaemic myocardium. It 
has been suggested that apoptosis is the major form of myocardial damage during 
ischaemic injury, with necrotic cell death following apoptosis (Kajustra et al., 1996). 
Of particular interest is not only the extent and order of myocyte cell death but also 
the severity and duration of the ischaemic insult, which are important in predicting 
and ultimately preventing myocyte cell loss. It has also been suggested that 
apoptosis primarily plays a role in the chronically ischaemic myocardium (Freude et 
al., 1998), while its role in the acute setting remains unclear. The new and growing 
field of autophagy brings about another dimension of the myocyte response to 
ischaemic injury (Fig. 5.1). Although autophagy may be activated during cell death, 
it has been described as the cell’s major adaptive strategy in response to metabolic 
challenges as well as a defence mechanism upon cell injury. In the heart, 
autophagy has been shown to take a key position in profoundly affecting the 
process of cell death (Nishida et al., 2009, Yu et al., 2008, Loos & Engelbrecht, 
2009), and in enhancing the heart’s tolerance to ischaemia (Hamacher-Brady et 
al., 2006).  
 
The above suggestions and findings imply that autophagy, apoptosis and necrosis 
are to be evaluated concomitantly and dynamically in context of severity and 
duration of an ischaemic insult, in order to clarify their respective importance during 
myocardial injury. A clear understanding of their role during myocardial injury is 
crucial in order to develop effective therapeutic strategies.    
 
The aims of this study are therefore to (i) characterize the contribution of each cell 
death type in context of the severity and duration of an ischaemic insult and (ii) to 
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determine whether manipulation of the autophagic pathway affects this contribution 
of cell death and translates into protection of the heart. For that purpose, a 
combination of viability techniques, ATP and MTT measurements, 
immunofluorescence and electron microscopy, live cell imaging and flow cytometry 
as well as western blotting, was employed. It was hypothesized that the relative 
contribution of each mode of cell death is dependent on the duration and severity 
of the ischaemic insult and is governed by the cells underlying metabolic capacity 
at a given point in time. It was further hypothesized that the onset of apoptosis and 
necrosis depends on the cell’s autophagic activity prior/during the ischaemic event 
due to the role of autophagy on the cell’s metabolic capacity.  
 
5.2. The effect of mild, moderate and severe simulated ischaemia on    
        apoptosis and necrosis 
 
Our results strongly indicate a differential manifestation of PI positive and pyknotic 
cells between mild, moderate and severe SI. Mild SI leads to a primarily apoptotic 
cellular phenotype with more than 60% of cells being pyknotic after 8 hrs SI (Fig. 
4.39, 4.40). Importantly, PI-positive cells are only detected after 8 hrs mild SI. 
However, moderate and severe SI manifest very early in a primarily necrotic 
cellular phenotype, indicated through early appearance of PI-positive cells. 
Following 2 hrs SI, a significant increase in PI-positive cells is observed. At this 
early time point the extent of cell death is, although significant, still rather limited 
(Fig. 4.2, 4.3). It has been shown that myocytes exposed to short periods of even 
severe ischaemia may almost completely be restored after reperfusion. However, 
this restoration is not immediate, indicating the dynamic behaviour of 
ischaemia/reperfusion injury (Jennings et al., 1985). In the own model, after 8 hrs 
moderate and severe SI, necrotic cells contribute to about two thirds of cell death, 
worsening upon reperfusion. Only about 1/3 of cells is pyknotic following 8 hrs 
moderate and severe SI (Fig. 4.39, 4.40).  
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Our model of mild SI leads to prominent features of apoptosis already during 
ischaemia which further increase at reperfusion. It is important to note that 
reperfusion injury observed in our model likely manifests in a differential manner, 
with the same morphology primarily present during SI. In mild SI, PI-positive cells 
made a minor contribution following reperfusion. However, in moderate and severe 
SI a major contribution has been observed already after 4 hrs SI followed by 
reperfusion (Fig. 4.21, 4.22). It has been suggested that necrosis (Zhao et al., 
2000), but also apoptosis, are ongoing processes during ischaemia and that 
reperfusion primarily “boosts” apoptosis (Eefting et al., 2003). This is supported by 
the findings that caspase-3 inhibition during early reperfusion limits apoptotic cell 
death in myocardial infarction (Mocanu et al., 2000). Our results indicate that this 
may be dependent on the severity of the ischaemic insult where more severe 
ischaemic injury primarily leads to necrosis, which is further exacerbated during 
reperfusion (Fig. 4.22). It is challenging to transfer results from an in vitro model 
into the ex vivo scenario. This may, however, be of clinical interest as it may imply 
a prediction of cell death based on the primary cell death phenotype of the tissue 
observed during the ischaemic event. A necrotic tissue area may increase with 
reperfusion. However, apoptotic areas may not necessarily become necrotic but 
might show a further increase in apoptotic morphology. Due to the implication of 
inflammation during necrosis this may be of particular importance. It is also of 
interest that in our model, moderate and severe SI follow a very similar trend in the 
contribution of apoptosis and necrosis during the progression of the ischaemic 
injury.     
 
5.3. The effect of mild, moderate and severe simulated ischaemia on   
       cellular ATP and mitochondrial reductive capacity 
 
The results showed a significant increase in ATP during mild SI (Fig 4.4) which 
reached its maximum at 4 hrs SI with a 10-fold increase compared to control cells 
(Fig. 4.23) and remained significantly increased even after 8 hrs mild SI (Fig. 4.41). 
With reperfusion ATP levels matched the ATP levels of control cells. However, 
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although ATP levels in moderate and severe SI stayed at that of control cells for up 
to 4 hrs SI, a significant ATP depletion was already observed after 2 hrs SI 
followed by reperfusion (Fig. 4.5). ATP levels were significantly decreased at 8 hrs 
moderate and severe SI compared to the ATP levels of control cells (Fig. 4.41, 
4.42).     
 
The ATP surge observed in mild SI (Fig. 4.4, 4.23, 4.41) is associated with 
increased autophagy, manifesting in prominent autophagosome formation (Fig. 
4.12, 4.30, 4.48). It may be suggested that the described ATP surge confers a 
degree of cytoprotection, creating a metabolically more favourable environment 
compared to the other ischaemic groups, favouring apoptosis over necrosis. 
Katayama and co-workers described a similar autophagy-associated increase in 
ATP in glioma cells, which had a cytoprotective effect (Katayama et al., 2007). 
Zamaraeva et al. have shown, through real time measurements, an increase in 
cytosolic ATP during apoptosis. However, autophagy has not been assessed in 
that model (Zamaraeva et al., 2005). It is of note that these are the only indications 
in the currently available literature where an ATP increase was observed. The 
results are therefore highly significant as in most studies conducted the inhibition of 
glycolysis by 2DG led to a rapid depletion of ATP (Lieberthal et al., 1998, Volbracht 
et al., 1999, Dagher, 2000, Bogliolo et al., 2002, Healy et al., 2002, Gonon-Giroud 
et al., 2002). However, in these studies different cell types such as mouse proximal 
tubular cells, cerebellar granule neurons and bone marrow derived cells have been 
employed. Also, the ischaemic condition varied in these experiments by 
maintaining the environment normoxic and by adding 2DG to the growth medium 
and not employing an ischaemic buffer. The time frame and capacity to upregulate 
autophagy and to maintain increased autophagy have been shown to be cell type 
specific (Mizushima et al., 2004). Therefore it is likely that in those studies the 
autophagic machinery was not induced timely, hence no metabolic contribution 
was made through autophagically-generated ATP. It is also plausible that 
increased autophagic flux provides substrates to fuel the ATP-consuming 
processes which may be increased in metabolically stressed cells to counteract the 
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metabolic perturbations. The ATP surge observed in this study (Fig. 4.4, 4.23, 
4.41) may be a manifestation of substrate provision which only becomes visible 
due to the fact that the demand for ATP consuming processes may abruptly cease 
as the cell starts to die from apoptosis. This would “unmask” the metabolic effect of 
increased autophagy on substrate provision and ATP generation which then 
becomes visible in the measured ATP surge. It has been shown that doxorubicin-
induced apoptosis can be reduced by 2-DG treatment (Thakkar & Potten, 1993) 
possibly indicating a similar scenario where increased autophagy may provide 
substrates to be utilized, providing a temporary metabolically selective advantage 
which delays apoptosis. Dietary restriction and 2DG treatment has also shown to 
reduce ischaemic brain damage (Yu & Mattson, 1999). However, autophagy has 
not been considered in these studies.  
 
Own MTT results indicate a rapid decrease in mitochondrial reductive capacity in 
mild, moderate and severe SI already after 2 hrs, indicating the potency of the 
ischaemic event (Fig. 4.4). After 4 hrs moderate and severe SI the reductive 
capacity measured by MTT decreased significantly compared to mild SI (Fig. 4.23). 
It is of note that with reperfusion, although reductive capacity remained significantly 
lower than control, it increased to an extent (Fig. 4.24). This may be indicative of 
temporal mitochondrial metabolic down-regulation during SI and partial up-
regulation during reperfusion. These results stress that MTT-reductive capacity is 
only an indication of cellular viability but not a measure of viability per se. Another  
interesting observation is the finding that after 8 hrs severe SI followed by 
reperfusion, more than 90% of the cells are PI positive, indicative of non-viable 
cells which died due to loss of membrane integrity, indicative of necrosis (Fig 4.40). 
The MTT results, however, revealed still more than 50% of cells with a reductive 
capacity even if the cell membranes were impaired (Fig. 4.42). These results 
suggest that mitochondrial enzymes may still be partially functional even when the 
cell is in the process of losing membrane integrity. These results also support the 
importance of performing multiple viability tests.  
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5.4. The effect of mild, moderate and severe simulated ischaemia-  
       metabolic sensing, autophagy and apoptosis 
 
Own western blot results support the abovementioned observation of a differential 
induction of cell death. The pAMPK results reveal a gradual increase in AMPK 
phosphorylation in mild, moderate and severe SI, which may indicate the 
differential metabolic demand prevalent in the three ischaemic conditions (Fig. 4.6, 
4.25, 4.43). Mild SI reveals a weak increase in pAMPK, however, in moderate and 
severe SI a stronger pAMPK pattern is observed. This differential phosphorylation 
pattern is lost after reperfusion (Fig. 4.6, 4.25, 4.43). Interestingly, only mild SI 
shows an increase in autophagy (Fig 4.12, 4.30, 4.48), and the loss in pAMPK after 
reperfusion is also mirrored by a decrease in autophagy (Fig 4.13, 4.31, 4.49). 
These results are supported by the functional role of AMPK to switch on ATP-
producing catabolic pathways and to switch off ATP-consuming processes (Hardie 
et al., 2003, Luiken et al., 2004). AMPK has been shown to play a direct role in fuel 
selection in response to the cellular energy status (Houten et al., 2009) by 
stimulating the protein expression of fatty acid transporters time and dose 
dependently (Chabowski et al., 2006). AMPK is rapidly inactivated after reperfusion 
(Takagi et al. 2007), which is also observed in our results.  It has been shown that 
autophagy is beneficial during the ischaemic event, whilst having opposing effects 
in the reperfusion phase. In the mouse heart ex vivo, 20 min of ischaemia induces 
autophagy with a further increase in autophagosome formation during reperfusion 
(Matsui et al., 2007). Furthermore, in glucose-deprived cardiac myocytes, 
autophagy resulting from ischaemia has been shown to be accompanied by AMPK 
activation and inhibited by dominant negative AMPK, suggesting an AMPK- 
dependent mechanism. AMPK is rapidly activated during myocardial ischaemia 
and leads to an increase in glucose uptake and oxidation as well as fatty acid 
oxidation (Gottlieb et al., 2009). Autophagy is enhanced after reperfusion which is 
accompanied by an inactivation of AMPK and an increase in beclin-1 (Matsui et al., 
2007). Most studies also suggest an anti-apoptotic role for AMPK. In another 
model where autophagy is serially induced in energy-starved and energy-
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unstarved conditions, ATP content rapidly recovers after reperfusion. Mice which 
overexpress AMPK in a dominant negative fashion showed decreased 
autophagosome formation in response to ischaemia which corresponded with a 
greater infarct size (Matsui et al., 2007). Interestingly, AMPK has shown to be 
differentially controlled depending on the severity of the ischaemic insult (Matsui et 
al., 2007). However, induction of autophagy during the reperfusion phase was 
attenuated by beclin-1+/- mice, indicating a beclin-1-dependent but AMPK-
independent mode of action. This response was accompanied by a smaller infarct 
area (Matsui et al., 2007).  
 
The pmTOR results in this study indicate, that simulated ischaemia has an effect 
on mTOR phosphorylation. Our results indicate that pmTOR was not yet affected 
after 2 hrs SI (Fig. 4.7), however it is decreased after 4 hrs SI (Fig. 4.26), with the 
greatest decrease visible in mild SI (Fig.4.26). This pattern is also maintained after 
reperfusion (Fig. 4.26). pmTOR remains decreased in mild, moderate and severe 
SI after 8 hrs SI/R (Fig. 4.44). These results indicate an association between 
mTOR induction and autophagy mainly during mild SI, which is mirrored by an 
increase in cells with numerous LC3 punctae (Fig. 4.12, 4.30, 4.48). mTOR is a 
key regulator for cell growth and autophagy and it is now generally accepted, that 
this nutrient sensor kinase negatively regulates autophagy. mTOR is a sensor for 
amino acids and ATP and can integrate hormonal stimuli via the class I PI3-K/PKB 
pathway. The class I PI3-K allows membrane binding and activation of Akt/PKB. 
Activation of this pathway has an inhibitory effect on autophagy (Sarbassov et al., 
2005). The phosphatase PTEN which hydrolyzes PIP3, has a stimulative effect on 
autophagy by inhibiting the actions of class I PI3-K /PKB (Klionsky, 2005). It is 
therefore important to note that mTOR controls protein synthesis and autophagic 
proteolysis through the same pathway although in opposite directions. 
 
The beclin-1 results indicate no significant changes following 2, 4 or 8 hrs SI/R 
(Fig. 4.8, 4.27, 4.45). It has been demonstrated, that overexpression of beclin-1 
protects against SI/R injury (Hamacher Brady et al., 2006). In an ex vivo model, 
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beclin-1 expression has been shown to be dramatically enhanced after 
ischaemia/reperfusion (Takagi et al., 2007). The caspase-3 results support a 
strong induction of apoptosis, particularly in mild SI (Fig. 4.9, 4.28, 4.46). The 
differential response through apoptosis between mild, moderate and severe SI can 
be better distinguished when observing the extent of PARP cleavage. Our results 
indicate cleaved PARP particularly in mild SI (Fig. 4.10, 4.29, 4.47).  
 
Our results indicate a differential induction of apoptosis, which is exacerbated after 
reperfusion. It has previously been shown that apoptosis may already be induced 
during ischaemia, but reperfusion may also be required for completion of the 
apoptotic cascade (Engelbrecht et al., 2004). Our results may be indicative of the 
progression of apoptosis induction within the apoptotic pathway, which is 
supported by the observation of nuclear condensation and apoptotic bodies (Fig. 
4.2). It has been demonstrated that TUNEL-positive cells are especially increased 
at the borders of subacute infarcts, indicating areas of mild ischaemic injury 
(Takemura et al., 2006). Our results indicate that apoptosis is the predominant 
form of cell death in mild SI but not in moderate and severe SI. In experimental 
models for myocardial infarction it has been shown that particularly in the first 2-4 
hours of coronary artery occlusion most cell death manifests with apoptotic 
morphology (Kajstura et al., 1996).  
 
5.5. The effect of mild, moderate and severe simulated ischaemia:   
       fluorescence and scanning electron microscopy  
 
The fluorescence imaging results reveal a distinct differential distribution of 
autophagy, apoptotic and necrotic cell death. In our model, mild SI resulted in 
primarily apoptosis with prominent features of autophagy (Fig. 4.14, 4.20, 4.32, 
4.38, 4.51, 4.56). Moderate and severe SI resulted primarily in necrosis, with partial 
apoptosis but no indication of autophagy. In cells exposed to mild SI, the LC3 
signal was most prominent in the perinulclear region (Fig. 4.11, 4.14). This may 
represent the normal location of lysosomes but it may also indicate a particular 
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area of metabolic need within the cell.  Mitochondria, which are highly dynamic and 
motile, constantly fuse and fragment, and it has also been shown that their 
intracellular arrangement can manifest around the nucleus due to an intracellular 
metabolic gradient from the middle of the cell to the periphery (Bereiter-Hahn et al., 
2009). This may, however, only be restricted to the in vitro model, as upregulation 
of autophagy in the in vivo heart does not result in a perinuclear LC3 signal 
(Mizushima et al., 2004). However, the mitochondrial dynamic behaviour is likely to 
be impaired upon collapse of cytoskeletal architecture, as shown in the actin 
fluorescence images, which may prevent a functional mitochondrial response upon 
metabolic stress such as in ischaemic injury.  Importantly, only in mild SI, a 
significant increase in cells with numerous LC3 punctae was observed, which was 
accompanied by pyknosis, but not necrosis. This may indicate, that a metabolically 
favorable environment is achieved with autophagy, favoring apoptosis over 
necrosis, resulting in less detrimental consequences. Yu and Mattson have 
observed a reduction in ischaemic brain damage, following dietary restriction and 
2DG treatment, which may indicate a similar underlying mechanism (Yu & Mattson, 
1999). However, autophagy has not been measured in that study. Our findings 
make clear, that mild SI may serve as an appropriate model to study autophagy.  
 
Our beclin-1 images show, to our knowledge for the first time, a very fine and 
tubulin-like distribution pattern throughout the cytoplasm (Fig. 4.16). Others (Sun et 
al., 2008; Pickford et al., 2008) have shown a cytoplasmic but granular signal of 
beclin-1, in close proximity to tubulin. Based on our fluorescence results, grey 
zones between apoptosis and necrosis become apparent. Our results indicate, for 
example, cytochrome c release in mild, moderate and severe ischaemia. 
Moreover, it has been shown that HMGB1 remains bound to chromatin in apoptotic 
cells due to histone underacetylation (Scaffidi et al., 2002). However, in our model 
also apoptotic cells (SI) seem to cause a relocation of HMGB1. Due to an intact 
membrane however, triggering of inflammation would be prevented. Flow 
cytometry analysis may be indicated for future studies to quantify both the release 
kinetics of cytochrome c and HMGB1. 
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5.6. Summary 
 
Taken together, these results demonstrate that the duration as well as the severity 
of the ischaemic insult lead to the induction of a differential cellular response 
manifesting in distinct cell death morphology. Mild SI induced a primarily apoptotic 
cell death, whilst moderate SI or severe SI led to both apoptotic and necrotic cell 
death in our model. Most interestingly and intriguing is the finding that only mild SI 
shows an almost entirely apoptotic cell death, an accumulation of autophagosomes 
as well as an ATP surge. These data highlight the role of the severity of an 
ischaemic insult in context with the cell’s metabolic capacity and mode of cell death 
induced. It is indicated that a mild ischaemic insult leads to an autophagic 
response and manifestation of apoptosis. It is likely that the autophagic response 
leads to an intracellular metabolic environment which prevents necrosis but 
induces apoptosis when a metabolic failure is inevitable.  
 
In contrast, a moderate or severe ischaemic insult leads to necrosis without an 
autophagic response and with ATP depletion. It is likely that a severe insult does 
not allow the autophagic machinery to be induced, hence apoptosis may switch 
rapidly to necrosis (Leist et al., 1997) as the metabolic environment is more rapidly 
depleted of ATP. Our data highlight the role of the severity of an ischaemic insult in 
context with the cells metabolic capacity and mode of cell death induced. It is 
indicated that a mild ischaemic insult leads to an autophagic response and 
apoptosis, whilst a more severe ischaemic insult leads to necrosis without an 
autophagic response but ATP depletion. 
 
Importantly, these results suggest that the concomitant study of autophagic activity 
in the context of apoptosis and necrosis as well as the cellular metabolic 
performance deserves more attention. These results stress the significance of the 
severity and duration of the stimulus to induce the autophagic machinery. In the 
heart, autophagy is induced during both acute and chronic ischaemia as well as 
during nutrient starvation (Gustafsson et al., 2008, Matsui et al., 2007). Myocardial 
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ischaemia is characterized by acidosis which is brought about by the breakdown of 
ATP, a rise of intracellular phosphates and stimulation of glycogenolysis (Poole-
Wilson, 1989). During severe myocardial ischaemia, glycolysis is even more 
increased due to the dramatic decline in oxidative phosphorylation. However, the 
uncoupling of glycolysis from glucose oxidation leads to an increase in lactate and 
protons, which decreases cardiac function. A fall of only 0.2 pH units causes a 50% 
decline in developed tension (Poole-Wilson, 1989). Reduction in proton production 
has been shown to counteract this decrease in efficiency (Liu et al., 1996). To 
maintain cardiac metabolism through increased autophagy and hence an increase 
in generated ATP would counteract the drop in intracellular pH and the 
accompanied decline in contractility. It may be that only a defined time window for 
an autophagic response exists, as autophagy is inhibited in severe or prolonged 
ischaemia (Hamacher-Brady et al., 2006, Takagi et al., 2007). It is therefore 
recommended to assess multiple parameters (Mizushima, 2005) to predict the 
outcome of autophagy either as stress adaptation and survival mechanism, or as a 
symptom of bioenergetic failure. Only the dissection of these factors may indicate 
this fine line between survival and death. 
 
In general, our results also highlight the importance of using multiple viability tests 
to avoid false negative results. For example, a trypan blue-based viability 
assessment of cells exposed to 8 hrs mild SI would, similar to PI results, show 18% 
nonviable cells, missing the 61% apoptotic cells, which still have an intact 
membrane (Fig. 4.39). These data may be of particular interest for the field of 
cardiovascular research as the results reveal that different in vitro models of 
simulated ischaemia may manifest in a differential mode of cell death, which can 
only be completely evaluated with a combination of viability tests. Recent 
guidelines to assess cell death modes suggest the use of multiple and 
methodologically nonrelated assays (Galuzzi et al., 2009), which is in agreement 
with our results. 
 
 
 135 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.1: Model of the cell’s capacity to respond to a defined insult, 
indicating   the typical morphological features of different types of cell death: 
‘autophagy  baseline’ 1, ‘autophagy induced’ 2, ‘cell death with autophagy’ 3, 
‘apoptosis induced’ 4, ‘apoptosis executed’ 5, ‘necrosis induced’ 6 and 
‘necrosis executed’ 7. Cells are counterstained for light chain 3 (LC3) (green), 
actin (red) and nuclei (blue). The manifestation and overlap of the above 
morphological features are dependent on the severity of the insult, its 
duration and the metabolic state of the cell. 
 
 
 
 
 
 
  
CHAPTER 6 RESULTS: ONSET DYNAMICS
 
6.1. Protocol - onset dynamics in vitro
In order to investigate whether autophagy is contributing to cell death or survival, 
autophagy was induced by rapamycin treatment and inhibited by 3 MA treatment. It 
was then investigated whether cell death is accelerated or delayed. Due to the 
findings of the differential death mode contribution in the first part of this study, we 
employed mild SI as model for apoptotic and moderate SI as a model for necrotic 
cell death respectively (Fig. 6.1). 
 
 
 
 
 
 
 
Figure 6.1
onset dynamics with induced or inhibited autophagic 
activity. Following 24 hrs of treatment with either 
rapamycin or 3MA, cells were exposed to 2 hrs of 
mild or moderate SI. 
 
 
 
 
 
 
 
 
 
:  In vitro experimental protocol for study
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6.2. Live Cell Imaging
In order to elucidate the relationship between a
apoptosis and necrosis, live cell imaging was employed to capture cellular events 
in real time. Cells seeded on chambered coverglass slides were transfected with a 
LC3-GFP construct and treated for 24 hrs with either rapamyc
to characterize the spatial and functional relationship between autophagosomes, 
lysosomes and mitochondria, transfected cells were treated with the appropriate 
organellar dye and images were acquired every 4 seconds.  
       
Figure 6.2:  Rapamycin treatment results in an rapid increase of autophagosomes (2a) 
compared to baseline autophagic activity (1a), Following fusion with lysosomes, their 
degraded content is released and provides additional substrates to be oxidized in respiring 
mitochondria (3b). H9c-
counterstained with Lyostracker Red (1b, 2b) or Tetramethylrhodamine Ethyl Ester (TMRE) 
(3b) to indicate autophagosomes, lysosmomes and actively respiring mitochondria 
respectively.  An overlay is shown (1c
 
utophagic activity and onset of 
 
2 myoblasts have been transfected with LC3
-3c). The data are shown as a movie clip on the CD. 
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in or 3-MA. In order 
 
-GFP (1a-3a), 
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6.2.1. LC-3 imaging 
Following a 24 hr treatment period with either rapamycin (micrograph panel2) or 3-
MA (micrograph panel3) of cells seeded on chambered coverglass slides were 
exposed to 2 hrs mild SI (micrographs B1-3) or moderate SI (micrographs C1-3) 
respectively and then stained for LC3 and nuclear DNA to visualize the autophagic 
response (Fig. 6.3). A1-A3 represent normoxic control cells. Exposure to 2 hrs mild 
and moderate SI led to a differential autophagic response as seen by the 
accumulation of LC3 punctae. In control conditions rapamycin treatment led to 
robust formation of autophagosomes (A2), whilst 3MA treatment resulted in a 
diffuse cytoplasmic LC3 signal (A3) comparable to non-treated cells (A1). It is 
therefore highly likely that autophagic flux was upregulated in the cells prior 
submission to the SI protocol (this is supported by the acridine orange-based flow 
cytometry and imaging results. See addendum). It can clearly be seen that mild SI 
induced the generation of autophagosomes (B1) which was maintained with 
rapamycin treatment (B2). This response was less prominent with 3MA treatment 
(B3). Cells exposed to moderate SI did not show this prominent autophagosome 
formation (C1) only rapamycin treatment (C2) but not 3MA treatment (C3) seems to 
have manifested in autophagosome formation.  
 
 
 
 
 
 
 
 
A 1 B 3 B 2 B 1 A 3 A 2 
C 2 C1 C3 
  
Figure 6.3:  Fluorescent micrographs showing LC3 
exposed to mild SI (micrographs B
Nuclear DNA is indicated in blue by using Hoechst 33342. A
cells.  
 
 
6.2.2. Propidium Iodide uptake dynamics
 
In order to assess the dynamic nature of the loss in cellular membrane integrity the 
dynamic characteristics of PI uptake during simulated ischaemia was investigated 
by time lapse imaging and multiple regions of interest analysis (ROI) (Fig. 6.4). 
Loss of membrane integrity is a major morphological feature of necrotic cell death. 
 
Our results (Fig. 6.5, 6.6) indicate a significant delay in the loss of membrane 
integrity in cells treated with rapamycin (EC 50: 86.4±4.1) compared to moderate 
(green) autophagosomes in cells 
1-3) or moderate SI (micrographs
1-A3 show normoxic control 
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 C1-3) respectively. 
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SI (EC 50: 64.7±4.1). 3MA treatment prior to the ischaemic event induced loss of 
membrane integrity similar to moderate SI
 
(EC 50: 69.4±4.1). Moreover, rapamycin 
treatment prior to ischaemia manifested in a significantly lower top value of the 
sigmoid intensity curve (results not shown) compared to simulated ischaemia, 
indicating not only a delayed loss in membrane integrity but also a weaker influx of 
the dye propidium iodide manifesting in weaker fluorescence signal at a given time. 
3MA treatment prior to the ischaemic event showed a top value similar to moderate 
SI compared to the control value. These data strongly indicate a delay in necrosis 
brought about by a rapamycin-induced increase in autophagic activity (Fig. 6.5).  
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Figure 6.4: Following 24 hrs treatment with either rapamycin or 3-MA, cells 
seeded on chambered coverglass slides were exposed to 2 hrs moderate SI, 
to model a primarily necrotic mode of cell death, whilst images were captured 
every 180 seconds, to visualize the dynamic characteristics of PI uptake. For 
each condition >120 ROI’s were analyzed. Four independent experiments 
have been performed.    
0 min 120 min ROI’s  
ROI’s intensity profile  
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Figure 6.5: Intensity distribution over time, indicating the onset of PI uptake and 
hence loss in membrane integrity. Fluorescence emission was monitored at 1 frame 
per 180 seconds for 2 hrs by collection windows for TexRed emission, using a UBG 
triple bandpass emission filter. For each condition >120 ROI’s were analyzed. 
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Figure 6.6: EC50 data showing moderate SI (SI), moderate SI + 
Rapamycin treatment (RAPA), moderate SI + 3MA treatment (3MA). A 
vector control (DMSO) is also shown. The EC 50 data indicate a 
significant difference in time, when using rapamycin compared to SI. 
The vector shows no effect.  
 
 
 
 
 
 
 
 
 
 
 
 
treatment; LS Means
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6.2.3. Fluorescence Resonance Energy Transfer (FRET) and mitochondrial   
           depolarization dynamics 
 
Caspase-3 activation (Youle & Strasser, 2008) and loss of mitochondrial 
membrane depolarization (Galluzzi et al., 2007) have both been described as a 
point-of-no-return (PONR) in apoptotic cell death. As previously shown (Tyas et al., 
2000) and verified in our cell line, the results also show that both depolarization of 
the mitochondrial inner membrane and the activation of caspase-3 are rapid events 
and occur in parallel (Fig. 6.8, 6.9). Our real time imaging results indicate a 
significant delay in the loss of mitochondrial membrane potential in cells treated 
with rapamycin (EC 50: 1.8 ±0.06) compared to mild SI (EC 50: 0.69±0.01) (Fig. 
6.7, 6.10, 6.11). 3MA treatment prior to the ischaemic event induced loss of 
membrane integrity significantly earlier when compared to mild SI (EC 50: 0.36 
±0.38.) and hence had a more detrimental effect (Fig. 6.10, 6.11). These findings 
are in agreement with a recent study, which has demonstrated that the inhibition of 
autophagy increases loss of mitochondrial depolarization (Qadir et al., 2008).    
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Figure 6.7: Following 24 hrs treatment with either rapamycin or 3-MA, cells 
seeded on chambered coverglass slides were exposed to 2 hrs mild SI, to 
model a primarily apoptotic mode of cell death, whilst images were captured 
every 180 seconds to visualize the dynamic characteristics of caspase-3 
activity and loss of mitochondrial membrane potential. For each condition 
>120 ROI’s were analyzed. Four independent experiments have been 
performed.  
0 min 120 min ROI’s 
ROI’s intensity profile  
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Figure 6.8: Depolarization of the mitochondrial inner membrane and the activation of   
caspase-3 are rapid events and occur in parallel. H9c-2 cells were exposed to mild SI 
whilst the CFP/YFP emission ratio and the TMRE fluorescence intensity were 
measured simultaneously. As TMRE intensity decreases (red lines), the CFP/YFP 
ratio increases (blue lines) (B). The CFP/YFP ratio of a representative cell was plotted 
alongside the TMRE fluorescence intensity over 120 min duration of imaging (A).  
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Figure 6.9: H9c-2 cells were maintained under normoxic conditions whilst the CFP/YFP emission 
ratio and the TMRE fluorescence intensity were measured simultaneously. TMRE intensity (red 
lines) and CFP/YFP ratio (blue lines) remain unchanged (B). The CFP/YFP ratio of a representative 
cell was plotted alongside the TMRE fluorescence intensity over 120 min duration of imaging (A).  
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Figure 6.10: Intensity distribution over time, indicating the loss in mitochondrial 
membrane depolarization.  Fluorescence emission was monitored at 1 frame per 180 
seconds for 2 hrs by collection windows for TexRed emission, using a UBG  triple 
bandpass emission filter. For each condition >120 ROI’s were analyzed.  
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Figure 6.11: EC50 data showing mild SI (SI), mild SI + Rapamycin 
treatment (RAPA), mild SI + 3MA treatment (3MA). A vector control 
(DMSO) is also shown. The EC 50 data indicate a significant 
difference in time, when using rapamycin or 3MA, compared to SI. 
The vector shows no effect.  
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6.3. Flow Cytometry 
In order to quantify the propidium iodide and Tetramethylrhodamine Ethyl Ester 
intensity dynamics described through real time imaging, flow cytometry was 
performed. Following a 24 hr treatment period with either rapamycin or 3-MA, cells 
were seeded in tissue culture flasks, exposed to 2 hrs mild or moderate SI and 
collected for analysis on the flow cytometer. At least 5000 events of the gated 
population were recorded.  Based on a 3-dimensional representation of the forward 
and side scatter, the differential morphology of cells exposed to mild or moderate 
SI is revealed (Fig. 6.12).  
 
 
 
 
 
 
 
 
 
Figure 6.12: Based on a 3-dimensional representation of the forward and side scatter, the 
earlier described differential morphology is revealed. Mild SI shows a tight and slightly 
upshifted population compared to control condition, indicating apoptosis-associated cell 
shrinkage and increase in granularity. Moderate SI on the other hand shows a broadened 
and slightly right-shifted population, indicating necrosis-associated cell swelling.   
 
 
 
 
Control Moderate SI Mild SI 
  
6.3.1. PI exclusion 
 
In order to quantify the abovementioned dynamics of PI uptake, flow cytometry was 
performed following 2 hrs moderate SI (Fig. 6.12). Our results show a significant 
decrease in PI-positive cells in moderate SI + Rapa [8.4±0.1% (p<0.05)] comp
to cells exposed to moderate SI (16±2.5%). 3MA treatment (17.7±1.5%) did not 
result in further increase in PI
(Fig. 6.13).   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.13: PI positive cells in % (B) assessed by flow cytometry 
following 24 hrs rapamycin and 3MA treatment and 2 hrs moderate SI. 
Data expressed as mean ± SEM, statistical analysis: ANOVA &
Bonferroni correction, * p<0.05 vs Con, 
representative intensity histogram is shown (A).
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6.3.2. Tetramethylrhodamine Ethyl Ester (TMRE) intensity analysis 
 
In order to quantify the above described dynamics of mitochondrial depolarization 
(Fig. 6.7, 6.10) flow cytometry was performed following 2 hrs mild SI. Our results 
show a significant increase in TMRE mean intensity signal in mild SI + Rapa 
[91.9±8% (p<0.05)] compared to cells exposed to mild SI (72.4±0.7%). 3MA 
treatment (71.1±0.9%) did not result in further decrease in TMRE mean intensity 
compared to mild SI (72.4±0.7%) (Fig. 6.14, 6.15).    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
Figure 6.14: TMRE mean intensity in % assessed by flow cytometry 
following 24 hrs rapamycin and 3MA treatment and 2 hrs mild SI. Data 
expressed as mean ± SEM, statistical analysis: ANOVA & Bonferroni 
correction, * p<0.05 vs Con, 
        
 
 
 
 
 
 
 
Figure 6.15
profile of Con (red); mild SI (green); mild SI + Rapa (blue) and 
mild SI+3MA (brown). 
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6.3.3. Reactive oxygen species (ROS) assessment 
 
In order to investigate the role of oxidative damage in H9c-2 cells during mild and 
moderate SI when pretreated with rapamycin or 3MA, cells were loaded with DCF 
(Fig. 6.16) and analyzed by flow cytometry. A 24 hr treatment period of cells with 
rapamycin without any ischaemic insult decreased DCF mean intensity significantly 
[91.5±0.9% (p<0.05)] compared to control cells (Fig. 6.17). In contrast, 3MA 
treatment increased DCF mean intensity significantly [105.8±1.7% (p<0.05)] 
compared to control cells. Cells exposed to 2 hrs mild SI showed no changes in 
DCF mean intensity compared to control cells. However,  mild SI + Rapa showed 
significant increase in DCF mean intensity [158.8±7.4% (p<0.05)] compared to 
cells exposed to mild SI (114.2±1.6%) (Fig. 6.18, 6.19). The mean DCF signal 
increased significantly in mild SI+3MA [214.3±20.6% (p<0.05)] compared to mild SI 
(114.2±1.6%). These results indicate that mild SI per se does not increase ROS 
production significantly. However, increased autophagy prior to the ischaemic 
event does (Fig. 6.18, 6.19). The inhibition of autophagy by 3MA leads to an even 
more robust increase in ROS. The same DCF intensity pattern can be observed in 
cells exposed to 2 hrs moderate SI (Fig. 6.20, 6.21). Cells exposed to 2 hrs 
moderate SI showed no changes in DCF mean intensity compared to control cells. 
However,  moderate SI + Rapa showed a significant increase in DCF mean 
intensity [225.2±27.8% (p<0.05)] compared to cells exposed to moderate SI 
(142.6±8.5%). The mean DCF signal increased significantly in moderate SI+3MA 
[265.1±18% (p<0.05)] compared to moderate SI + Rapa (225.2±27.8%) (Fig. 6.20, 
6.21). 
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Figure 6.16: H9c-2 myoblasts following 
incubation with DCF and Hoechst 33342.  
 
 
 
 
 
 
 
 
 
 
Figure 6.17: DCF mean intensity in % assessed by flow cytometry following 
24 hrs rapamycin and 3MA treatment, kept under control conditions. Data 
expressed as mean ± SEM, statistical analysis: ANOVA & Bonferroni 
correction, * p<0.05 vs Con, # p<0.05 vs Con+Rapa, n=3. 
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Figure 6.18: DCF mean intensity in % assessed by flow cytometry following 
24 hrs rapamycin and 3MA treatment and 2 hrs mild SI. Data expressed as 
mean ± SEM, statistical analysis: ANOVA & Bonferroni correction, * p<0.05 
vs Con, # p<0.05 vs mild SI, n=3.
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Figure 6.19
profile of Con (black); mild SI (green); mild SI + Rapa (orange) 
and mild SI+3MA (blue). H
control and is shown as green dotted line.
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Figure 6.20
24 hrs rapamycin and 3MA treatment and 2 hrs moderate SI. Data 
expressed as mean ± SEM, statistical analysis: ANOVA & Bonferroni 
correction, * p<0.05 vs Con, 
        
 
 
 
 
 
 
Figure 6.21
Con (black); moderate SI (green); moderate SI + Rapa (blue) and 
moderate SI+3MA (orange). H
and is shown as green dotted line.
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6.4. ATP 
Following a 24 hr treatment period with either rapamycin or 3-MA, cells were 
exposed to 2 hrs mild or moderate SI, followed by 1 hr reperfusion and collected 
for ATP analysis. A 24 hr treatment period of cells with rapamycin without any 
ischaemic insult significantly decreased ATP [81.6±4.8% (p<0.05) vs 100%] 
compared to control cells (Fig. 6.22). In addition, 3MA treatment also decreased 
ATP significantly [74.5±3.9% (p<0.05)] compared to control cells. As shown in the 
first part of the study, cells exposed to 2 hrs mild SI showed significant increase in 
ATP [264.7±70.4% (p<0.05)] compared to control cells. However, this ATP surge is 
completely lost in mild SI+Rapa (118.2±30.5%) as well as in mild SI+3MA 
(123.2±32.7%) (Fig. 6.23). In addition, as described earlier, cells exposed to 2 hrs 
moderate SI showed no significant change in ATP (99.5±39.5%) compared to 
control cells. These ATP levels are maintained in moderate SI+Rapa (60.6±13.6%) 
as well as in moderate SI+3MA (54.8±13.2%), with no significant changes (Fig. 
6.24).  
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Figure 6.22:  ATP levels of control cells following 24 hrs rapamycin and 
3MA treatment. Data expressed as mean ± SEM, statistical analysis: 
ANOVA & Bonferroni correction, * p<0.05 vs Con, n=16.  
 
                    
               
Figure 6.23: ATP levels following 24 hrs rapamycin and 3MA treatment 
and 2 hrs mild SI. Data expressed as mean ± SEM, statistical analysis: 
ANOVA & Bonferroni correction, * p<0.05 vs Con, n=10.  
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Figure 6.24: ATP levels following 24 hrs rapamycin and 3MA treatment 
and 2 hrs moderate SI. Data expressed as mean ± SEM, statistical 
analysis: ANOVA & Bonferroni correction, * p<0.05 vs Con, # p<0.05 vs 
moderate SI, n=10. 
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CHAPTER 7 DISCUSSION: ONSET DYNAMICS 
 
7.1. In vitro onset dynamics of apoptosis and necrosis 
 
Cellular processes are of highly dynamic nature and there is a growing attempt to 
capture such processes and cellular responses in real time. Due to the 
development of novel techniques and innovative strategies, both the in vitro (Gong 
et al., 2007) and in vivo environment (De Saint-Hubert et al., 2009, Schoenberger 
et al., 2008) can be studied and cellular responses or cell death captured through, 
for example, molecular imaging techniques. A major advantage of a real-time 
approach lies in the fact that it allows the study of a cellular response in its dynamic 
nature. Literature suggests that autophagy plays a fundamental role in the cell’s 
survival mechanism (Lockshin & Zakeri, 2004, Degterev et al., 2005). Although it 
may be activated in cell death, evidence suggests that in most cases it is not a 
contributing factor (Han et al., 2007). When cell death is viewed as a dynamic 
response, interchanging the terminology for apoptosis or necrosis “inhibition” with 
“onset delay” is needed. This view suggests that autophagy promotes cell survival 
primarily by delaying the onset of apoptosis and necrosis. It also proposes that 
autophagic response time, capacity and net flux determine the time of death onset 
by creating a metabolically favourable intracellular environment.  
 
Our findings of a protective role of autophagy are in agreement with a number of 
studies. An inhibition of autophagy in isolated cardiomyocytes, exposed to anoxia-
reoxygenation, has been shown to increase necrotic cell death which was further 
increased by additional inhibition of apoptosis (Dosenko et al., 2006). On the other 
hand, enhancing autophagic flux in cardiac myocytes protects them against 
ischaemic injury by reducing apoptosis (Hamacher-Brady et al., 2006). When 
autophagy is enhanced through overexpressing bcl-2 in cardiac HL-1 cells, 
proapoptotic molecules such as Bax are reduced (Hamacher-Brady et al., 2006). 
Moreover, autophagy has been described in the ischaemic myocardium following 
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six episodes of ischaemia with an increase in cathepsin D, beclin-1 and other 
autophagic indicators.  
 
7.2. In vitro onset dynamics – ROS assessed by flow cytometry 
 
In the myocardium all cell types generate ROS specifically through the 
mitochondrial electron transport chain, xanthine oxidases, ‘uncoupled’ nitric oxide 
synthases, cytochrome P450 and NADPH oxidases (Akki et al., 2009). An 
important parameter for maintaining a metabolically favorable environment is the 
role of autophagy in degenerating damaged and oxidized proteins, thus indicating 
its role in the homeostasis of cellular oxidative stress. Reactive oxygen species 
(ROS) is a side product of mitochondrial respiration which initiates cell damaging 
peroxidation chain reactions. Amino acid starvation-induced H2O2 generation in 
mitochondria has been shown to lead to Atg4 oxidization which enables 
autophagosome formation to proceed (Scherz-Shouval et al., 2007). An apoptotic-
like response has been described when oxidative damage is left unrepaired 
(Arcangioli & Hassine, 2009), hence, sensing ROS and reacting to it through 
increased degradation of oxidatively damaged proteins (Moore, 2008, Zheng et al., 
2006) would decrease the load of oxidatively damaged structures, thus preserving 
mitochondria function for longer.  
 
Our results indicate a profound effect of autophagy on ROS generation. Under 
normoxic conditions, increased autophagy through rapamycin treatment induces a 
significant decrease in ROS (Fig. 6.17). In contrast, the inhibition of autophagy 
through 3MA treatment induces a significant increase in ROS (Fig. 6.17). These 
results are important, as they indicate the effect of autophagic activity on ROS 
generation in cells under normoxic conditions and normal metabolic performance. 
The cells have not been metabolically challenged through ischaemic injury, which 
in itself may result in a change in mitochondrial activity and ROS generation. 
However, when increasing or decreasing autophagy prior to the ischaemic insult, 
ROS increases significantly in both scenarios (Fig. 6.18-6.21). 
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How can these findings be explained? It is likely that mitochondria as crucial nexus 
in the generation of ROS and ATP in response to changing autophagic activity are 
responsible for the observed results. Firstly, as damaged or depolarized 
mitochondria are selectively eliminated through autophagy (Lemasters, 2005), a 
decrease in mitochondrial load is rapidly achieved, creating a role for autophagy in 
sequestering death-promoting molecules, protein aggregates and pro-apoptotic 
signals. Secondly, and possibly more important, autophagy may through substrate 
supply increase mitochondrial activity with a resultant increase in ROS. 
 
We hypothesize that rapamycin treatment induces increased autophagic activity 
which, through substrate provision, results in increased mitochondrial activity. This 
effect combined with the ischaemic insult, translates into the increased ROS 
generation observed in both mild and moderate SI (Fig. 6.18, 6.20). However, 
although ROS increases even further with 3MA treatment followed by SI, the 
underlying mechanism is likely to be different. 3MA treatment results in decreased 
autophagic activity as seen in the control cells (Fig. 6.17). However, the ischaemic 
insult combined with the lost autophagic “ROS defense system” now translates into 
a robust increase in ROS generation (Fig. 6.18, 6.20).   
 
Rapamycin renders cells more susceptible to the cytotoxic effect of tumour 
necrosis factor-α (TNF-α) (Djavaheri-Mergny et al., 2007), indicating autophagy as 
a primary response scheme to decrease ROS. Furthermore, both TNF-α and ROS 
cause an increase in beclin-1 expression (Djavaheri-Mergny et al., 2007). This is 
consistent with the observation that the protective effect of rapamycin is lost when 
inhibiting cytochrome c release (Menzies et al., 2006). This mechanism of delaying 
apoptosis onset would provide a protective time-window in which the primary 
inducing stimulus could cease and the cell could more likely recover. Recently it 
has been shown that activation of autophagy by rapamycin suppresses LPS-
mediated ROS production and protects myocytes against LPS toxicity, indicating 
that autophagy limits damaging ROS production (Yuan et al., 2008). 
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In contrast, when using the inhibitor of autophagy, 3MA, ROS increases even more 
in SI (Fig. 6.18, 6.20), indicating the role of basal autophagy in sequestering 
oxidized and death-promoting molecules and protein aggregates. Moreover, the 
generation of ROS itself has been proposed to regulate autophagy (Huang & 
Brumell, 2009) and is in fact needed for the autophagic process to take place 
(Kaushik & Cuervo, 2006). An investigation of mitochondrial load/weight, their 
activity and oxygen consumption as well as the use of a mitochondria-specific ROS 
dye is proposed for future work.  
 
7.3. In vitro onset dynamics – ATP availability 
 
These results (Fig 6.22-6.24) indicate that the extent of autophagic activity 
influences cellular ATP availability. The exact mechanisms, however, remain to be 
elucidated. How can the difference in ATP between mild and severe ischaemia be 
explained? In mild SI, increased autophagosomes are present. We hypothesize 
that the increased autophagic flux results in an increased supply of metabolites. As 
the cells are dying apoptotically the demand for ATP drops, while the supply is 
increased. However, as ATP-consuming processes cease to function, less ATP is 
actually utilized. When increasing autophagy with rapamycin, prior to mild SI, the 
observed ATP surge disappears. This is associated with increased survival 
indicated by the TMRE results. The increased autophagic flux results in an 
increased supply of metabolites. However, as cells stay alive and ATP- consuming 
processes remain functional, ATP is now utilized, resulting in the loss of the ATP 
surge.   
 
This hypothesis may also explain the results observed in moderate SI. Here, no 
ATP surge is observed after 2 hrs SI. Cells are dying primarily necrotically, 
however, with baseline levels of autophagy as there is no indication for increased 
autophagosomes. Hence, the supply in metabolites remains at baseline levels. As 
the cells are starting to die the demand for ATP drops, ATP-consuming processes 
cease to function, while the supply remains at basal levels. When increasing 
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autophagy with rapamycin prior to moderate SI, ATP levels remain constant. 
Similar to the scenario in mild SI the increased autophagic flux results in an 
increased supply of metabolites. However, as cells stay alive, indicated by the 
decrease in PI positive cells, ATP consuming processes remain functional. ATP is 
now utilized with the result that ATP levels remain constant.  
Mutations in autophagy genes manifest with defects in mitochondrial maintenance, 
resulting in mitochondria with lower oxygen consumption rates, lower membrane 
potential and higher reactive oxygen species (ROS) levels (Zhang et al., 2007), 
indicating a vital relationship between autophagy and the cell’s ATP-generating 
system. The intracellular ATP availability may be modulated by the autophagic flux, 
therefore favouring and promoting a cellular response other than necrosis and 
delaying apoptosis (Loos & Engelbrecht, 2009). It has been shown that the 
accumulation of autophagic vacuoles in the myocardium precedes apoptotic cell 
death (González-Polo et al., 2005), and that the incidence of apoptotic 
cardiomyocytes is significantly increased at the borders of infarcted tissue 
(Takemura et al., 2006), indicating the metabolic gradient in that area. Both 
glucose deprivation and amino acid deprivation but not serum starvation, induce 
autophagy in cardiac myocytes (Matsui et al., 2007). Furthermore, ischaemia-
induced autophagy may be mediated through the eukaryotic elongation factor-2 
(eEF2) rather than via mTOR inhibition, leading to an inhibition of protein synthesis 
(Horman et al., 2003) which is most sensitive to energy supply.  
 
In addition, to assess an autophagic response it may be necessary to consider the 
cell’s own energetic profile and energy demand under control conditions to define 
its response to starvation. The cell’s metabolic turnover may be a crucial factor in 
determining the context-dependent behaviour of autophagy (Cuervo et al., 2005, 
Bergmann, 2007) and may explain tissue-specific autophagic response kinetics. 
Autophagy is active at a basal level in most of the cells in the organism, although 
individual autophagic capacity may vary (Codongo & Meijer, 2005). An indirect 
indication of a causal link between the cell’s metabolism and basal autophagy may 
be given through metabolically different - yet histologically identical - tissue types 
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which rely differentially on glycolysis and oxidative phosphorylation (Mizushima et 
al., 2004). A transgenic mouse model expressing green fluorescent protein-light 
chain 3 (GFP-LC3) revealed differential autophagic response kinetics which might 
indicate tissue-specific metabolic demands. Organs with a high degree of energy 
requirement such as the myocardium often show the highest rates of autophagy, 
which possibly reflects a continuous ATP demand (Mizushima et al., 2004). Mice 
lacking Atg5 which is part of the autophagy conjugation system, die during the 
neonatal period. Atg5-/- mice also show myocardial damage, have decreased 
amino acid levels and decreased cardiac ATP production (Levine & Yuan, 2005). 
As ATP production indicates the energy contribution of basal autophagy turn-over, 
this is of importance when describing autophagy kinetically. The baseline level of 
autophagy, the threshold which triggers additional autophagy, the time needed in 
doing so, as well as the flux through the autophagic pathway are likely to determine 
the degree of resistance to a given stress stimulus (Moore, 2008, Hamacher-Brady 
et al., 2006). 
 
The above results indicate that mitochondria are a crucial nexus in the generation 
of ROS and ATP and deserve a closer investigation regarding differential cellular 
autophagic flux, particularly under conditions of increased metabolic stress.  
 
7.4. Summary 
 
In summary, our data provide as far as known a unprecedented direct evidence 
that increased autophagy delays the loss of cellular membrane integrity and delays 
caspase-3 activation as well as mitochondrial depolarization in ischaemic 
cardiomyocytes. Our results show a profound effect of increased autophagy on the 
onset of apoptosis as well as necrosis under simulated ischaemic conditions by 
providing cellular protection. The above results acquired through real-time imaging 
suggest that an increase in autophagic responsiveness and flux as induced 
through rapamycin treatment, provides a selective advantage for tissue against 
injury, possibly by maintaining intracellular ATP levels and nutrients and shifting 
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the PONR for apoptosis and necrosis to a later point (Fig. 7.1, 7.2). Our results 
also show that decreased autophagy may induce apoptosis earlier (Fig. 7.1, 7.2). 
Therefore a fast response to a decreasing intracellular ATP concentration with the 
induction of additional autophagy is crucial. In our model, intracellular ATP levels 
decrease with rapamycin treatment as well as with 3MA treatment. This leaves 
cells exposed to SI with seemingly less ATP. However, it is likely that increased 
autophagy provides metabolic substrates and a more favourable metabolic 
environment, which may be responsible for maintaining ATP-consuming processes 
for longer, hence maintaining membrane integrity and mitochondrial function. Our 
data therefore indicate that autophagic flux impacts the metabolic balance sheet of 
the heart.  
 
7.5. In vitro model: shortcomings 
 
A shortcoming of this model may lie in the fact that the inhibition of glycolysis with 
2-deoxy-D-glucose which traps phosphate as 2-deoxy-D-glucose-phosphate, is an 
irreversible process. It functions as a phosphate binding agent therefore leads to 
the depletion of inorganic phosphate from the cells, creating a phosphate shortage, 
with the result that ATP and creatine phosphate levels decrease. The reperfusion 
phase in that particular case truly represents only a re-oxygenation phase, allowing 
mitochondrial respiration to proceed. Other models make use of iodoacetic acid 
(IAA) as an inhibitor of the glycolytic enzyme 3-phosphoglyceraldehyde 
dehydrogenase to achieve relatively specific but also irreversible inhibition of 
glycolysis (Corbett & Lees, 1997). Although this in vitro model is suitable to study 
the molecular mechanisms involved in the cell death process, the non-contracting 
nature of the cells demands careful interpretation of results compared to 
contracting isolated cardiomyocytes in terms of ATP demand and work 
performance. In the ischaemic myocardium, necrosis has been observed when 
ATP is depleted (Neely et al., 1973). However, our in vitro model indicated an 
increase in PI positive cells in moderate ischaemia, even when ATP levels are still 
high, indicating differences in metabolic conditions between the models. Moreover, 
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it appears that multiple viability tests may be of particular importance in the in vitro 
setting. TTC staining after 2 or more hours of reperfusion agrees very closely with 
infarct size measured 3-4 days later, indicating a short period of dynamic behavior 
only during the actual time of injury development. For future experiments, it is 
advised to employ a range of autophagy inhibitors in order to increase specificity of 
autophagy inhibition. Bafilomycin A1 as well as 3MA, although commonly used to 
inhibit autophagy (Maruyama et al., 2008), are not very specific. 3MA may in fact 
also be used as a substrate by the cell. Better inhibitors of autophagy are siRNAs 
against genes required for autophagy, such as beclin-1, Atg5, and Atg7 (Quadir et 
al., 2008).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.1: Relationship 
induction, execution of cell death: With increasing degree of a 
stressful insult, but a steady autophagic flux, cell death is reached 
earlier, the z
decreases. ‘autophagy baseline’ 1, ‘autophagy induced’ 2, ‘cell death 
with autophagy’ 3, ‘apoptosis induced’ 4, ‘apoptosis executed’ 5, 
‘necrosis induced’ 6 and ‘necrosis executed’ 7. The z
between the micrographs may 
endpoint (execution) of dying, separated by the point
PONR. The degree of stress may determine the position of the 
PONR.  
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Figure 7.2: 
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CHAPTER 8 RESULTS: FUNCTIONAL RECOVERY 
 
8.1. Functional recovery: three durations of ischaemia 
In order to assess the effect of the severity of an ischaemic insult on myocardial 
function, hearts were subjected to 10, 20 or 30 min of sustained ischaemia 
(normothermic total global ischaemia) followed by reperfusion (Fig. 8.1).  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8.1:  In vivo experimental protocol. Hearts were submitted 
to a protocol of 10, 20 or 30 min global ischaemia, followed by 30 
min of reperfusion respectively.  
 
 
 
  
A significant decrease in myocardial function compared to control values assessed 
by cardiac output, stroke volume and mean external power is described. Ten min 
of global ischaemia induced a significant decrease in cardiac output [42.4 
ml/min±4.5 (p<0.05)] 
decreased significantly after 20 min of global ischaemia (10.6 ml/min±1.4) (Fig. 
8.2). These results were mirrored when measuring stroke volume (Fig. 8.3) and 
mean external power produced by the 
30 min of sustained ischaemia were unable to recover (Fig. 8.2, 8.3, 8.4). 
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8.2. Functional recovery: Rapamycin and 3MA treatment 
However, when hearts were stabilized and then perfused with 1 nM rapamycin for 
10 min in working heart mode, followed by 40 min retrograde perfusion in the 
Langendorff mode followed by their subjection to 20 min sustained ischaemia (Fig. 
8.5), cardiac output significantly improved [12.5  ml/min±2.3 (p<0.05)] compared to 
20 min global ischaemia (0.6 ml/min±0.5). In contrast, 3MA treatment did not 
improve functional recovery (6.1 ml/min±2.5) (Fig. 8.6). These results were 
mirrored when measuring mean external power produced by the left ventricle (Fig. 
8.7). 
 
 
 
 
 
 
 
 
Figure 8.5: In vivo experimental protocol of global ischaemia 
with induced and inhibited autophagic activity. Following 
perfusion with rapamycin or 3MA, hearts were submitted to a 
protocol of 20 min global ischaemia, followed by 30 min 
reperfusion.  
 
 
 
 
  
 
              
 
 
 
 
 
 
 
Figure 8.6: Cardiac output CO in ml/min (CO=Coronary (Qe) + aortic (Qa) 
flow rates). Data
& Bonferroni correction, * p<0.05 vs Con, 
 
 
 
 
 
 
 
 
 
                    
Figure 8.7: Mean external power produced by the left ventricle TW [Tw = 
0.002222 (Aortic pressure PAO
expressed as mean ± SEM, statistical analysis: ANOVA & Bonferroni 
correction, * p<0.05 vs Con, 
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CHAPTER 9 DISCUSSION FUNCTIONAL RECOVERY 
 
9.1. Ex vivo model: functional recovery  
 
The aim of this part of the study is to determine whether the protective effects 
observed in the in vitro model of simulated ischaemia are also evident in the 
perfused heart model. A standard laboratory model of severe total ischaemia 
(Opie, 1991) has been chosen, where the effect of three different time points on 
the dynamic character of ischaemic injury development and functional performance 
was assessed. Hearts were subjected to sustained ischaemia (normothermic total 
global ischaemia) by simultaneous clamping of both aorta and left atrial supply 
tubes. This perfusion model of global ischaemia has been shown to result in total 
anoxia within 20 seconds (Opie, 1991).   
 
Our results are in agreement with the current literature; it is to the best of our 
knowledge, however novel, that functional recovery improves upon rapamycin 
treatment specifically in a rat heart model of global ischaemia, using rapamycin in 
the perfusate. Rapamycin, an antibiotic derived from Streptomyces hygrosopius, 
binds to mTOR and attenuates protein synthesis whilst inducing autophagy. It has 
been used for many years as an immunosuppressant in the treatment of organ 
rejection (Khan et al., 2006). The inhibition of mTOR in the cardiovascular arena 
has been shown to be effective as it reduces coronary artery re-stenosis when 
impregnating stents with rapamycin (Khan et al., 2006). In the mouse heart, 
rapamycin has also shown to confer to preconditioning-like protection against 
ischaemic injury, when injected intraperitoneal prior to heart excision, with a 
decrease in TUNEL and trypan blue positive cells (Khan et al., 2006), indicating a 
beneficial effect when autophagy is pharmacologically upregulated. Moreover, 
mTOR inhibition has recently been shown to substantially regress left ventricular 
hypertrophy (McMullen et al., 2004). It also preserved left ventricular fractional 
shortening and decreased collagen deposition significantly (Gao et al., 2006). The 
importance of mTOR in governing cardiac growth and controlling the homeostasis 
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of protein synthesis and autophagy has been shown in a transgenic mouse model, 
where mTOR kinase activity was knocked out. In these mice myocardial function 
was impaired through reduced ejection fraction and shortening (Shen et al., 2008). 
This may indicate a role for autophagy in the onset and progression of heart failure, 
particularly in the phase of cardiac hypertrophy, preventing or delaying its 
commencement and slowing down its progression.  
 
9.2. Summary 
 
The ex vivo results indicate that myocardial function rapidly declines during global 
ischaemia and that rapamycin treatment improves functional recovery significantly. 
It remains to be elucidated whether increased autophagy in the heart improves 
myocardial energetics, which translates into improved functional recovery. Current 
literature seems to indicate that this may likely be the case. Under normal 
conditions glucose, lactate and fatty acids are the main energy substrates 
maintaining cardiac function (Kantor et al., 2000, Ashrafian et al., 2007). The adult 
heart derives 60-90% of its energy from fatty acid metabolism and 10-40% through 
glycolysis (Kodde et al., 2007). Oxygen availability is fundamental, as >90% of 
cardiac ATP production is generated through oxidative phosphorylation (Kodde et 
al., 2007) via the reducing equivalents NADH and FADH2 produced in the 
tricarboxylic acid (TCA) cycle. In addition, however, a growing body of evidence 
strongly suggests another fundamental level of substrate interregulation. 
Proteomics of the oxygenated myocardium reveals that 11% of the identified 
proteins are involved in electron transport, 11% in carbohydrate metabolism and 
10% in protein metabolism (Lam et al., 2007), indicating an almost equal 
distribution between the metabolic control of carbohydrate and protein breakdown. 
Proteins make up about one sixth of the wet mass of the heart (Gevers, 1984). As 
cardiac proteolysis is a fast responding and complete degradation mechanism, 
amino acids for utilization can be generated rapidly (Gevers, 1984), suggesting a 
profound role in cardiac protein turnover. These findings support the view that 
autophagy contributes to the metabolic balance sheet of the heart and highlight the 
 178 
 
relevance of autophagic processes when ATP becomes limited. We propose that 
autophagically-generated amino acids and substrate intermediates form an integral 
and possibly underestimated part of substrate interregulation to control the 
efficiency of ATP production in the heart (Fig. 9.1). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9.1: Relationship between increased autophagy and 
amino acid generation. An increase in autophagic flux, mediated 
through decreased nutrients, increased metabolic stress and 
increased ATP demand could rapidly generate amino acids as 
alternative fuels. They may be converted into pyruvate or TCA 
cycle intermediates (glucogenic amino acids) or acetyl and 
acetoacetyl-CoA (ketogenic amino acids) and have multiple 
entrypoints into the TCA cycle.  
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Chronic or less severe conditions of the heart such as mild ischaemia, hypoxia, 
hypobaric stress or dietary restriction may have a differential effect on autophagy 
and metabolic substrate availability, as they provide a larger timewindow for the 
autophagic machinery to be induced. Such conditions in turn, may provide insights 
into the dynamics of autophagy regulation. Most interestingly, in the chronically 
ischaemic myocardium a proteomics approach revealed an increased expression 
of beclin-1, LC3 (microtubule-associated protein 1 light chain 3) and cathepsin D 
(Yan et al., 2005), indicating an increased flux through the autophagic pathway. In 
that way deleterious effects of chronic ischaemia may be limited, as the metabolic 
environment becomes more beneficial. It has been suggested that an upregulation 
of autophagy may be part of a “smart heart” response where myocardial function 
and metabolism adjust in response to ischaemia (Yan et al., 2005). Also, 
myocardial amino acid metabolism is markedly influenced by exposure to hypoxia, 
indicating an adaptation with alterations in substrate utilization (Rumsey et al., 
1999). For example, hypoxia has shown to decrease the total amount of cytosolic 
free amino acids in the heart, particularly arginine and glutamine (Gabrys et al., 
2003) and to enhance the capacity for glucose phosphorylation (Rumsey et al., 
1999). Interestingly, the immature heart, which relies more on glucose as substrate 
compared to the adult myocardium, also showed much higher resting 
concentrations of amino acids, which are depleted during acute hypoxia (Caputo, 
2006). During mild myocardial ischaemia, glycolysis is accelerated due to the 
decreased capacity of mitochondrial ATP supply. In this period, where glycolysis 
and glucose oxidation are not uncoupled yet, autophagy might function as an ally 
supporting glucose oxidation via TCA cycle intermediates. The multiple substrate 
entrypoints of the TCA cycle intermediates might provide a fast metabolic response 
(Fig. 9.1).  
 
In summary, autophagy may counteract the detrimental effects of fatty acid 
oxidation, as it “partners” with glucose oxidation, keeping the TCA cycle flux high. 
Treatment with partial fatty acid oxidation inhibitors (pFOXi) (e.g. Trimetazidine) 
combined with AMPK-mediated and mTOR-mediated autophagy using rapamycin, 
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might maximize glucose oxidation and delay the deleterious uncoupling of 
glycolysis from glucose oxidation (Lam & Lopaschuk, 2007). Rapamycin induces a 
rapid increase in autophagosomes which, after fusion with lysosomes may release 
their degraded content and thus provide additional fuel to be oxidized in the 
mitochondria. These data indicate that autophagy may be metabolically more 
potent in a setting which is less severe. We suggest future work to indicate the role 
of autophagy in myocardial energy homeostasis. This may include the use of a 
GFP-LC3 transgenic mouse model (Mizushima et al., 2004), which would allow to 
visualize whether areas of increased autophagic activity may exist in the 
metabolically-challenged myocardium in a similar manner as microzones of 
discrete heterogeneous areas of anoxic tissue, which have been visualized through 
NADH fluorescence (Steenbergen et al., 1979).  
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CHAPTER 10 SUMMARY AND CONCLUSIONS 
 
10.1. Is autophagy beneficial or detrimental? A model is proposed   
 
It has been suggested that autophagy plays a dual role in the heart where it can 
protect against or contribute to cell death, depending on the stimulus (Gustafsson 
et al., 2008). However, the cell’s metabolic demands and substrate profile may be 
crucial in determining this context-dependent behaviour of autophagy. Therefore, 
we propose a conceptual model which considers the role of autophagy in energy 
homeostasis (Loos & Engelbrecht, 2009). According to this model, the extracellular 
(A) and intracellular (B) environment will determine whether autophagy leads to an 
adaptive and protective response (CP) or whether bioenergetic failure and 
autophagic cell death (CF) is the manifestation of a response unable to meet the 
metabolic demands of the cardiac myocyte (Fig. 10.1). This model indicates 
autophagy as a highly dynamic stress response where A (the severity and duration 
of an ischaemic insult) and B (the autophagic baseline flux, autophagic response 
time, the substrate utilization profile and the metabolic capacity at the insult onset) 
determine its outcome. A and B may then define the timewindow for and the 
efficiency and outcome of a given autophagic response according to ↓A+↑B→ CP 
and ↑A+↓B→ CF. This dynamic approach may predict the likelihood of cell death 
with autophagy or cell survival, based on the cell’s metabolic demands and 
substrate profile, and may explain the context-dependent behaviour of autophagy. 
It also indicates that a metabolic perspective on the position of autophagy in the 
heart is crucial to further reveal its significance in the context of the onset of 
myocardial apoptosis and necrosis. If this model is valid, then A and B show a 
differential profile during detrimental energetic perturbations such as myocardial 
ischaemia and heart failure and hence define the functional role of autophagy in 
these conditions.  
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Figure 10.1: Proposed conceptual model defining the functional role of 
autophagy in cardiomyocytes. The extracellular (A) and intracellular (B) 
environment may determine whether autophagy leads to an adaptive and 
protective response (CP) or whether bioenergetic failure and autophagic 
cell death (CF) will manifest. A (severity and duration of an ischaemic 
insult) and B (autophagic baseline flux, autophagic response time, 
substrate utilization profile and metabolic capacity at the insult onset) 
determine its outcome according to: ↓A+↑B→ CP and ↑A+↓B→ CF.  
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10.2. Final Conclusions  
 
This study of myocardial injury highlights a number of important aspects. 
 
Firstly, it becomes clear that the metabolic microenvironment of the cell has an 
influence on the distribution of the manifestations of cell death. It was hypothesized 
that the relative contribution of cell death with autophagy, apoptosis and necrosis is 
dependent on the duration and severity of the ischaemic insult and is governed by 
the cell’s underlying metabolic capacity at a given point in time. Since our results 
indicate that this is the case, the hypothesis is verified. In our model a mild 
ischaemic insult leads to the induction of autophagy and apoptosis, whilst a 
moderate and severe insult primarily induces necrosis without aspects of 
autophagy.  
 
Secondly, it was hypothesized that the onset of apoptosis and necrosis depends 
on the cell’s autophagic activity prior to the ischaemic event due to an impact of 
autophagy on the cell’s metabolic capacity. Our results strongly indicate that this is 
the case, thus verifying the hypothesis and further substantiating the concomitant 
analysis of autophagy, apoptosis and necrosis. Upregulation of autophagy prior to 
an ischaemic insult delays cleavage of caspase-3, loss of mitochondrial 
depolarization and loss of membrane integrity, hence the onset of apoptosis and 
necrosis. Our results indeed clarify that autophagic activity plays a fundamental 
role in influencing the onset of apoptosis and necrosis and delaying their onset 
significantly when upregulated (Fig. 7.1). The obtained results show that rapamycin 
treatment is protective in the cellular model and improves functional recovery after 
global ischaemia in the perfused rat heart model.  
 
Lastly, these results indicate the significance of monitoring autophagy, apoptosis 
and necrosis concomitantly, in order to assess the viability of the myocardium. The 
use of multiple techniques is essential to place the metabolic performance into 
context with cell death morphological features. It remains to be elucidated which 
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exact mechanisms are underlying the observed impact of autophagy on apoptosis 
and necrosis. Our results indicate that the mitochondria as nexus between ROS 
and ATP generation play a pivotal part in the mechanism by which increased 
autophagy confers cytoprotection.  
 
In summary, our results strongly indicate that autophagy may rather be seen as a 
stress response of the cell, aimed at maintaining energy homeostasis in order to 
fuel ATP- consuming processes, which are vital for maintaining cellular function. 
Based on the obtained results it appears unlikely that autophagy is a mode of cell 
death per se in the myocardium. It becomes clear that it may be highly beneficial if 
the onset of apoptosis and necrosis as well as a change in autophagic activity be 
studied dynamically. This will allow the study of the exact time of the onset of 
apoptosis and necrosis in context with the exact intra and extracellular metabolic 
parameters present. Such an approach may prove beneficial in order to assess the 
potential reversibility of cell death.  
 
A dynamic approach may allow opportunities for new treatment strategies, 
focussed on delaying the onset of each death mode rather than inhibiting it, by 
controlling the cell’s inherent autophagic machinery. Such strategies may be based 
on combined therapy, targeting autophagic as well as apoptotic pathways 
(McMullen et al., 2004). This may have particular implications for the treatment of 
terminal differentiated cells during brain (Amaravadi et al., 2007) or myocardial 
injury (Ravikumar et al., 2006, Camarata et al., 1994) which ranks among the 
primary causes of morbidity and mortality (Artal-Sanz & Tavernarakis, 2005).  
 
10.3. Future Prospects 
 
Despite the therapeutic advances in reducing cardiovascular-derived morbidity and 
mortality through optimizing myocardial metabolic disturbances, little attention has 
been paid to the role of autophagy and autophagically-derived amino acids in the 
diseased myocardium. However, literature indicates that autophagy affects 
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myocardial repair function in response to injury and influences cell death dynamics 
(Loos & Engelbrecht, 2009). A severe decrease in substrate availability and an 
increase in ATP demand translate into AMPK activation and mTOR inhibition which 
induces the autophagic machinery to respond rapidly (Meijer et al., 2004) and 
reducing protein synthesis concomitantly. Due to the dynamic nature of autophagy, 
it is suggested to not only re-consider the concepts of temporal and spatial border 
zones in the diseased myocardium (Hearse et al., 1981) but also to extend the 
dynamic role of autophagy in the gradual progression of metabolism and injury, 
into the setting of myocardial hypertrophy and heart failure. This approach may 
concentrate on the temporal correlation of ATP depletion and autophagic activity in 
myocardial regions of “tolerable”, “critical” and “lethal” ischaemia (Hearse et al., 
1983) as well as the association of autophagic flux, metabolic parameters (Loos & 
Engelbrecht, 2009) and myocardial hypertrophy. The wavefront phenomenon and 
concept of irreversible injury (Reimer & Jennings, 1979) may be related to the 
PONR and onset dynamics described in this study. A modernized tissue sampling 
device which enables the collection of multiple tissue samples across the area of 
injury [and which has been employed for a short period in the past (Hearse et al., 
1981)], may be useful to answer those urgent questions and to co-localize the 
degree of myocardial energy deficiency or hypertrophy with autophagic activity and 
cell death kinetic parameters (Loos & Engelbrecht, 2009). More studies are 
urgently needed to unravel the ATP changes observed in mild and moderate SI 
with rapamycin and 3MA treatment and to understand the underlying mechanism 
thereof. It becomes very clear that the study and control of autophagic flux is of the 
utmost importance for understanding its exact role in steering cellular energy 
homeostasis and in influencing cell death onset. The appearance of autophagic 
vacuolization, as indicated by the LC3 pattern, is not in itself evidence that 
autophagic flux is elevated. We believe that those studies have to focus on 
autophagic flux control and the ATP charge ratio within a supply/demand system 
(Wieser & Krumschnabel, 2001, Buttgereit & Brand, 1995) in order to unmask the 
changes observed in ATP as well as ROS generation.  
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The outcome of differential amino acid oxidation rates at increasing levels of 
autophagy as well as the substrate turnover time for each amino acid (turnover 
time a = [intermediate a]/TCA cycle flux) may indicate flux and duration of 
autophagy. Such differential investigation may reveal the ATP yield per amino acid 
molecule and carbon atom and expose the effect of increased autophagy on 
pyruvate/acetate oxidation. Current treatment regimens may be complemented 
with the aid of caloric restriction diet (Hannigan et al., 2009, Bursch et al., 2008) or 
rapamycin treatment (Ravikumar et al., 2006, Menzies et al., 2006, Halapas et al., 
2008) to delineate whether the control of myocardial autophagy can become part of 
therapeutic strategies to manage cardiac energetics. In managing cellular energy 
homeostasis for the benefit of survival, autophagy may serve as key regulator to 
unlock interventions through metabolic-based therapy. Most crucially, this present 
study indicates that the role of autophagic flux in delaying the onset of cell death 
through the modification of cellular metabolic performance and possibly substrate 
availability and preference, deserves more study. 
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ADDENDUM 
 
 
Dose response trials before start of study 
Characterization of H9c-2 cell viability-time points using ischaemic buffer without  
2DG, pH 6.2. 
 
 
 
 
 
 
 
 
 
 
                             Figure A.1: Minor response after 8 hrs. The use of ischaemic 
                             buffer with 2DG, pH 6.4 is suggested. 
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Using ischaemic buffer with 2DG, pH 6.4 as well as 0.5 or 1.0 mM (Lin, 2004, 
Seyedi 2002) sodium dithionate.  
 
 
 
 
 
 
 
  
 
Figure A.2: Ischaemic buffer+2DG is suitable as it results in 
37.8 % non viable cells after 10 hrs SI. 0.5 mM SDT more 
suitable than 1 mM SDT as it results in 88.4 % non viable cells 
after 10 hrs SI. But less than 10 hrs as longest time point SI is 
required. The time points 2, 4 and 8 hrs are suggested.  
 
 
Although literature suggests a frame of reference regarding the concentration of 
rapamycin to be used in H9c-2 cells, we verified this in our system. To evaluate the 
induction of autophagy, a dose response with 25 nM, 50 nM and 100 nM 
rapamycin for 1 hr and 24 hrs was conducted, and assessed by fluorescence 
microscopy and flow cytometry. 
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Figure A.3: Images showing acridine orange (AO) signal. AO signal  
appears stronger already following 1 hr treatment.  
 
 
Control Control 
25 nM 1 hr 
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Figure A.4: A clear response can be seen based on the right-shift of 
the intensity histogram in the red channel (PE-Texas Red), 
indicating an increase in acidic vesicular organelles (AVO’s) 
suggesting an increase in autophagic activity. Red: Control, Green: 
1 hr rapamycin treatment, Blue: 24 hrs rapamycin treatment. The 24 
hr time point with 50nM rapamycin were therefore chosen to be 
employed in the second part of the study.   
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Ischaemic buffer without 2DG or SDT 
 
The effect of the ischemic buffer without 2DG or SDT was investigated at the 2 hr 
SI time point. 
 
           
 
          
 
 
 
Figure A.5:  2 hrs SI Data expressed as mean ± SEM, statistical 
analysis: ANOVA & Bonferroni correction,* p<0.05 vs Con, n=9, 
>150 cells counted. 
 
 
 
          
 
             
 
Figure A.6:  2 hrs SI/R Data expressed as mean ± SEM, 
statistical analysis: ANOVA & Bonferroni correction,* p<0.05 vs 
Con, n=9, >150 cells counted. 
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The above results indicate no significant effect of the buffer without 2DG or SDT on 
% PI positive cells or % pyknotic cells following 2 hrs SI (Hoechst: Con: 
1.7%±0.7%; Buffer: 1.1%±0.4%, PI: Con: 1.5%±0.4%; Buffer: 0.5%±0.1%) followed 
by 1 hrs reperfusion (Hoechst: Con: 1.7%±0.7%; Buffer: 1.3%±0.7%, PI: Con: 
1.5%±0.4%; Buffer: 1.6%±0.4%).  
 
                       
 
 
 
 
 
Figure A.7: 2 hrs Data expressed as mean ± SEM, statistical 
analysis: ANOVA & Bonferroni correction, * p<0.05 vs Con, # 
p<0.05 vs mild SI, n=8. 
             
 
 
 
 
 
 
 
 
Figure A.8: 2 hrs R Data expressed as mean ± SEM, statistical 
analysis: ANOVA & Bonferroni correction, * p<0.05 vs Con, # 
p<0.05 vs mild SI, n=8. 
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The above results indicate no significant effect of the buffer without 2DG or SDT on 
% ATP in cells following 2 hrs SI (ATP: Con: 100±0; mild SI: 264 ±62.1; moderate 
SI: 99.5 ±39.5; Buffer: 95.01±8.4) followed by 1 hrs reperfusion (ATP: Con: 100±0; 
mild SI: 85.5±; moderate SI:  68.3±14.4; Buffer: 102.3±17.9).  
 
Trial for fluorescence imaging in the whole heart 
 
In order to investigate, whether global ischaemia would lead to defined areas with 
increased autophagic activity, according to the heterogeneous  areas of anoxic 
tissue, which have been visualized before (Steenbergen, 1979), we aimed to 
perform a whole tissue immunofluorescence staining. LC-3 (green) and PI (red) 
were used to identify the extent and localization of an autophagic response and 
necrotic tissue damage respectively. Images were acquired using the Xenogen In 
Vivo Imaging System (IVISO of Caliper/Xenogen).   
 
 
 
 
 
 
 
 
 
Figure A.9: Hearts were exposed to 10, 20 or 30 min global 
ischaemia or ischaemia/reperfusion. 
Control 
20 min global 
Ischaemia/Reperfusion 
10 min global 
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30 min global 
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Figure A.10: Whole organ fluorescence micrographs of hearts submitted to 10, 20 and 30 min 
global ischaemia. Hearts were stained for LC-3 (green, A-panel) and PI (red, B-panel) to indicate 
autophagic- and necrotic areas respectively. Images show the fluorescence emission (A/B1), an 
intensity based cold/warm/hot LUT (A/B2), a normal light photograph (A/B3) and an overlay of the 
latter two.   
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Figure A.11: Whole organ fluorescence micrographs of hearts submitted to 10, 20 and 30 min 
global ischaemia followed by reperfusion. Hearts were stained for LC-3 (green, A-panel) and PI (red, 
B-panel) to indicate autophagic- and necrotic areas respectively. Images show the fluorescence 
emission (C/D1), an intensity based cold/warm/hot LUT (C/D2), a normal light photograph (C/D3) 
and an overlay of the latter two.   
 
The images indicate differences in the intensity between control hearts and hearts 
exposed to global ischaemia/reperfusion. Both, LC-3- and PI emission intensity 
appear to be increased in hearts exposed to global ischaemia. We feel however, 
that the staining methodology deserves optimization, before being able to draw any 
conclusions.  
 
 
 
 
C1 
D4 D3 D2 D1 
C4 C3 C2 
 197 
 
Histology of the myocardium 
 
 
 Histology 
 
 Haematoxylin Eosin (H&E)  
 
In order to assess myocardial morphology, hearts were stained with 
haematoxylin/eosin.  
 
  
 
 
 
 
 
 
 
       Figure A.12: Control hearts showing the morphology of a normal myocardium.  
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Figure A.13: Micrographs showing hearts submitted to 10, 20 and 30 min global ischaemia. 
The epicardium, sub-endocardium and epicardium is shown. 
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Figure A.14: Micrographs showing hearts submitted to 10, 20 and 30 min global ischaemia 
followed by reperfusion. The epicardium, sub
indicate patches of non
SI/R, possibly indicative for acidophilic regions. These regions were also found in close 
proximity to blood vessels. 
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Immunofluorescence 
 
To evaluate the induction of autophagy, apoptosis or necrosis, hearts were 
subjected to immune-fluorescence staining for LC-3, cleaved PARP and HMGB1 
respectively. Nuclei were counterstained with Hoechst 33342.  
 
 
 
 
 
 
 
 
Figure A.15: Control hearts showing a weak and homogeneously distributed LC-3 FITC signal 
(green), indicative for myocardial baseline autophagic activity. 
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Figure A.16: Fluorescence micrographs showing 
submitted to 10, 20 and 30 min global ischaemia. 
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Figure A.17: Micrographs showing hearts submitted to 10, 20 and 30 min global ischaemia 
followed by reperfusion. 
and more prominent at 30 min SI and SI/R, indicative for regions where autophagic activ
has been increased. Note the patch
lining of endo- and epicardium. 
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Figure A.18: Control hearts showing a weak and evenly distributed cleaved PARP TexRed signal 
(red).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure A.19: Fluorescence micrographs showing 
submitted to 10, 20 and 30 min global ischaemia. 
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Figure A.20: Fluorescence
ischaemia followed by reperfusion. 
TexRed (red) primarily at 30 min SI and SI/R, indicative for regions where apoptosis has been 
executed.  
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Figure A.21: Control hearts showing a weak and evenly distributed HMGB1 FITC signal 
(green).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure A.22: Fluorescence micrographs showing 
submitted to 10, 20 and 30 min global ischaemia. 
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Figure A.23: Fluorescence
global ischaemia followed by reperfusion.
HMGB1 FITC (green) at 20 and 30 min SI and  SI/R, indicative for regions where HMGB1 
been released. Note the lining of endo
The above preliminary results indicate that autophagy (LC
apoptosis (PARP-positive areas) and necrosis (HMGB1positive areas) appear to 
be concomitantly induced in the heart exposed to global ischaemia. More work is 
needed to correlate su
these regions.    
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